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The use of pharmaceutical products has steadily increased in the United States from 2 
billion prescriptions in 1999 to 3.9 billion in 2009. Half of patients do not comply with 
the recommended prescription regimen and dispose of unused drugs in the environment. 
The U.S. Environmental Protection Agency and many researchers have highlighted the 
human-health risks associated with improperly disposing of pharmaceutical products. 
This quantitative cross-sectional study examined the potential correlations between 
people’s actual disposal practices and their knowledge of the impact of disposal practices 
on the environment and human health, and availability of disposal options. The 
conceptual framework selected for this study comprised 2 models: the health belief model 
and the theory of planned behavior. Respondents to an online survey were 485 residents 
of the northeast United States, polled from the general population. Descriptive statistics 
and logistic regression were used to model responses from the dependent variable actual 
disposal practice (ADP) across the independent variables, and analysis of variance 
explored whether ADP differed across demographic variables. Statistically significant 
associations emerged among individuals’ knowledge of environment and human-health 
impact, recommended disposal practices, disposal options, and that person’s likelihood to 
practice recommended disposal. Demographic variables did not impact disposal behavior. 
To promote positive social change, it is recommended that policymakers plan and 
implement the expansion of convenient drug disposal options, as well as information 
campaigns on proper disposal practices. In parallel, health care professionals should 
stress to their patients the importance of complying with prescribed regimens, thus 
minimizing the amount of unused or expired medications.
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This dissertation is dedicated to those people who feel there is an unequivocal 
need to restore the ecological balance of our planet. Humans need to make it a goal to 
support the health of the myriads of ecosystems that make up our planet’s global health. 
Proper disposal of pharmaceutical products in the environment requires a social-change 
approach at different levels, as well as strong dedication from all involved. 
Although the topic of this dissertation may be viewed as a minuscule contribution 
toward our planet’s global health, its recommendations, if implemented, could still 
provide meaningful improvements. 
This dissertation is also dedicated to those people who, for whatever reason, are 
not yet seeing the “big picture”: the one where humans, animals, skies, oceans, the flora, 
and all their related ecosystems contribute to “global health.” It is my hope that this 
dissertation will at least inspire these people to ask questions, demand answers, and 
further develop their own awareness. 
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Chapter 1: Introduction 
For more than a century, indispensable elements of human and veterinary 
medicine—pharmaceutical agents—have been entering the natural environment (de 
Cazes, Abejou, Belleville, & Sanchez-Marcano, 2014). Notably, it was in the United 
States that investigators first discovered evidence of the active ingredients of 
pharmaceutical drugs in water, revealing the presence of analgesics, heart medications, 
and contraceptive drugs in wastewater (World Health Organization [WHO], 2011). These 
early studies (Garrison, Pope, & Allen, 1976; Hignite & Azarnoff, 1977; Tabak & Bunch, 
1970), published in the 1970s, spurred ongoing domestic and international research, 
documenting in detail not only the presence of pharmaceuticals in the environment, but 
also their adverse effects on organic life. In fact, even miniscule concentrations of 
pharmaceutical ingredients have been implicated in abnormalities found in fish 
populations (Corcoran, Winter, & Tyler, 2010; Ortner & McCullagh, 2010). Beyond the 
adverse effects on aquatic life, recent ecotoxicity studies, with more sensitive analytical 
techniques, have demonstrated that pharmaceutical pollutants are capable of affecting the 
growth, reproduction, and behavior of birds, invertebrates, plants, and bacteria, even at 
very low levels of concentrations (de Cazes et al., 2014). Directly connected with food 
and drinking water, trace concentrations in soils present a hazard to human health (de 
Cazes et al., 2014). Moreover, the levels of pharmaceuticals in soils and sediments tend 
to exceed concentrations detected in water (Fatta-Kassinos, Meric, & Nikoalaou, 2011). 
Pharmaceuticals differ from other environmental pollutants in that they are 
created to be biologically active and will interact with cell tissue following specific 
absorption, distribution, metabolism, and excretion properties (Fatta-Kassinos et al., 
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2011). These properties can be beneficial at the prescribed dose, but they can have 
adverse effects when dispersed into the environment or in uncontrolled concentrations, as 
is the case when the drugs are flushed down the toilet or drained into the sink. 
Furthermore, to boost their intended action, pharmaceuticals are designed to resist 
biodegradation. Many drugs are extraordinarily potent. Oral chemotherapy agents, for 
example, represent the new generation of cancer treatments (Lester, 2012). From a 
consumer perspective, one of the many advantages of these drugs is that they allow 
patients the convenience and comfort of taking their medication at home. At the same 
time, the increasing presence of powerful pharmaceutical agents in U.S. homes 
underscores concerns regarding safe and proper disposal. 
The use of prescription drugs in the United States has been labeled an epidemic 
(Maxwell, 2011). In the course of a decade, from 1999 to 2009, the number of drug 
prescriptions nearly doubled from 2 billion to 3.9 billion (Tong, Peake, & Braund, 2011). 
In addition, most households contain over-the-counter (OTC) prescription drugs, such as 
nonsteroidal anti-inflammatory drugs (NSAIDs), the most widely used drug class, which 
includes aspirin and ibuprofen. These drugs have the potential to cause kidney damage; 
kidney failure has been observed in animals exposed to NSAIDs in water (Ortner & 
McCullough, 2010). Tetracycline, a common antibiotic, was one of the first drugs 
discovered in water (Zhang, Zhang, & Fang, 2009). Significantly, the growth of 
tetracycline-resistant bacteria has been reported ever since. Hundreds of antibiotic 
resistant genes (ARGs) associated with resistance to a wide range of antibiotics have 
been detected in wastewaters, wastewater treatment plants, surface water, ground water, 
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and drinking water (Fatta-Kassinos et al., 2011). All carry the potential to be transferred 
to humans through direct and indirect contact. 
For decades, recommendations by researchers and international and U.S. health 
organizations for disposing of unused or expired medications were guided by concerns 
about inadvertent or intentional poisoning. Flushing them down the toilet or rinsing them 
down the drain was considered the safest and simplest way to dispose of unwanted drugs 
(McCullagh, Schim, & Ortner, 2012; Ortner & McCullagh, 2010). Given increasing 
awareness of the consequences of pollution from pharmaceuticals on the environment 
and its potential effects on human health, numerous international and government bodies 
recommend adopting strategies to minimize the amount of pharmaceuticals that enter the 
natural environment (WHO, 2011). Unfortunately, these recommendations have left the 
timeline for implementing the policies and the funding for providing consumers with safe 
disposal options to the respective governments. These strategies include drug take-back 
programs, guidelines and regulations, increased public awareness, and consumer 
education aimed at promoting the proper disposal of unused, unwanted, and expired 
medications. All take-back programs in the United States are administered by the Drug 
Enforcement Administration (DEA), which provides the destruction of the drugs through 
incineration. 
According to Nisbet and Gick (2008), who envisioned a key role for health 
psychology in environmental protection, people generally desire a “safe, healthy 
environment” (p. 296). However, the concept of a safe, healthy environment is fairly 
abstract and, as a result, many people do not comprehend or do not link the issue of 
problems in the environment with the potential impact on human health. Moreover, even 
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public-awareness campaigns designed to educate consumers about the impact of their 
behavior on the environment do not necessarily result in behavior change. A long history 
of public health campaigns has failed to produce the desired results, especially in 
changing behaviors that are deeply entrenched. Most consumers are so accustomed to 
disposing of drugs in the sink or toilet that they may not question their behavior, despite 
health and environmental concerns. Even nurses, pharmacists, and other health care staff 
who are highly aware of proper and improper disposal practices dispose of unused 
pharmaceuticals in the toilet or drain (Abahussain, Waheedi, & Koshy, 2012; McCullagh 
et al., 2012; U.S. Environmental Protection Agency [EPA], 2010). 
A critical flaw in many public health and awareness campaigns is that they 
underestimate the complex array of factors that underlie human behavior (Nisbet & Gick, 
2008). It has become a cliché in health and behavioral psychology that education is 
essential but not sufficient to effectively change people’s behavior. In 2008, the White 
House Office of National Drug Control Policy (ONDCP) presented the first federal 
guidelines for the disposal of prescription drugs by consumers and health professionals 
(McCullagh et al., 2012). Initially, regulations governing transportation of controlled 
substances posed an obstacle to the return of consumer drugs for proper disposal. In 
2009, the DEA conducted a public-opinion survey to get input on developing a safe 
disposal policy, which led to the Secure and Responsible Drug Disposal Act of 2010 and 
the Safe Drug Disposal Act of 2010, paving the way for drug take-back programs that 
allow for the return of controlled and uncontrolled substances (Fass, 2011). 
In February 2016, Walgreens launched the first national initiative to promote 
proper drug disposal by a pharmacy retail chain by installing safe medication disposal 
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kiosks in more than 500 locations, mostly in stores, open 24 hours daily (Walgreens, 
2017). This pioneering effort, which began in California, encompassed drugstores in 39 
states and the District of Columbia and was scheduled to be completed by end of 2016. 
As of September 2017, Walgreen has installed disposal kiosks in more than 600 
pharmacies across 45 states. 
The purpose of this quantitative cross-sectional study was to examine knowledge 
and behavior regarding drug disposal practices in a sample of residents in the northeast 
United States. Specifically, I examined people’s disposal practices, local availability of 
disposal options, awareness of proper disposal practices, and the potential correlations 
between people’s actual disposal practices and their knowledge of the impact that 
disposal practices may have on the environment and human health. 
I started Chapter 1 with a high-level overview of the issue around drug disposal, 
and why it is a relevant and important topic to be studied within the realm of public 
health; I also introduce the research gaps, the conceptual framework, research questions 
and hypotheses, study design and sampling approach, data analysis plan, overview of the 
literature, and limitations of the study. 
The scholarly literature has a glaring gap regarding the pharmaceutical disposal 
practices of the general population. Although drug take-back programs date back to the 
mid-2000s when they were recommended by the federal government, they inspired few 
empirical studies. The program “Safe Medication for ME” was implemented in the State 
of Maine in response to excessively high rates of deaths from prescription drug 
overdoses, and has been hailed as a model program for drug disposal (Ruhoy & Kaye, 
2010). This unique program, which initially ran in conjunction with DEA take-back 
6 
 
events, allowed people to anonymously return controlled and uncontrolled substances 
free of charge, through the mail. The program is currently under the direction of the 
University of Maine Center on Aging; consumers can obtain prepaid, tamper-resistant 
envelopes from community distributors, including pharmacies, medical offices, 
community organizations, police departments, hospice, and other sites located throughout 
the state. Each envelope includes explicit instructions for safely packaging and mailing 
pharmaceuticals of various types. 
Although advocates of the Maine program often point to the ease of returning 
drugs through the mail as its defining characteristic, according to Ruhoy and Kaye 
(2010), the most notable feature is that the program systematically gathers data in a 
database on the returned medications. The first published study of the Maine Prescription 
Monitoring Program focused on detailed information on the types and amounts of drugs 
returned through six DEA take-back events (Stewart et al., 2015). However, the Ruhoy 
and Kaye study did not provide information on participants’ attitudes toward the 
program, or their motivations to take part in it. Only two studies of take-back events 
surveyed participants, one covering 11 take-back events in the rural Appalachian region 
of northeast Tennessee and southwest Virginia (Gray & Hagemeier, 2012), and one 
involving 11 take-back events in Hawaii (Ma, Batz, Juarez, & Ladeo, 2014). 
As drug take-back programs become more prevalent, it is likely more studies will 
query feedback to help improve such programs. However, research is still limited in 
disclosing relationships between consumers’ knowledge, attitudes, and behaviors, in that 
such knowledge involves only those individuals who have actively made the decision to 
avail themselves of safe medication disposal options. A dearth of research explores the 
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drug disposal habits of the general public; in fact, studies of pharmaceutical disposal 
practices tend to focus on nurses (McCullagh et al., 2012), pharmacists (Abahussain et 
al., 2012), or Veterans Affairs (VA) hospital outpatients (Seehusen & Edwards, 2006; 
Trovato & Tuttle, 2014). In view of this gap in the literature, it was necessary to 
extrapolate from the research on recycling to gain insight on consumer knowledge, 
attitudes, and behaviors related to environmental protection (Best & Mayerl, 2013; 
Culiberg, 2014; Nigbur, Lyons, & Uzzell, 2010; Pearson, Dawson, & Breitkopf, 2012; 
Seacat & Northup, 2010; White, Smith, Terry, Greenslade, & McKimmie, 2009). 
The framework selected to guide this study comprised two models: the health 
belief model (HBM) and the theory of planned behavior (TPB). Despite parallels between 
health and environmental behavior, the fields of health promotion and health behavior 
change are rarely applied to environmental issues (Nisbet & Gick, 2008). Environmental 
behavior is multifactorial, and consequently, I considered more than one model to address 
the complexity of this environment–human health-related issue. By surveying members 
of the general public on their attitudes and behaviors related to disposal of 
pharmaceuticals, I was able to address the knowledge gap on this significant public health 
and environmental issue. 
Problem Statement 
Guided by recommendations from poison-control centers, or only by 
convenience, health professionals and consumers alike have customarily disposed of 
unused pharmaceuticals into the public water system by flushing them down the toilet or 
rinsing them down the drain (McCullagh et al., 2012; Ortner & McCullagh, 2010). This 
practice was standard until the discovery of measurable amounts of pharmaceutical 
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chemicals in water triggered alarm about the consequences of pharmaceutical pollution in 
the environment, and its potential effects on human health (Blair, Crago, Hedman, & 
Klaper, 2013; Fatta-Kassinos et al., 2011; Kotchen, Kallaos, Wheeler, Wong, & Zahller, 
2009; A. Kumar, Chang, & Xagoraraki, 2010; Musson, Townsend, Seaburg, & Mousa, 
2007; Nikoalaou, Meric, & Fatta, 2007; WHO, 2011). In the United States, this situation 
is magnified by the sheer number of prescriptions given to consumers, coupled with poor 
medication adherence, which increases the amount of unused and expired drugs in the 
home (Daughton & Ruhoy, 2013). 
The first federal guidelines for prescription-drug disposal were issued in 2007, 
providing consumers with a list of options for disposing of medications (Ortner & 
McCullagh, 2010; Ruhoy & Daughton, 2008). In 2010, the ONDCP announced that the 
guidelines for individual medication disposal had been replaced by official take-back 
days. At the same time, challenges existed in the widespread implementation and 
availability of take-back programs (Fain & Alexander, 2014). Of the options cited in the 
original guidelines, the U.S. Food and Drug Administration (FDA) continues to 
recommend consumers to mix unused drugs with unpalatable substances and place the 
mixture in sealed containers as a safe disposal technique (FDA, 2011); this process 
renders the drugs unusable to those for whom they were not prescribed, but the impact 
that these mixtures could have on the environment when placed in a landfill is unknown. 
The guidelines explicitly state that drugs should not be flushed down the toilet unless the 
instructions specifically say to do so, which the FDA recommends for a small number of 
drugs that could be “especially harmful and, in some cases, fatal with just one dose if 
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they are used by someone other than the person for whom the medicine was prescribed, 
as, for example, fentanyl patches for pain” (FDA, 2017, para 11). 
The few studies of drug take-back events suggest they are well-received by 
community members (Gray & Hagemeier, 2012; Ma et al., 2014). However, no recent 
studies explored the knowledge of community members on human health as the 
consequence of pharmaceutical disposal in the environment, general disposal practices, 
and the potential relationship that may exist between people’s knowledge of the disposal 
options and their actual disposal practices. I designed my study to help address that gap. 
Purpose of the Study 
The purpose of this quantitative cross-sectional study was to investigate consumer 
knowledge of the environmental and human-health impact of pharmaceutical disposal, 
knowledge of recommended disposal practices, and actual practices for disposing of 
unwanted, unused, and expired drugs. According to research using the HBM across 
numerous studies and types of behaviors, perceived barriers are the decisive factor in 
adopting health-related behaviors (Strecher & Rosenstock, 1997). In view of this 
predisposition, I also examined the relationship of locally available disposal options to 
consumers’ actual disposal practices. 
The sample for this study consisted of adults (aged 18 years or older) who were 
residents of the northeast United States and had taken a prescription drug in the past 2 
years. A questionnaire designed for this study was administered via the Internet. The U.S. 
Census Bureau (n.d.) defined the northeast region as comprising nine states: Connecticut, 
Maine, Massachusetts, New Hampshire, Rhode Island, Vermont, New Jersey, New York, 
and Pennsylvania. As of 2013, the estimated size of this population was approximately 56 
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million residents. Findings from this study intend to provide insights on the hypothesized 
associations between disposal practices and knowledge, attitudes, and disposal options. 
This study contributes to increasing overall knowledge on pharmaceutical product 
disposal processes and helps identify key factors that may promote or inhibit safe 
disposal practices in the target population. The results of the study may create momentum 
for the future development of strategies that will promote positive social change and 
additional research opportunities. A change of behavior in disposal practices will 
translate into a reduction of the toxic substances released into the environment, 
minimizing the negative impact on human health. 
Significance of the Study 
Compelling evidence suggests that pharmaceutical substances often accumulate in 
one’s home due to various disposal habits. For example, some patients may stop the full 
course of their medication regimen because they experience changes in symptoms or 
dosage requirements, or they may begin to feel better. In aggregate, these behaviors 
become a threat to the environment and ultimately impact public health. Research 
detecting the presence of pharmaceuticals in waters began in the 1970s, gaining 
momentum during the next 3 decades (WHO, 2011). The most widely cited work in the 
scholarly literature on the presence of drugs in surface water involves a study conducted 
by the U.S. Geological Survey in 1999 and 2000 that discovered more than 50 
pharmaceuticals in 139 streams across 30 U.S. states. An alarming 80% of the streams 
explored yielded at least one contaminant, with an average of seven contaminants per 
stream (Ortner & McCullagh, 2010). Nearly a decade later, a 2008 report entitled 
PharmaWater I described the findings of an Associated Press (AP) Investigative Team, 
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disclosing that at least 41 million Americans are served by water supplies with evidence 
of pharmaceuticals including anticonvulsants, antibiotics, mood stabilizers, and hormones 
(Ortner & McCullagh, 2010). 
Studies conducted in Europe produced comparable results. In Germany, for 
example, a research synthesis documented the presence of cholesterol medications, 
analgesics, and anticonvulsants in groundwater and surface water (Ortner & McCullagh, 
2010). Researchers from the United States and the United Kingdom reported that 
treatment plants were not completely effective in removing active pharmaceutical agents 
from treated water. In fact, a major concern is that conventional treatment plants are not 
equipped to completely remove micropollutants such as pharmaceuticals from 
wastewaters (de Cazes et al., 2014; Fatta-Kassinos et al., 2011; Milic et al., 2013; Uslu, 
Jasim, Arval, Bewta, & Biswas, 2013; WHO, 2011). Moreover, even the most advanced 
and expensive treatment techniques leave detectable traces of pharmaceuticals (Li, Shi, 
Lik, Zhang, & Gan, 2014). 
The United States lags behind many other developed countries in establishing 
formal guidelines and policies for the safe disposal of pharmaceuticals. Countries such as 
Australia, France, Sweden, Portugal, Spain, New Zealand, and the United Kingdom have 
had formal programs for collecting unused medications for quite some time (Ruhoy & 
Daughton, 2008). A study conducted by Health Canada (2009) compared the status of the 
recommended disposal practices across the European Union and member states to 
establish a benchmark against which to compare those established in Canada. For 
example, the report illustrated that Sweden has one of the most successful programs for 
the proper disposal of pharmaceuticals (Health Canada, 2009). Apoteket B is the 
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Swedish, government-owned pharmacy chain that oversees an environmental program 
driven by targeted public-awareness campaigns to educate the public about the harmful 
effects of flushing drugs down the drain or throwing them into the trash. In response, 
more than 70% of Swedish consumers return unused drugs to the pharmacy (Health 
Canada, 2009). Another reported example is in Spain, where the Spain Integrated Waste 
Management System also conducts intensive public-awareness campaigns, successfully 
generating large volumes of returned medications (Health Canada, 2009). From a 
broader, global perspective, it is important to acknowledge that global awareness of the 
issue of drug disposal has increased. For example, Pfizer, one of the largest 
pharmaceutical companies, has addressed the issue of proper drug disposal (Pfizer, 2017), 
and Asian countries, such as Japan (Nagaizumi Town, 2014) and India (Udupa, 
Muragundi, Nagappa, & Janodia, 2013), have either implemented or are in the process of 
finalizing drug disposal recommendations and the infrastructure to support them. 
It seems evident that national policies and programs facilitate successful drug 
return programs; in the case of Sweden, through a unique retail-pharmacy system 
organized into a single government-owned chain (Health Canada, 2009). In contrast, 
disposing of unused drugs in the United States has historically been complicated by 
contradictory regulations from various agencies and legal regulations on controlled 
substances that, even with DEA involvement, continue to result in conflict with state laws 
(Ortner & McCullagh, 2010; Ruhoy & Kaye, 2010). The federal government has 
advocated for drug take-back programs as the gold standard for safe drug disposal since 
2010, but these programs often take the form of occasional one-day or weekend events. 
Thus far, only the Maine Prescription Monitoring Program has produced evidence of a 
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successful, ongoing statewide effort to encourage consumers to return unused and expired 
drugs (Stewart et al., 2015). 
After years of disposing of pharmaceuticals into the drain or toilet, which may 
seem the most convenient method of disposing of unused drugs, gathering unused or 
expired drugs and taking them to a designated location for proper disposal, or even 
mixing the drugs with unappetizing substances (e.g., coffee grounds or cat litter as the 
FDA [2011] recommended), represents a radical change of behavior. Frameworks such as 
the HBM and the TPB have been applied to understand what motivates or inhibits health-
related behavior change (Nisbet & Gick, 2008) in drug disposal practices. Pharmaceutical 
disposal differs from changing behaviors related to health issues that may present an 
immediate threat to the individual, such as obesity or cardiovascular risk. However, 
empirical research into recycling behavior demonstrates that behavior-change models can 
be effectively applied to environmental protection. Improper disposal of pharmaceuticals 
threatens the environment and human health (Fatta-Kassinos et al., 2011). 
A review of the literature has shown a lack of research in exploring the 
knowledge, attitudes, and behavior of the general public toward the proper disposal of 
pharmaceuticals. Given this gap, limited evidence exists on the success of campaigns to 
promote proper disposal and, thus, no empirical foundation exists to design successful 
public-awareness and education campaigns or improve those that exist. Findings from 
this study provide valuable insight into disposal practices, and the factors that motivate 
individuals to properly dispose of unused and expired medications or, alternatively, what 
inhibits them from doing so. The ultimate goal of this study is to create momentum for 
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the future development of strategies that will promote social change, reducing the impact 
on human health from toxic substances that are released in the environment. 
With the advent of programs such as Walgreens’ (2016) initiative to provide local 
disposal kiosks available 24 hours a day, residents in communities across most of the 
United States will have greater access to a convenient disposal option. However, a large 
body of health-psychology research demonstrates that subjective perceptions, rather than 
structural barriers or knowledge per se, play a pivotal role in changing health-related 
behavior, especially when it is deeply ingrained (Nisbet & Gick, 2008). Findings from 
this study are significant for public health officials and health professionals who advocate 
the safe and proper disposal of pharmaceuticals. In particular, this information should be 
useful to health professionals (e.g., nurses, pharmacists) who are at the forefront of 
patient education on the safe administration, storage, and disposal of pharmaceutical 
products. Above all, these findings may guide the development of strategies that improve 
public awareness (e.g., public health promotion campaigns and local community 
programs to educate consumers on proper disposal of pharmaceuticals) as well as the 
availability of flexible and convenient options for disposing of pharmaceutical products. 
Theoretical Framework 
Environmental behavior is multifactorial; consequently, I considered two 
conceptual models for behavior change: the HBM and the TPB. I deemed the TPB most 
relevant to the issue of proper pharmaceutical disposal from the perspective of the 
motivation that results into the intention to perform an action or behavior. Will 
motivation be triggered by the consumers’ knowledge or perceptions of disposal practices 
and their impact on human health? Will motivation be triggered by the information 
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received, if any, on disposal recommended practices? Will both factors motivate 
consumers and to what degree? The key aim of this study was to examine these research 
objectives. 
The HBM aligns with studies that involve recycling and environmental 
protection. Strecher and Rosenstock (1997) discussed how perceived barriers were the 
decisive factor in adopting health-related behaviors. Consequently, one objective of this 
study was to examine the degree to which the availability and convenience to reach and 
use locally available disposal options may impact consumers’ actual disposal practices. 
Despite extensive interest by the public in protecting the environment and 
improving personal health, many public health campaigns fail to generate changes in 
peoples’ behavior. A critical reason for this perennial problem is that program designers 
and policymakers fail to recognize marked discrepancies among attitudes toward health, 
the environment, and related behavior (Nisbet & Gick, 2008). Virtually all guidelines, 
reports, policy and position papers, and standards issued by government agencies, 
international bodies, and professional associations stress the importance of consumer and 
patient education in the safe use and disposal of medications. Education is an essential 
prerequisite; however, information, per se, is notoriously ineffective in altering human 
behavior, especially when it is deeply entrenched. 
Campaigns designed to inspire healthy and proenvironmental behavior are 
typically “information-intensive” on the assumption “that once people are informed they 
will act differently” (Nisbet & Gick, 2008, p. 297). The failure of a myriad of public 
health programs to produce the desired effects underscores the misguided nature of that 
approach. Indeed, the development of the HBM in the 1950s arose from the poor 
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response to public health campaigns to promote disease screening (Strecher & 
Rosenstock, 1997). 
Building on detailed analyses of probability samples of adults in cities that offered 
tuberculosis screening, Hochbaum identified the beliefs that underpin the HBM: 
perceived susceptibility and perceived benefits of action (Strecher & Rosenstock, 1997). 
Hochbaum also recognized the role of intrinsic and extrinsic cues or triggers in 
motivating people to act. Decades later, the HBM has been refined and expanded and has 
a firm empirical base (Strecher & Rosenstock, 1997). The model includes several 
essential components. Perceived susceptibility refers to an individual’s subjective 
perception of experiencing a health or medical condition. This dimension encompasses 
susceptibility to illness in general in addition to vulnerability to a specific condition. 
Perceived severity is a related factor, denoting the seriousness of experiencing the 
condition or allowing it to remain untreated or unaddressed. This aspect includes medical 
consequences (pain, disability, and death) and social consequences (such as the impact of 
the condition on work and social relationships). In conjunction, perceived susceptibility 
and perceived severity produce perceived threat. 
Although acceptance of a perceived personal threat is a prerequisite for taking 
action, the specific course of action an individual chooses to take rests on the perceived 
benefits of the available options (Strecher & Rosenstock, 1997). Bringing unused and 
expired drugs to a take-back event or disposal center neutralizes the potential hazard to 
people and pets and does not contribute to environmental pollution. Beyond the practical 
benefit, this action might produce the intrinsic reward of believing one has done the right 
thing. A drug take-back event can offer an opportunity for socializing with friends or 
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neighbors or meeting others in the local community. For young people in particular, peer 
pressure to engage in environmentally friendly behavior might influence drug disposal 
practices. 
Despite awareness of the potential benefits of a given health behavior or 
behaviors, perceived barriers serve as obstacles to the recommended course of action. In 
a comprehensive research review of the HBM, perceived barriers emerged as the single 
most important factor in health behaviors across all studies and behaviors (Strecher & 
Rosenstock, 1997). For preventive behaviors, perceived susceptibility and perceived 
barriers are the best predictors of behavior, whereas for behavior related to a current 
health problem (such as adhering to medication), perceived severity and perceived 
barriers are most significant (Nisbet & Gick, 2008). Notably, poor medication adherence 
is a key contributor to pharmaceutical pollution (Daughton & Ruhoy, 2013). Although it 
is not the focus of this study, it is possible that efforts to promote the proper disposal of 
pharmaceuticals may have the additional benefit of improving consumers’ adherence to 
their prescribed medications. 
The TPB is an extension of Ajzen and Fishbein’s theory of reasoned action (TRA) 
(Ajzen & Madden, 1986). The TPB and TRA models hinge on intention; that is, the 
immediate antecedent of any action is the person’s intention to perform it. According to 
the TRA, two key determinants of intention are attitude toward the behavior and 
subjective norm, representing an individual and a social factor, respectively. The TRA 
also addresses the antecedents of these two factors. Behavioral beliefs are presumed to 
influence attitudes toward a behavior, whereas normative beliefs underpin subjective 
norms. Cote, Gagnon, Houme, Ben Abdeljelil, and Gagnon (2012) included moral norms 
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in their research model, and they identified this attribute in nurse intentions when 
performing their duties in caring for patients; in their study, these researchers identified 
moral norms as the strongest predictive factor in drug disposal behavior. This finding 
may be valuable in explaining nurse decisions to dispose of unused medications. Moral 
and ethical perspectives may be especially useful for examining behavior related to 
environmental protection. 
Researchers have also used the TPB model to examine behavior in organizations. 
Sanchez-Medina, Romero-Quintero, and Sosa-Cabrera (2014) applied the TPB to the 
study of environmental measures taken by managers of small and midsized firms. Waste 
disposal was one of the practices they investigated. 
Studies by Culiberg (2014), Nigbur et al. (2010), White et al. (2009), and 
Sanchez-Medina et al. (2014) added to a small but growing body of research using the 
TPB as a framework to investigate behaviors related to environmental protection. Most 
studies in this line of research focus on recycling behavior (Nisbet & Gick, 2008). In their 
review of this research, Nisbet and Gick (2008) found that, on the whole, intentions to 
recycle arise from positive attitudes toward recycling and that “people feel their own 
contribution is important” (p. 298). 
Cues to action are important factors in health behaviors but have not been 
systematically investigated (Strecher & Rosenstock, 1997). In general, it is difficult to 
quantify cues because they are often subtle. In addition, they rest markedly on individual 
perceptions. 
The HBM has been applied to a wide range of health behaviors, including cancer 
screening, sunscreen use, dental hygiene, medication adherence, and HIV risk behaviors 
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(Nisbet & Gick, 2008). Nisbet and Gick (2008) found only one published study in which 
the HBM was applied to behaviors related to environmental protection, specifically 
recycling. Given that improper disposal of pharmaceuticals may adversely affect personal 
health as well as the natural environment, the HBM was useful in helping understand the 
connection between the more abstract threat (environmental pollution) and the more 
proximal threat (personal health) in consumers’ adherence to recommendations for proper 
disposal of medications. The TPB model complemented the HBM by providing a broader 
perspective on attitude toward the behavior and subjective and moral norms, which were 
useful in exploring the possible rationale for why people do what the accepted social 
norms indicate, such as bringing unused drugs to a take-back event or disposal site. 
Background of the Study 
It seems ironic that the same substances that have been helping people live longer 
and healthier lives are polluting our natural environment and posing a threat to the future 
of human health. Virtually all classes of drugs have been detected in the environment. 
Abundant evidence shows that medications containing estrogens, such as contraceptives 
and hormone-replacement therapy, antidepressants, and antibiotics, all link to 
abnormalities in aquatic life (Corcoran et al., 2010; Ortner & McCullagh, 2010). The 
phenomenon now known as endocrine disruption was first identified in the 1970s, when 
zoologist and former pharmacist Theo Colbern presented evidence derived from hundreds 
of studies examining how pollution impacted wildlife in the Great Lakes (Ortner & 
McCullagh, 2010). The detrimental effects of estrogens on fish populations are probably 
the most heavily documented consequences of pharmaceutical pollution (Corcoran et al., 
2010; Ortner & McCullagh, 2010). These numerous adverse effects include changes in 
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mitochondrial activity, energy metabolism, and cell-cycle regulation, as well as the 
feminization of male fish and the development of genital abnormalities. In some cases, 
entire fish colonies have collapsed due to reproductive failure (Ortner & McCullagh, 
2010). 
Anti-infectives refer to several bioactive compounds with the ability to inhibit the 
growth or survival of microorganisms without harming the host (Segura, François, 
Gagnon, & Sauvé, 2009). This category includes some antifungal agents and synthetic 
drugs, as well as antibiotics, which have become a key focus in the literature on 
pharmaceutical pollution due to the presence of ARGs found in water supplies, soils, and 
sediments, and their potentially harmful impact on human health (Fatta-Kassinos et al., 
2011; Marti, Jofre, & Balcazar, 2013; Milic et al., 2013; Uslu et al., 2013; Zhang et al., 
2009). ARGs can be transferred to humans from the environment through direct and 
indirect contact, and miniscule levels of antibiotics may act as “signaling agents in 
microbial environments” (Fatta-Kassinos et al., 2011, p. 228) to various plants equipped 
with receptors for antibiotics and disinfectants. 
Adding to the prospective threat presented by ARGs in the environment, these 
microorganisms are also resistant to wastewater treatment (de Cazes et al., 2014; Milic et 
al., 2013; Zhang et al., 2009). Technological advances have enabled researchers to detect 
increasingly smaller traces of pharmaceuticals in the natural environment, but the 
techniques for removing them have not kept up and are inadequate. As Segura et al. 
(2009) observed, “Anti-infectives, the miracle drugs of the 20th century have become 
environmental contaminants of emerging concern in the 21st century” (p. 682). 
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Pharmaceuticals enter the environment through various pathways. Manufacturing 
and agriculture unquestionably play a prominent role. Through individual drug 
consumers, household pharmaceuticals enter the environment in three ways. The first is 
through natural excretion, as only a fraction of medication, whether ingested, injected, or 
infused, is metabolized by the body (Daughton & Ruhoy, 2013; Harvard Health, 2011; 
Ortner & McCullagh, 2010; Rodriguez-Mozaz & Weinberg, 2010; Ruhoy & Daughton, 
2008). The unmetabolized compound and its metabolites are excreted in urine and feces, 
and to a lesser extent, perspiration. A second pathway is the removal of topical products 
while bathing. The third pathway, which is the focus of this research project, is the 
disposal of unused, unwanted, and expired medications. 
At the same time, the three routes of environmental pollution are interrelated. The 
terms upstream and downstream have been used to describe two approaches to reducing 
the amount of presence of pharmaceuticals in the environment (Daughton, 2014a). The 
upstream approach concentrates on minimizing the amount and toxicity that a given 
pharmaceutical product would release when discarded in the environment. Also called 
“green pharmacy” or “eco-friendly pharmacy,” this approach starts by designing drugs 
with maximum absorption potential, such that smaller traces are excreted. For drugs 
currently on the market, an upstream approach involves limiting overprescribing, 
curtailing aggressive drug marketing, and improving patient adherence to the prescribed 
drug regimen (Daughton & Ruhoy, 2013; Ruhoy & Daughton, 2008; Ruhoy & Kaye, 
2010). Diligent monitoring of drugs released in the environment is another element of the 
upstream approach (Daughton, 2014b; Ruhoy, 2009). 
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The downstream approach focuses on promoting the safe and proper disposal of 
unused, unwanted, and expired medications (Ruhoy & Daughton, 2008). This approach is 
exemplified by drug take-back programs that allow consumers to bring unused 
pharmaceuticals to a designated site where the drugs are collected and transported to be 
destroyed. According to preliminary findings, drug take-back events are successfully 
attracting people and collecting millions of tons of pharmaceutical waste for safe disposal 
(Fain & Alexander, 2014; Fass, 2011; Gray & Hagemeier, 2012; Lubick, 2010; Ma et al., 
2014; Stewart et al., 2015; Tucker, 2011). However, many drug take-back programs are 
no more than annual events. For drug return strategies to effectively reduce the massive 
amount of pharmaceutical chemicals systematically entering the natural environment, 
consumers need return sites that are readily accessible and available daily. 
Pharmacies are considered the ideal venue for returning unused medications 
(Abahussain et al., 2012; Fain & Alexander, 2014; Fass, 2011; Zimmermann, Wengler, & 
Popowski, 2011). Pharmacies are also excellent places to educate the public about proper 
medication management and disposal. However, challenges exist to the widespread 
adoption of pharmacy returns. Although providing consumers with access to receptacles 
is typically recommended and likely to be popular with the public, some pharmacies have 
raised concerns about the burdens and costs of requisite measures as well as potential 
legal liability. The effectiveness of this strategy depends on the voluntary participation of 
pharmacies, as well as adequate funding to offset the costs involved in adhering to DEA 
requirements (Fain & Alexander, 2014). With Walgreens in the lead, other large 
pharmacy chains may adopt similar programs, thereby greatly expanding the access of 
local communities to safe and convenient drug disposal options. 
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Upstream approaches may be preferable theoretically, but they do not address the 
drugs that already proliferate in household medicine cabinets. Medication take-back 
programs appear to be promising. Ultimately, their success depends on the active 
participation of stakeholders, including local pharmacies or other sites, and above all, the 
everyday consumers of prescription and OTC drugs. 
Research Questions 
This cross-sectional, quantitative study is driven by the following research 
questions: 
RQ1: Is there an association between knowledge of the environmental and the 
human-health impact of pharmaceutical disposal and actual disposal 
practices? 
RQ2: Is there an association between knowledge of recommended disposal 
practices and actual disposal practices? 
RQ3: Is there an association between available disposal options and actual 
disposal practices? 
RQ4: To what degree can actual disposal practices (the dependent variable) be 
explained by the combined and differential contribution of the three 
independent variables: knowledge of the environmental and human-health 
impact, knowledge of recommended disposal practices, and locally available 
disposal options? 





The following hypotheses derived from the research questions: 
H01: No significant association exists between knowledge of the environmental 
and the human-health impact of pharmaceutical disposal and actual disposal 
practices. 
H11: A significant association exists between knowledge of the environmental and 
the human-health impact of pharmaceutical disposal and actual disposal 
practices. 
H02: No association exists between knowledge of recommended disposal 
practices and actual disposal practices. 
H12: An association exists between knowledge of recommended disposal 
practices and actual disposal practices. 
H03: No association exists between available disposal options and actual disposal 
practices. 
H13: An association exists between available disposal options and actual disposal 
practices. 
H04: Actual disposal practices cannot be explained to a significant degree by the 
combined and differential contribution of knowledge of the environmental and 
the human-health impact, knowledge of recommended disposal practices, and 
locally available disposal options. 
H14: Actual disposal practices can be explained to a significant degree by the 
combined and differential contribution of knowledge of the environmental and 
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the human-health impact, knowledge of recommended disposal practices, and 
locally available disposal options. 
H05: No significant demographic differences exist in the relationships of 
knowledge of the environmental and the human-health impact, knowledge of 
recommended disposal practices, and locally available disposal options to 
actual disposal practices. 
H15: Significant demographic differences exist in the relationships of knowledge 
of the environmental and the human-health impact, knowledge of 
recommended disposal practices, and locally available disposal options to 
actual disposal practices, when controlling by demographic variables (e.g., 
age, race, education level). 
Nature of the Study and Study Design 
Research Design 
The research design for this study was quantitative and cross-sectional. When a 
researcher’s goal is to examine associations between quantifiable and objectively 
measurable concepts, a quantitative method is appropriate (Howell, 2010). The main 
objective of this study was to investigate the hypothesized association between 
consumers’ actual disposal practices (outcome of interest/dependent variable) and the 
factors (independent variables) that may influence them. Because the variables under 
investigation are quantifiable and objectively measurable, a quantitative method was 
appropriate. Specifically, I selected a cross-sectional design because my aim was to 
examine associations between variables measured at a single point in time. 
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Typical disadvantages of using a cross-sectional design include the challenges 
associated with establishing causal inferences, and the notion that the findings represent 
the phenomenon in a specific single time and place (Pine, Pitts, & Nugent, 1997). To 
inspire social change, results from this study can be applied toward the design of health-
promotion programs that encourage optimal drug disposal practices, encourage the 
simplification of disposal options, improve patient drug compliance, and generate 
momentum for the development of drugs that are less toxic to the environment. In 
aggregate, if adopted, the aforementioned approaches could reduce the posed risks to 
human health by improper disposal of pharmaceutical products in the environment. 
Dependent and Independent Variables 
Actual disposal practices was the outcome (dependent) variable. As suggested by 
the reviewed literature, this study used the following key independent variables: (a) 
knowledge of environmental and human-health impacts, (b) knowledge of recommended 
disposal practices, and (c) availability of disposal options. Data on the outcome variable 
and the independent variables were collected using a questionnaire. 
Survey Instrument 
The contents of the survey instrument for this study were adapted from items used 
by Seehusen and Edwards (2006). Approval for the use and adaptation of the 
questionnaire was given by Dr. Seehusen and can be found in Appendix A. The final 
draft version of the questionnaire was pilot tested after Institutional Review Board (IRB) 
review and approval, following the process recommended by Radhakrishna, Francisco, 
and Baggett (2003). 
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The questionnaire consists of content questions used to measure the constructs of 
interest as well as demographic questions. The survey questionnaire was administered via 
the Internet by SurveyMonkey, an online survey service provider, using web-based, 
electronic forms for data input. Cottrell and McKenzie (2010) argued that researchers 
cannot assume that most U.S. residents would be sufficiently computer literate and have 
Internet access to complete a survey online. Within the last few years, however, Internet 
access and broadband have become so widely available that large government programs, 
such as the Affordable Care Act (U.S. Department of Health and Human Services [HHS], 
n.d.), are administered via the Internet. On the basis of these considerations, I deemed the 
online approach to be a practical and efficient medium for the administration of the 
survey questionnaire. 
The questionnaire consists of content questions used to measure the constructs of 
interest, as well as demographic questions. The first question of the survey asks, “What is 
your most used method for disposing of unused or expired medications?” Participants 
answered this question by selecting one of eight possible response options that included 
“I flush them down the toilet” and “I follow the disposal instructions that accompany the 
medicine,” among others. This question was used to measure the dependent variable: 
actual disposal practices. 
The next questions on the survey were, “In your area, is there a designated 
collection location where you can dispose of your unused or expired medication?” and 
“How convenient is it for you to reach the designated disposal location?” These questions 
represented the independent variable: available disposal options. Next, participants were 
asked, “Do you believe that improper disposal of medications in the environment could 
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have negative consequences on human health?” Participants responded to this question 
on an ordinal scale and their responses represented the independent variable: knowledge 
of environmental and the human-health impact. Participants were also asked four 
questions, which were answered on categorical and ordinal scales that assessed the 
participants’ knowledge of disposal practices. These questions were used to represent the 
independent variable: knowledge of recommended disposal practices. Finally, 
participants were asked to provide basic demographic information. Specifically, they 
were asked to report their gender, year of birth, race, highest level of education 
completed, and their state of residence. 
Questions related to knowledge and awareness were scored using a coded ordinal 
scale, as suggested by Monnin and Perneger (2002). In contrast, data from the dependent 
variable, actual disposal practices, were categorical. A dichotomous Yes/No outcome 
was used to assess and code the dependent variable. 
Population and Sample 
The sampling approach for this study was convenience sampling. A convenience-
sampling method is appropriate when a true random sample is not feasible to obtain. 
Because I was unable to randomly sample all possible residents in the northeast United 
States, a convenience sample was appropriate. Participants in this study had to meet the 
following three inclusion criteria: (a) resident of the northeast United States, (b) aged 18 
or older, and (c) having used a prescription drug in the prior 2 years. The U.S. Census 
Bureau (n.d.) defined the northeast region as comprising nine states: Connecticut, Maine, 
Massachusetts, New Hampshire, Rhode Island, Vermont, New Jersey, New York, and 
Pennsylvania. As of 2013, the estimated size of this population was approximately 56 
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million residents. Participants who met these criteria were recruited online from 
SurveyMonkey’s participant pool. The appropriate sample size was calculated using as 
input in the algorithm the following parameters: (a) population size = 55,943,073, 
corresponding to the entire northeast region (U.S. Census Bureau, n.d.), (b) confidence 
level = 95%, and (c) margin of error = 5%. The resulting sample size was 385 
(SurveyMonkey, 2016). 
Data Collection 
After obtaining IRB approval to conduct the study, I used SurveyMonkey to 
recruit participants who met the eligibility criteria of the study. The study consisted of an 
online survey hosted by SurveyMonkey. Cottrell and McKenzie (2010) argued that 
researchers could not assume that most U.S. residents would be sufficiently computer 
literate and have Internet access to complete a survey online. In recent years, however, 
Internet access and broadband have become so widely available that even large 
government programs, such as the Affordable Care Act (HHS, n.d.), are administered 
through the Internet. On the basis of these considerations, I deemed the online medium to 
be practical and efficient to administer the survey questionnaire. 
Aligned with Walden University’s IRB policy regarding participation in online 
surveys, given that participants had the option to take or ignore the survey, I had no need 
to include a separate consent form; however, the survey included a section that described 
the participants’ rights and provided contact information for Walden’s IRB and me. 
Individuals who agreed to participate after indicating they met the three inclusion criteria 
were directed to the survey. The survey was intended to be open to potential participants 
for up to 3 weeks; however, the target sample size was achieved in a much shorter time. 
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Participants received no compensation for participation in the study. At the end of the 
recruitment period, SurveyMonkey provided me with two data files on their secure server 
for download: one Excel and one SPSS-formatted file. I stored the survey data files on a 
password-protected personal computer that is only accessible to me. The data are also 
backed up on a password-protected storage medium, stored safely and securely. 
Data Analyses 
I performed all data analyses using SPSS. Prior to the analyses, and upon 
collection, I cleaned the data to ensure all records had sufficient and accurate data for 
analysis. I accomplished the data cleaning by running frequency distributions for each 
variable, ensuring the data were within the acceptable range of values. Given that the data 
were collected electronically using a web-based form that only accepts predefined input 
values, there were no values entered outside the acceptable range; however, there were 
several cases in which the survey participants had skipped some questions, and this 
resulted in fields with missing data. In addition to descriptive statistics, the key statistical 
procedures to address the research questions and test the stated hypotheses were binary 
logistic regression and analysis of variance. 
Definition of Key Terms 
The following terms are defined for the purpose of this study: 
Downstream approach: Approach to reducing the amount of pharmaceutical 
substances in the environment by promoting the safe and proper disposal of unused, 
unwanted, and expired drugs (Ruhoy & Daughton, 2008). 
Drug take-back programs: Under the auspices of the DEA, drug take-back 
programs allow consumers to return unused OTC and prescription human and pet 
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medications to specific locations equipped with receptacles for their safe disposal (Fain & 
Alexander, 2014). 
Endocrine-disrupting chemicals: Chemicals that can interfere with endocrine 
functioning to cause damage to the developmental, reproductive, neurological, and 
immune systems of human and animal life (Ortner & McCullagh, 2010). 
Green pharmacy or ecofriendly pharmacy: A key component of the upstream 
approach focuses on designing drugs with highly specific drug action and the capacity for 
maximal absorption by the body so smaller trace amounts are excreted (Daughton & 
Ruhoy, 2008). 
Nonsteroidal anti-inflammatory drugs (NSAIDs). The most widely used class of 
drugs including acetylsalicylic acid (aspirin), ibuprofen, and diclofenac; NSAIDs have 
the potential to cause kidney damage, which has been observed in animals exposed to 
NSAIDs in water (Ortner & McCullagh, 2010). 
Pharmaceuticals: Compounds manufactured for medicinal purposes, 
pharmaceuticals are distinguished from other environmental pollutants because they are 
made to be biologically active (Fatta-Kassinos et al., 2011). 
Upstream approach: A proactive approach to reducing the amount of 
pharmaceutical substances in the environment by minimizing the amount and toxicity of 
drugs with the potential to contaminate the environment, and for drugs already on the 
market, curbing overprescription, ensuring patients are prescribed the most effective 




Brief Review of the Literature 
Disposal Practices Among Nurses 
Nurses counsel and educate patients; thus, they are ideally positioned to inform 
patients about proper medication disposal procedures. However, few studies examined 
practices among nurses. McCullagh et al. (2012) examined the medication disposal 
practices and attitudes toward medication disposal of home hospice nurses. Educating 
patients and caregivers regarding how to store, manage, and dispose of medications is a 
key aspect of the  professional role of nurses. Upon a patient’s death, however, the nurse 
is often entrusted with discarding unused medications. A total of 138 home hospice 
nurses completed an online survey. Almost half of the nurses (44%) reported disposing of 
11 or more medication doses upon a patient’s death. Although close to two-thirds (64%) 
of the nurses reported always or often mixing the drugs with unpalatable substances, as 
recommended, more than half discarded them in the toilet or drain with the same 
frequency. 
The vast majority of nurses considered mixing medications with an unpleasant 
substance as acceptable (94%) and safe (91%). Striking about the study was the notable 
discrepancy between the almost unanimous endorsement of the safety and acceptability 
of mixing drugs with an undesirable substance, and the number of participants who 
regularly disposed of drugs in that manner (McCullagh et al., 2012). The nurses gave 
high priority to ensuring that drugs were not diverted, which could help to explain why 
they were inclined to dispose of medication to sewage. Nevertheless, it was clear that 
their actions were not consistent with their beliefs about how drugs should be discarded. 
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Most nurses drew their information on safe medication disposal from their own reading 
rather than from formal training in nursing school or on the job. 
Disposal Practices Among Patients 
In a unique study on the handling, storage, and disposal practices of patients 
taking anticancer drugs at home, Trovato and Tuttle (2014) surveyed 42 patients (95% 
male) being treated at a VA hospital. In the course of a year, the use of oral 
chemotherapy by outpatients increased substantially. Patients received education from 
medical, nursing, and pharmacy staff, but had no standardized practices. 
Overall,  storage practices among patients conformed to recommended guidelines 
(Trovato & Tuttle, 2014). All kept their medication away from children and pets, most 
kept the drugs free of extreme temperatures or humidity, and those who did not keep the 
drugs in the original container made use of a pill sorter to simplify adherence to the 
prescribed regimen. Few participants had unused drugs. 
The gaps between recommended practices for the safe handling and disposal of 
anticancer drugs were attributed to lack of patient education (Trovato & Tuttle, 2014). 
Close to half of the patients (45%) had not received information on safe handling and 
storage practices. Those who were informed had acquired their information from nurses 
and pharmacists, and to a lesser extent, physicians. Health professionals who counsel 
cancer patients on medication often focus primarily on administration and potential side 
effects (Trovato & Tuttle, 2014). With limited time, health professionals are likely to give 
precedence to these critical issues. However, a definite need exists for better patient 
education on the storage, handling, and disposal of anticancer drugs. The pharmacist 
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authors altered their practices in response to the survey to ensure the safe management 
and disposal of the powerful chemotherapy drugs. 
Drug Take-Back Programs 
Gray and Hagemeier (2012) examined the characteristics of rural residents who 
participated in 11 take-back events held between 2009 and 2011, and the medicines they 
brought. A total of 752 individuals returned 16,956 containers of medications prescribed 
for 1,210 patients. Participants were mostly White, on average about 40 years old, and 
women accounted for more than half of the group (57%). In descending order, the 
dominant reasons for participating were a desire to clean out their medicine cabinets 
(68%), environmental concerns associated with disposing of drugs and other waste 
materials (45%), and concerns about accidental poisoning (14%). The surveyed 
participants were those who participated in the take-back events and were therefore 
already motivated to comply with the proper disposal of expired or unused drugs. Most 
participants lived within 10 miles of the take-back site, leading to the conclusion that 
geographic distance is a consideration in people’s attendance at take-back events (Gray & 
Hagemeier, 2012). For urban and suburban residents, other issues such as time concerns 
may emerge as more relevant perceived barriers. 
Ma et al. (2014) presented the results of 11 drug take-back events held in Hawaii. 
These events were advertised in the media (television, radio, and newspapers), through 
brochures and flyers in pharmacies and medical offices, and by word of mouth. 
Participants at the 2011 Good Life Senior Expo were surveyed regarding prior 
experiences with unused or expired drugs. Most discovered the event through newspaper 
or TV advertisements. Before the take-back events, the predominant methods for 
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managing unused medications were throwing them in the trash (34%), keeping them at 
home (32%), or flushing them down the toilet (24%). Only 10% had returned 
medications to a pharmacy or medical office. Two-thirds of the participants kept unused 
medications at home for a year or longer. All participants (> 99%) wanted the take-back 
events to continue. 
The 11 events yielded 8,011 pounds of medication, primarily pills or tablets (Ma 
et al., 2014). The largest proportion was categorized as “Other” or miscellaneous. 
Antihypertensives were the next largest drug class, similar to the prevalence of 
cardiovascular drugs in the Maine take-backs (Stewart et al., 2015). Other drugs returned 
in large quantities were gastrointestinal drugs and analgesics. The most common OTC 
drugs fell into this last category: aspirin, naproxen, and ibuprofen. A substantial amount 
of pseudoephedrine was returned, used in the manufacture of methamphetamine, and one 
of the most common OTC drugs returned. Controlled substances accounted for 10% of 
the drugs. This occurrence seemed to be fairly consistent, as similar proportions of 
controlled substances were returned in Maine (Stewart et al., 2015) and Appalachia (Gray 
& Hagemeier, 2012). 
Ma et al. (2014) did not collect participant information as did Gray and 
Hagemeier (2012). However, both studies generated enthusiastic responses. As staunch 
advocates of drug take-back programs, Ma et al. called for efforts to identify prospective 
process champions and stakeholders, including consumers, government organizations, 
and “all parties involved in the medication chain of manufacturing, ordering, prescribing, 




The main assumption guiding this study was that the participants would respond 
to the questionnaire honestly and accurately. Participation was entirely voluntary, the 
survey was completed anonymously, and participants were assured of complete 
confidentiality. The anonymity of this online survey is assumed to have facilitated 
truthfulness and has reduced the potential for responses based on social desirability. 
Limitations 
Participation in this study was limited to adults residing in the northeast United 
States. This region is known for its diverse demographic composition (U.S. Census 
Bureau, n.d.). According to the 2010 U.S. Census (recounted in the U.S. Census, 2011), 
the socioeconomics characteristics of the northeast region of the United States include the 
following: 
• Median household income = $53,283, compared to the Midwest = $48,445, 
the South = $45,492, and the West = $53,142. 
• Percent in poverty level = 11.8, compared to the Midwest = 13.3, South = 
15.7, and the West = 14.8 
• Number of people without health insurance coverage = 11.8, compared to the 
Midwest = 12.7, the South = 19.2, and the West = 17.7 
These data illustrate how the northeast appears to have socioeconomic 
characteristics more favorable than those of other regions. Consequently, the 
generalization of the results of this study to the general U.S. population can be drawn 
with caution. In fact, socioeconomic characteristics such as income, employment status, 
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and health insurance coverage have been associated with health care use and interaction 
with health care professionals (Blackwell, Martinez, Gentleman, Sanmartin, & Berthelot, 
2009), and, by inference, these factors may have influenced the likelihood of receiving 
drug disposal information. 
Given the emphasis on prescription drugs in the national strategy to reduce the 
amount of pharmaceuticals in the environment, this study was restricted only to 
individuals who have used at least one prescription. However, OTC drugs, especially 
NSAIDs, are widely used, and like prescription drugs, have the potential to pollute the 
environment and present a threat to human health. Thus, this study had intrinsic 
limitations by excluding a sizable proportion of consumers of common pharmaceuticals, 
who may be less likely than those with prescription drugs to have accurate knowledge of 
recommended disposal practices. 
The use of the Internet may have also excluded those people who are unfamiliar 
or uncomfortable with this technology. In spite of optimistic figures of large diffusion of 
the use of the Internet, groups of people, due to age or financial condition, may not have 
had the opportunity to be part of the population sample. The survey was only in the 
English language; therefore, people who were not fluent in English may not have 
completed it. Consequently it is unknown what disposal practices are being used by that 
population group. 
This chapter began with an introduction to the problem area, significance of the 
study, theoretical frameworks, research questions, and study design. In Chapter 2, I 
present a review of the literature on the theoretical framework, types of drugs and their 
effects, and the evolution of policy. In Chapter 3, I provide the research design, 
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methodology of the study, and the data analysis plan. In Chapter 4, I present the results of 
the study, and Chapter 5 includes conclusions and recommendations for social change 
and future research and practices. 
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Chapter 2: Literature Review 
For decades, poison-control centers in the United States recommended disposing 
of unused or expired medications by flushing them down the toilet or rinsing them down 
the drain to prevent inadvertent or intentional poisoning (McCullagh et al., 2012; Ortner 
& McCullagh, 2010). Health professionals believed they were acting responsibly by 
disposing of drugs in the safest possible way, and few consumers would reject such a 
simple and convenient mode of disposal. However, detection of measurable amounts of 
pharmaceutical substances in water raised alarm about the consequences of pollution 
from pharmaceuticals on the environment and its potential effects on human health (Blair 
et al., 2013; Fatta-Kassinos et al., 2011; Kotchen et al., 2009; A. Kumar et al., 2010; 
Musson et al., 2007; Nikoalaou et al., 2007; WHO, 2011). 
The presence of pharmaceuticals and personal-care products as traces of 
environmental pollutants first gained attention in the 1980s (Daughton, 2003a). 
Developments in analytical techniques have allowed scientists to detect, quantify, and 
document trace amounts of pharmaceutical substances in wastewaters, sediments, 
groundwater, surface water, and even drinking water (Bound & Voulvoulis, 2005; 
Daughton, 2014b; de Cazes et al., 2014; Fatta-Kassinos et al., 2011; A. Kumar et al., 
2010; Larsson, 2014; Nikoalaou et al., 2007; Orton & McCullagh, 2010; Rodriguez-
Mozaz & Weinberg, 2010; Segura et al., 2009; Uslu et al., 2013; WHO, 2011; Zhang et 
al., 2009). Pharmaceuticals are unique among environmental pollutants in that they are 
designed to be bioactive. Numerous studies of water samples have detected antibiotics, 
anticonvulsants, analgesics, mood stabilizers, hormones, and chemotherapy agents 
(Bound & Voulvoulis, 2005; Corcoran et al., 2010; Harvard Health, 2011; McCullagh et 
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al., 2012; Ortner & McCullagh, 2010; Uslu et al., 2013). These substances have been 
linked with disruptions to aquatic life, such as genital abnormalities in fish, foot 
detachment in frogs, and, in some cases, the collapse of entire fish populations. 
In 2009, the WHO (2011) formed a working group composed of experts in the 
fields of pharmacology, toxicology, water chemistry, water quality and health, water 
treatment, and water regulation and policy. The group conducted an exhaustive and 
detailed review of the existing literature and called in additional experts to consult and 
further review scientific evidence. According to the WHO experts, trace concentrations 
of pharmaceutical substances in drinking water are low enough that they are unlikely to 
present risks to human health. At the same time, the same experts acknowledged that 
limited understanding exists of potential health risks associated with long-term exposure 
to low levels of pharmaceutical substances in drinking water or of the combined effects 
of mixtures of pharmaceutical compounds. 
Other experts raise the question of the potential effects of pharmaceutical 
exposure on sensitive populations such as pregnant women, children, elders, and 
individuals with compromised immune systems (A. Kumar et al., 2010). The discovery of 
ARGs in treated wastewater also raises the issue of whether that resistance might transfer 
to microbes capable of affecting human health (Lubick, 2011; Marti et al., 2013; Sahoo, 
Tamhankar, Johansson, & Lundborg, 2010; Segura et al., 2009; Zhang et al., 2009). 
WHO (2011) is one of many international and government bodies that 
recommend adopting strategies to minimize exposure to pharmaceuticals in water, such 
as take-back programs, guidelines and regulations, public-awareness campaigns, and 
consumer education to promote the proper disposal of unused, unwanted, and expired 
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medications and reduce the amount of pharmaceuticals that enter the environment. In 
2008, the White House ONDCP formulated the first federal guidelines for the disposal of 
prescription drugs by consumers and health professionals (McCullagh et al., 2012). 
However, regulations governing the transport of controlled substances presented a barrier 
to the return of consumer drugs for proper disposal. In 2009, the DEA solicited public 
opinion on the issue of disposing of controlled substance dispensed to individual patients 
to develop a safe disposal policy (Fass, 2011). This led to the enactment of the Secure 
and Responsible Drug Disposal Act of 2010 and the Safe Drug Disposal Act of 2010, 
thereby paving the way for drug take-back programs that allow for the return of 
controlled and uncontrolled substance. The ONDCP (2011) emphasized the importance 
of proper medication disposal to protect human health and the natural environment. 
The purpose of this quantitative cross-sectional study was to examine the disposal 
practices and disposal attitudes of a sample population in the northeast United States. 
This study was guided by five research questions: 
1. Is there an association between knowledge of the environmental and the 
human-health impact of pharmaceutical disposal and actual disposal 
practices? 
2. Is there an association between knowledge of recommended disposal practices 
and actual disposal practices? 
3. Is there an association between locally available disposal options and actual 
disposal practices? 
4. To what degree can people’s actual disposal practices be explained by the 
combined and unique contributions of knowledge of environmental and 
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human-health impact, knowledge of recommended practices, and locally 
available disposal options? 
5. Do differences exist among RQ1, RQ2, and RQ3 across demographic groups? 
Numerous theories and models have evolved in health psychology to explain 
health-related attitudes, beliefs, and motivations and their influence on individual 
behavior (Bandura, 1997; Nisbet & Gick, 2008; Strecher & Rosenstock, 1997). 
Environmental behavior is multifactorial; consequently, I found it important to consider 
more than one model as the theoretical framework for behavior change: the HBM and the 
TPB. 
Search Strategy 
The literature presented in this review drew primarily from PubMed/MEDLINE 
and the following EBSCO databases: Academic Search Premier, MasterFILE Premier, 
Business Source Premier, PsycINFO, and PsycARTICLES. I did not restrict the searches 
to peer-reviewed scholarly articles, as I deemed reports and guidelines from government 
agencies as well as international bodies such as the WHO to be important sources of 
information on the topic. In the initial searches, keywords, used either individually or in 
conjunction, included pharmaceuticals, drugs, medication, disposal, waste, pollution, 
contamination, contaminants, toxins, environment, and health. This strategy produced a 
large number of research studies. Many were from the biochemistry and environmental-
science literature. These articles provided compelling evidence of what is happening to 
the physical environment as a result of massive amounts of pharmaceuticals entering the 
environment. A review of these articles generated additional searches including the 
following keyword searches: antibiotics, antibiotic resistance, analgesics, 
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antidepressants, hormones, endocrine disrupting chemicals, measurement, evaluation, 
water treatment, water treatment facilities, wastewater, drinking water, soils, sediments, 
and removal. 
Environmental studies also confirmed the role of human actions in the 
accumulation of pharmaceutical pollutants. Many studies in this line of research advocate 
strategies such as drug take-back programs to reduce the amount of pharmaceutical 
compounds entering the natural environment. However, they do not directly relate to the 
behavioral aspects of drug disposal by consumers or health care professionals who handle 
unused or expired drugs. Thus, I needed to conduct additional searches. The keywords 
drug disposal programs, drug take-back programs, and take-back events produced a 
number of articles on the topic. Although take-back programs date to the mid-2000s 
when they were recommended by the federal government as a strategy for safe 
medication disposal, they generated few empirical studies. The new generation of take-
back programs under the auspices of the DEA is a recent phenomenon. Highlighting the 
relative newness of the DEA programs, the first study of the Maine Prescription 
Monitoring Program (the most publicized program) appeared in the January 2015 issue of 
the American Journal of Public Health (Stewart et al., 2015). 
The theoretical frameworks selected for this study were the TPB and the HBM. 
These models, as well as the keywords health, health psychology, public health, 
knowledge, awareness, beliefs, education, information, attitudes, behavior, and 
environment, produced several studies, although more research appeared to focus on the 
attitudes and practices of health professionals than the general public. I added the terms 
patients and consumers to the search criteria. Theory of planned behavior and health 
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belief model and environment revealed several studies involving recycling behavior and 
other environmental-protection activities, and they are included in this chapter. 
The articles that I selected for this review span the years 2003 to 2015, with the 
exception of theoretical material. Numerous scientific studies were published during the 
1990s documenting the presence of pharmaceutical substances in water. Not until the 
early to mid-2000s, however, did this knowledge spur calls to take action to address the 
burgeoning problem. The selected dates cover the time frame from which pharmaceutical 
waste captured global attention as an important environmental and public health concern, 
from warnings by environmentalists of polluted waterways—including drinking water 
supplies—to government recognition of the potential public threat. Calls ensued to 
educate the general public about proper medication disposal and to encourage this 
behavior through patient education, public-awareness campaigns, medication take-back 
events, and the provision of disposal sites at pharmacy chains and health care facilities. 
The literature reveals glaring gaps in knowledge of the potential effects of 
pharmaceuticals in the environment on human health due to weaknesses in the existing 
research, as well as a dearth of empirical studies examining the medication disposal 
practices of consumers and the effectiveness of programs and strategies to encourage 
proper disposal. 
Organization of the Literature Review 
This chapter began with an introduction to the problem of pharmaceutical 
pollution in the environment, its potential impact on human health, and steps being taken 
to address the problem. I followed with a brief statement of the purpose and research 
questions of this study, the organization of the literature review, the theoretical 
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framework guiding the study, the presence of pharmaceuticals in the environment, the 
evolution of policies and programs, knowledge, attitudes, and disposal practices of health 
professionals and consumers, medication take-back groups, recycling attitudes, and 
behavior, and a brief summary and conclusion. 
Theoretical Framework 
According to Nisbet and Gick (2008), despite parallels between health and 
environmental behavior, the fields of health promotion and health-behavior change are 
not often applied to environmental issues. Environmental behavior is multifactorial; 
consequently, I decided to consider more than one model as the theoretical framework of 
behavior change: the HBM and the TPB. I deemed the TPB most relevant to the issue of 
proper pharmaceutical disposal, whereas the HBM aligned with studies that involved 
recycling and environmental protection. 
Theory of Planned Behavior 
The TPB is an extension of Ajzen and Fishbein’s TRA (Ajzen & Madden, 1986). 
Both models hinge on intention; that is, the immediate antecedent of any action is the 
person’s intention to perform it. According to the TRA, people have two key 
determinants of intention: attitude toward the behavior and subjective norm, representing 
an individual and a social factor, respectively. The theory also addresses the antecedents 
of these two factors. Behavioral beliefs are presumed to influence attitudes toward the 
behavior, while normative beliefs underpin subjective norms. 
Missing from the original model, according to Ajzen and Madden (1986), was the 
issue of behavioral control, and the extent to which an individual has the control to 
achieve the behavioral goal. Given that numerous factors can interfere with the actual 
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control one has over carrying out a given behavior, behavioral control was 
conceptualized as perceived control, “the person’s belief as to how easy or difficult 
performance of the behavior is likely to be” (Ajzen & Madden, 1986, p. 457). The more 
internal and external resources and opportunities people perceive they have and the fewer 
obstacles they anticipate, the stronger their sense of perceived control over performing 
the target behavior. Attitudes, subjective norms, and perceived behavioral control all have 
distinct effects on behavior (Ajzen & Madden, 1986). 
Ajzen and Madden (1986) tested two versions of the TPB in two experiments. 
Both experiments confirmed that the TPB was superior to its predecessor. Consistent 
with expectations, the addition of perceived behavioral control greatly enhanced the 
ability of the theory to predict intentions and subsequent achievement of behavioral 
goals. 
Since its inception, researchers have used the TPB extensively in examining 
health-related behaviors such as smoking cessation, health screening, and dental flossing 
(Nisbet & Gick, 2008), as well as the behavior of health care professionals (Cote et al., 
2012; Ward, 2013). Ajzen recognized that subsequent research was likely to disclose 
additional factors that influence intention and outcomes (Ward, 2013). Furthermore, 
Ajzen and Fishbein (as cited in Ajzen & Madden, 1986) acknowledged that social norms 
did not necessarily represent a unitary construct. Rather, descriptive norms, denoting 
perceptions of others’ behavior, and injunctive norms, denoting perceived expectations 
for how one should act, may have independent effects on intentions (Nigbur et al., 2010; 
White et al., 2009). Nigbur et al. (2010) and White et al. (2009) explored the respective 
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influences of descriptive and injunctive norms, as well as aspects of social identity in 
their application of the TPB to household recycling behavior. 
Culiberg (2014) added moral perspectives, applying the TPB to recycling 
behavior. Also expanding the TPB in this direction, Cote et al. (2012) included moral 
norms in research exploring nurse intentions to incorporate research evidence into 
clinical decision making. In fact, moral norms emerged as the strongest predictive factor. 
This finding may be valuable for explaining nurse decisions in disposing of unused 
medications. Moral and ethical perspectives may be especially useful in examining 
behavior related to environmental protection. 
Researchers also used the TPB to examine behavior in organizations. Sanchez-
Medina et al. (2014) applied the TPB to the study of environmental measures taken by 
managers of small and midsized firms. Waste disposal was one of the practices 
investigated. For health care facilities, proper pharmaceutical disposal must be managed 
at the organizational as well as the individual level (EPA, 2008, 2010). 
Studies by Culiberg (2014), Nigbur et al. (2010), White et al. (2009), and 
Sanchez-Medina et al. (2014) added to a small but growing body of research using the 
TPB as a framework to investigate behaviors related to environmental protection. Most 
studies in this line of research focused on recycling behavior (Nisbet & Gick, 2008). In 
their review of this research, Nisbet and Gick (2008) found that intentions to recycle 
arose from positive attitudes toward recycling and perceived behavioral control, provided 
that “people feel their own contribution is important” (p. 298). The influence of 
subjective norms on recycling was less consistent. Nigbur et al. and White et al. 
deliberately chose to focus on the influence of subjective norms on recycling. 
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In summary, the behaviors that trigger the disposal of unused or expired 
pharmaceutical products are multifactorial and can therefore be best explained by using 
two theoretical frameworks: the TPB and the HBM. The TPB model (Ajzen & Madden, 
1986) hinges on the concept of intention to perform an action, given that the individual 
has the perception of having behavioral control. In the context of this study, the TPB has 
provided clues on the need for individuals to have feasible (and available) disposal 
options. Culiberg (2014), Nigbur et al. (2010), White et al. (2009), and Sanchez-Medina 
et al. (2014) used the TPB to investigate behaviors related to environmental protection, 
whereas Nisbet and Gick (2008) used the TPB to explore behaviors related to recycling. 
Health-Belief Model 
Hochbaum developed the HBM in the 1950s in response to the poor success of 
public health campaigns to promote disease screening (Strecher & Rosenstock, 1997). 
Based on detailed analyses of probability samples of adults in cities that offered 
tuberculosis screening, Hochbaum identified the beliefs that form the basis of the model: 
perceived susceptibility and perceived benefits of action. Hochbaum also recognized the 
role of intrinsic and extrinsic cues or triggers in motivating people to take action, 
although never empirically investigating that feature of the model (Strecher & 
Rosenstock, 1997). 
Decades later, the HBM has been refined and expanded, and has a strong 
empirical foundation (Strecher & Rosenstock, 1997). The model has several essential 
components. Perceived susceptibility denotes the person’s subjective perception of 
experiencing a health or medical condition. This dimension encompasses susceptibility to 
illness in general, as well as vulnerability to a specific condition. A related factor is 
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perceived severity, referencing the seriousness of experiencing the condition or allowing 
it to remain untreated. This component includes medical consequences (pain, disability, 
and death) and social consequences (for example, the impact of the condition on work 
and social relationships). Taken together, perceived susceptibility and perceived severity 
produce perceived threat. 
Although acceptance of a perceived personal threat is a prerequisite for taking 
action, the specific course of action the person chooses to take depends on the perceived 
benefits of the available options (Strecher & Rosenstock, 1997). Bringing unused and 
expired medications to a take-back event or disposal center neutralizes the potential threat 
those drugs might present to people and pets, and does not contribute to environmental 
pollution. The action might carry the intrinsic reward of feeling one has done the right 
thing. A drug take-back event might offer an opportunity for socializing. For young 
people in particular, peer pressure to engage in environmentally friendly actions might 
influence drug disposal behavior. 
Despite awareness of the potential benefits of a given health behavior or 
behaviors, perceived barriers can arise as obstacles to the recommended course of action. 
A comprehensive research review of the HBM found perceived barriers to be the single 
most important factor in health behaviors across all studies and behaviors (Strecher & 
Rosenstock, 1997). For preventive behaviors, perceived susceptibility and perceived 
barriers are the best predictors of behavior, whereas for behavior related to a current 
health problem (such as adhering to medication), perceived severity and perceived 
barriers are most important (Nisbet & Gick, 2008). 
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Cues to action are recognized as important factors in health behaviors, but have 
not been systematically examined (Strecher & Rosenstock, 1997). In fact, it is difficult to 
quantify cues because they are often subtle and highly individual. For example, people 
who love nature or are aware of the toxic impact of improperly disposing of medications 
in the environment might be more likely to change behavior and implement a proper 
disposal practice. The HBM has been applied to a wide variety of health behaviors. A 
short list includes cancer screening, wearing sunscreen, dental hygiene, medication 
adherence, and HIV risk behavior (Nisbet & Gick, 2008). To date, the HBM has been 
used in only one published study related to the environment: recycling behavior. In a 
1997 study by Lindsay and Strathman, individuals who viewed the consequences of not 
recycling as more of a serious threat were more inclined to comply. Self-efficacy and 
greater perception of benefits (or lower perceived costs) also aligned with recycling. Self-
efficacy has been applied to a myriad of health behaviors. The more confident people feel 
in executing a course of action and accomplishing the desired results, the more likely 
they are to undertake the behavior and persist through challenges to achieve their goals 
(Bandura, 1997). 
According to Nisbet and Gick (2008), health psychology is a model with an 
important role in the realm of environmental protection. In Canada, the environment has 
supplanted health as the Canadians’ top concern, although health still ranks high on the 
list. In Canada, as in the United States, the majority of consumers continue to dispose of a 
large proportion of unused and expired medications in the toilet and drain (Health 
Canada, 2009). In a fashion similar to the United States, Canada has a federal structure 
whereby programs that encourage the proper disposal of pharmaceuticals are being 
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enacted at the provincial level, with a substantial degree of variation between provinces. 
In the United States and Canada, results have been promising, but many people are 
unaware of the options for safe disposal of drugs, and barriers do exist. Barriers to the 
return of medications to pharmacies and other disposal sites include lack of locally 
available facilities and limited hours for return, as well as lack of awareness. 
Nisbet and Gick (2008) pointed out that, in general, people desire a “safe, healthy 
environment” (p. 296). However, the concept of a safe, healthy environment is relatively 
abstract, and many people do not understand the potential and actual consequences of 
environmental problems such as climate change, habitat destruction, and pollution impact 
on human health. Despite widespread interest by the public in protecting the environment 
and improving personal health, many public health campaigns fail to elicit changes in 
people’s behavior. A key reason for this persistent problem is that program designers and 
policymakers fail to recognize inconsistencies between attitudes toward health and the 
environment and related behavior. Virtually all guidelines, reports, position papers, and 
standards issued by government agencies, international bodies, and professional 
associations emphasize the importance of consumer and patient education on the safe use 
and disposal of medications. Education is an essential prerequisite for behavior change, 
but information per se is notoriously ineffective for changing human behavior. 
Nisbet and Gick (2008) observed, “Attempts to inspire healthy and pro-
environmental behavior often rely on information-intensive messages, assuming that once 
people are informed they will act differently” (p. 297). A plethora of public health 
programs that have failed to produce the intended effects that rely on that assumption. 
However, the problem is that the complexity of factors affecting behavior is 
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underestimated (Nisbet & Gick, 2008). External factors such as lack of transportation, 
lack of recycling or drug disposal centers, and low socioeconomic status are impediments 
to proenvironmental and health behavior. Proximity is an important concern in 
encouraging rural residents to participate in medication take-back events (Gray & 
Hagemeier, 2012). 
Furthermore, many health and environmental behaviors are deeply entrenched. 
Most consumers are so used to disposing of medications in the sink or toilet that they 
may not give a second thought to their behavior, despite health and environmental 
concerns. Even nurses, pharmacists, and other health care staff who are aware of proper 
and improper disposal practices dispose of unused pharmaceuticals in the drain or toilet 
(Abahussain et al., 2012; McCullagh et al., 2012; EPA, 2010). 
Another reason that inhibits behavior change is the belief that the risk (to the 
environment or to one’s health) is low (Nisbet & Gick, 2008). The use of prescription 
drugs in the United States has been labeled an epidemic (Maxwell, 2011; ONDCP, 2011). 
Publicity for medication take-back programs emphasizes the dangers of keeping unused 
and expired medications in the home. If the perception is that it is more hazardous to 
keep medication at home than to discard it to sewage (a more immediate versus a more 
distant risk) in the absence of a conveniently accessed disposal program, the messages 
may inadvertently reinforce the continued use of improper disposal practices. Threats to 
personal health from subtle changes to the environment may be perceived as not 
happening in one’s lifetime. People with young children may be most receptive to 
messages about the human-health threat of discarding drugs to sewage. 
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Nisbet and Gick (2008) also pointed out that people are prone to unrealistic 
optimism regarding health and environmental risks that have not yet happened and are 
thought to be unlikely. Even if individuals are convinced of the seriousness of a health or 
environmental threat, their optimism may lead them to believe they are less vulnerable 
than others, and thus would be less likely to take action to change their behavior. Other 
individual attributes such as a sense of responsibility toward nature and the environment 
are likely to influence behavior related to environmental protection and health. 
In conclusion, the HBM hinges on a strong empirical foundation (Strecher & 
Rosenstock, 1997), whereby an individual’s perceived susceptibility and perceived 
severity of a threat are at the core of its conceptual framework. For example, the results 
of the study by Nisbet and Gick (2008) suggested that the more people were concerned 
about the threat (consequences) of missing a dose of their prescribed medication, the 
more likely they were to comply with their medication intake. Certain behaviors, such as 
that of disposing of pharmaceutical drugs in the drain or toilet, are deeply entrenched; 
therefore suggesting that the perceived threat to one’s health from a polluted environment 
is either too low to be worth considering, or nonexistent. 
Toward Managing Pharmaceutical Disposal 
Daughton and Ruhoy (2013) referenced the increasing presence of 
pharmaceuticals in the environment as a side effect of medication prescribing. The same 
substances that have been helping people in contemporary society to live longer, healthier 
lives are polluting the natural environment. Pharmaceuticals enter the environment 
through various routes. The manufacturing process certainly plays a key role in the way it 
impacts the environment; for example, in a region of India that serves as a manufacturing 
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hub for the global production of pharmaceuticals, the wastewater has registered levels of 
some pharmaceuticals that surpass the amount in the blood of patients on that medication 
(Larsson, 2014). Agricultural practices also contribute to pharmaceutical pollution; for 
example, antibiotics are dispersed in the environment through the excretion of antibiotics 
by animals which are provided antibiotics with their feed to promote growth (K. Kumar, 
Gupta, Baidoo, Chander, & Rosen, 2005). 
However, for household pharmaceuticals, pharmaceuticals enter the environment 
in three pathways. The first is through natural excretion: the body metabolizes only a 
fraction of medication ingested, injected, or infused (Daughton & Ruhoy, 2013; Harvard 
Health, 2011; Ortner & McCullagh, 2010; Rodriguez-Mozaz & Weinberg, 2010; Ruhoy 
& Daughton, 2008). The unmetabolized compound and its metabolites are excreted in 
urine and feces and to a lesser degree, sweat. A second pathway is the removal of topical 
medications while bathing. The third pathway, which is the focus of this study, is the 
disposal of unused, unwanted, and expired medications. 
However, the three pathways interrelate and contribute to the overall impact on 
the environment. Daughton (2014a) used the terms upstream and downstream to denote 
two approaches to reducing the amount of pharmaceutical substances in the environment. 
The upstream approach focuses on minimizing the amount and toxicity of substances that 
have the potential to contaminate the environment. This approach can also be called 
green pharmacy or ecofriendly pharmacy (Daughton, 2003a, 2003b; Daughton & Ruhoy, 
2008). The upstream approach begins with the design of drugs with maximum potential 
to be absorbed by the body so smaller trace amounts are excreted. Drugs in this category 
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are designed to increase the specificity of drug action at the target cells, and can be 
prescribed in lower dosages. 
For drugs that are already on the market, an upstream approach involves curbing 
the overprescribing of medications, limiting aggressive marketing that encourages 
patients to request medications that may not be necessary and leaves household medicine 
cabinets with samples of numerous drugs that go unused. Improving diagnostic 
procedures for such drugs allows patients to be prescribed the most effective drugs and 
precise dosages, thereby improving patient adherence to the prescribed medication 
regimen; poor medication adherence is a major contributor to the unused drugs that find 
their way into the waterways (Daughton, 2003a, 2003b; Daughton & Ruhoy, 2013; 
Ruhoy & Daughton, 2008; Ruhoy & Kaye, 2010). 
Diligent monitoring is another aspect of the upstream approach (Daughton, 
2014b; Ruhoy, 2009). Gathering inventory data from coroner’s offices provides a novel 
and effective mechanism to identify precisely how much of a particular pharmaceutical 
ingredient has been disposed of in a given geographic region and the frequency with 
which the substance is disclosed in the disposal inventories. Researchers investigating the 
unusual variability in pharmaceutical concentrations in water surrounding a college town 
found that variations in the chemical composition aligned with changes in the average 
age of the population when students were on vacation or on campus (Ottmar, Colosi, & 
Smith, 2013). Specifically, the effect they observed was due to higher and lower levels of 
oral contraceptives. When students were absent, more evidence accrued of cardiovascular 
drugs. Researchers were able to track the prescribing and use volume of tamiflu during 
real or anticipated flu epidemics by analyzing their concentrations in the environment 
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(Singer et al., 2008, 2014). Knowledge of where drugs accumulate and the factors leading 
to that accumulation provide a foundation to curb the accumulation of pharmaceutical 
waste. 
The downstream approach involves promoting the safe and proper disposal of the 
unused, unwanted, and expired medications that accumulate in most households (Ruhoy 
& Daughton, 2008). This approach is exemplified by drug take-back programs that allow 
consumers to bring unused pharmaceuticals to a specific site where the drugs are 
collected and transported to be destroyed. These programs have been carried out since 
2010 under the direction of the DEA so that controlled substances can be returned and 
transported (Fain & Alexander, 2014). Preliminary data indicate that drug take-back 
events across the United States effectively draw people and collect millions of tons of 
pharmaceutical waste, nationally, for safe disposal (Fain & Alexander, 2014; Fass, 2011; 
Gray & Hagemeier, 2012; Lubick, 2010; Ma et al., 2014; Stewart et al., 2015; Tucker, 
2011). Participants at a take-back event in Honolulu were virtually unanimous in wanting 
to see the event repeated (Ma et al., 2014). However, annual take-back events remain 
sporadic, and for drug return strategies to effectively reduce the huge amount of 
pharmaceutical substances that enter the environment, consumers should be able to 
access return sites whenever they have a need. 
Pharmacies are routinely hailed as the ideal venue for returning unused 
medications (Abahussain et al., 2012; Fain & Alexander, 2014; Fass, 2011; Zimmermann 
et al., 2011). Pharmacies are also excellent sites to educate the public about proper 
medication management and disposal. However, the widespread adoption of pharmacy 
returns has marked challenges. Medication-return programs existed before the DEA 
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became involved to allow the return of controlled substances (Musson et al., 2007; 
Thompson, 2007). In September 2014, the DEA issued a regulation requiring pharmacies 
to follow specific guidelines to implement take-back programs (Fain & Alexander, 2014). 
The regulation stipulates specific ways patients are allowed to return unused and expired 
drugs, such as through collection boxes at registered pharmacies. Indeed, providing 
consumers with access to receptacles is often recommended and likely to be popular with 
the general public. However, some pharmacies have raised concerns about the burdens 
and costs of requisite measures, as well as potential legal liability. 
The effectiveness of this strategy also rests on the voluntary participation of 
pharmacies and adequate funding, especially to offset additional costs due to DEA 
requirements (Fain & Alexander, 2014). Many pharmacies have enthusiastically 
participated in drug take-back events and are interested in continuing. Upstream 
approaches may be preferable in theory, but they do not address the drugs that are already 
in medicine cabinets. Medication take-back programs have shown a good deal of 
promise, but their success depends on the active involvement of stakeholders. 
Environmental Impact: Empirical Evidence 
Pharmaceutical compounds have been steadily entering the natural environment 
since their introduction into human and veterinary medicine more than a century ago (de 
Cazes et al., 2014). The first studies documenting the presence of drugs in environmental 
waters date back to the 1970s, when researchers in the United States detected evidence of 
analgesics, heart medications, and contraceptive drugs in wastewater (WHO, 2011). This 
line of research gathered momentum in the 1980s and 1990s. The most extensively cited 
work in the peer-reviewed literature of the presence of drugs in surface water is an 
58 
 
investigation conducted by the U.S. Geological Survey in 1999 and 2000, revealing more 
than 50 pharmaceuticals in 139 streams across 30 U.S. states. Of the streams examined, 
80% contained at least one contaminant, with an average of seven contaminants per 
stream (Ortner & McCullagh, 2010). 
Similar studies conducted in Europe showed comparable results. A research 
synthesis published in 1997 reported the presence of cholesterol medications, analgesics, 
and anticonvulsants in surface waters and groundwater in Germany (Ortner & 
McCullagh, 2010). In March 2008, the AP released a report entitled PharmaWater I, 
detailing the findings of an AP investigative team. The report revealed that at least 41 
million Americans were served by water supplies with evidence of pharmaceuticals, 
including anticonvulsants, antibiotics, mood stabilizers, and hormones (Ortner & 
McCullagh, 2010). The team found drugs in the water supplies of 24 major metropolitan 
areas across the United States. Studies from the United States and the United Kingdom 
disclosed treatment plants were not completely effective in removing active 
pharmaceutical ingredients from treated water. 
Indeed, a key concern is that conventional treatment plants are not equipped to 
fully remove micropollutants such as pharmaceuticals from wastewaters (de Cazes et al., 
2014; Fatta-Kassinos et al., 2011; Milic et al., 2013; Uslu et al., 2013; WHO, 2011). 
Advanced treatment techniques such as ozonation, advanced oxidation, activated carbon, 
and membrane are capable of removal rates exceeding 99% for specially-targeted 
pharmaceutical compounds (WHO, 2011). However, even the most advanced and 
expensive treatment techniques leave detectable levels of pharmaceuticals. Prevalence of 
advanced treatment plants across the United States was estimated as 18.3% of the total 
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budgeted needs for clean watersheds, aligned with the EPA survey conducted in 2012 
(EPA, 2016). 
For conventional methods, the effective removal of pharmaceuticals ranges 
substantially, from more than 90% to less than 20%. To an extent, this variation depends 
on the nature of the wastewater treatment plant and treatment techniques employed; in 
fact, the EPA (2016) listed several categories of treatment that have distinct functions, for 
example secondary, advanced, and storm-water management. Even more significant, the 
pharmaceuticals currently produced represent more than 4,000 molecules with varying 
properties related to absorption, bioactivity, and biodegradability (de Cazes et al., 2014). 
ARGs have been discovered in treated wastewater, raising concern as to whether 
that resistance might transfer to microorganisms capable of affecting human health 
(Lubick, 2011; Marti et al., 2013; Sahoo et al., 2010; Segura et al., 2009; Zhang et al., 
2009). Wastewater-treatment plants reduce the total amount of bacteria in water, but are 
not effective enough to remove ARGs (Marti et al., 2013; Milic et al., 2013; Zhang et al., 
2009). Furthermore, beyond being inefficient in removing ARGs from wastewater, 
treatment plants may facilitate the “horizontal transfer of resistance determinants” among 
an array of microorganisms, thus treatment plants may actually “contribute to the 
occurrence, spread and persistence of both antibiotic-resistant bacteria and antibiotic 
resistant determinants in the environment” (Marti et al., 2013, p. 2). 
Pharmaceuticals are distinguished from other environmental pollutants because 
they are made to be biologically active. Unique characteristics of pharmaceuticals include 
their highly complex chemical structure, polymorphism (the ability of a molecule to 
crystallize into more than one crystalline form), and their ability to be ionized and have 
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multiple ionization sites dispersed throughout the molecule (Fatta-Kassinos et al., 2011). 
To strengthen their intended action, pharmaceuticals are created to be resistant to 
biodegradability, and many drugs are extremely powerful. The complex nature of 
compounds that are typical of pharmaceutical products is a challenge, even to more 
advanced treatment plants and technology. 
An additional distinction is that pharmaceuticals often enter the environment after 
being metabolized by human or veterinary patients. In addition, drugs also enter the 
environment in an unmetabolized form, by direct disposal to sewage. Sales of 
pharmaceuticals have been increasing annually at about 5% to 7% (Corcoran et al., 
2010). In the United States, hospitals, care facilities, and pharmacies discard an estimated 
$1 billion of unused drugs each year, exceeding the amount of drugs discarded by 
consumers. 
Because pharmaceuticals have been detected in a wide range of environmental 
sources with concentrations typically ranging from traces to even smaller concentrations 
in the order of parts per billion has led to some speculation that pharmaceuticals are not 
likely to have a harmful impact on the environment (Fatta-Kassinos et al., 2011; WHO, 
2011). However, Fatta-Kassinos et al. (2011) are among a number of sources that are 
skeptical of that assumption, citing weaknesses in the existing research, ambiguous 
findings, and glaring knowledge gaps (de Cazes et al., 2014; Daughton, 2014b; A. Kumar 
et al., 2010; Ortner & McCullagh, 2010; Rahman et al., 2010; Rodriguez-Mozaz & 
Weinberg, 2010). Ortner and McCullagh (2010) pointed out that, “Active pharmaceutical 
ingredients have been found in the ambient environment that not long ago were 
considered infinitesimally low” (p. 18). Even these very low concentrations have been 
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implicated in abnormalities found in fish populations (Corcoran et al., 2010; Ortner & 
McCullagh, 2010). In addition to the adverse effects on fish, ecotoxicity studies have 
shown that pharmaceutical pollutants are capable of affecting the growth, reproduction, 
and behavior of birds, invertebrates, plants, and bacteria, even at very low levels (e.g., a 
few nanograms per liter; de Cazes et al., 2014). According to de Cazes et al. (2014), trace 
concentrations in soils, which directly link with food and drinking water, present a hazard 
to human health. Notably, concentrations of pharmaceuticals in soils and sediments tend 
to be higher than levels detected in water (Fatta-Kassinos et al., 2011). 
Analytical and Research Techniques 
The discovery of very low concentrations of pharmaceuticals in the environment 
is due primarily to the development of increasingly sensitive, sophisticated, and accurate 
detection equipment and analytical techniques (Fatta-Kassinos et al., 2011; WHO, 2011). 
Gas chromatography with mass spectrometry or tandem mass spectrometry and liquid 
chromatography with mass spectrometry or tandem mass spectrometry are capable of 
discerning target compounds near a nanogram per liter. Technicians routinely use these 
advanced techniques to detect pharmaceuticals in water and wastewater. The precise 
choice of method depends on the chemical and physical properties of the target 
compound. Similarly, the inherent degree of variability increases the challenge of 
understanding the potential effects of pharmaceuticals on the environment and human 
health. Specifically, the absence of standardized methods or protocols for sampling and 
analyzing the presence of pharmaceuticals in water, soils, sediments, or other 
environmental features precludes the ability to ensure “the comparability and quality of 
the data generated” (WHO, 2011, p. 2). 
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Daughton (2014b) raised a particularly interesting and significant criticism of the 
existing research on pharmaceutical pollution. According to Daughton, risk-assessment 
studies on pharmaceutical pollution were governed by the “Matthew Effect.” That is, 
monitoring surveys tend to focus on active pharmaceutical ingredients (APIs) that have 
already been the subject of previous research, ignoring the vast majority of 
pharmaceuticals discharged into the environment and resulting in research findings that 
are redundant and incomplete. For example, a review of research on the presence of 203 
common APIs in 41 countries found that most monitoring efforts focused on only 14 
APIs, representing a scant 7% of the drugs. 
Daughton (2014b) referenced chemicals marked by a dearth of research as 
“Matthew Effect Orphaned Chemicals” (MEOCs). In a case study of more than 200 drugs 
designed to discern the scope of MEOCs, Daughton found 73 MEOCs, with 33 having no 
published data, 20 with minimal published data (one or two published reports), and 20 
with limited published data (a maximum of three to six studies reporting positive 
findings). Daughton noted that these 73 APIs had been previously described as high-
volume pharmaceuticals that had not been captured in research, but were “estimated to be 
persistent and/or bioaccumulative” (Howard & Muir, 2011, as cited in Daughton, 2014b, 
p. 319). Notably, Daughton pointed to the lack of occurrence data on 14 APIs still 
classified as MEOCs as early as 2001. These still unmonitored but widely prescribed 
drugs include alendronate, amiodarone, benazepril, chlorthalidone, clonazepam, 
cyclobenzaprine, doxazosin, glipizide, guaifenesin, pramipexole, quinapril, ropinirole, 
spironolactone, and terazosin. With respect to half-life of pharmaceutical products, a 
large spectrum of variability exists across compounds, even in the same category of 
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products. For example, a study conducted by Halling-Sorensen, Lutzhoft Holten, 
Andersen, and Ingerslev (2000) to assess biodegradability compared three types of 
antibiotics: mecillinam, ciprofloxacin, and trimethoprim. Study results indicated that 
mecillinam and ciprofloxacin were readily biodegradable whereas trimethoprim was not. 
These findings pose an additional challenge to the overall strategy for water treatment; 
however, they also provide hope that it may be possible to engineer pharmaceutical 
compounds that are environment friendly. 
Daughton (2014b) acknowledged that the absence of data on some APIs may be 
due to presumed pharmacokinetic properties, for example based on the properties of a 
parent drug that is “extensively metabolized” (p. 322). However, Daughton (2014b) 
argued that the pharmacokinetics of many drugs is poorly understood. In addition, this 
approach ignores the fact that regardless of pharmacokinetic properties, these drugs will 
enter the sewage system directly when people dispose of their unused medications in the 
sink or toilet. Inadherence is a major reason to discard medications, often due to a drug’s 
toxic side effects. If not completely removed by wastewater treatment, virtually all APIs 
are capable of interacting with other drugs. Daughton (2014b) also noted that seven of the 
73 MEOPs are highly active topical medications released through bathing or sweat. 
Transdermal and transmucosal devices retain significant amounts of their original 
content, even after several days of use (Ortner & McCullagh, 2010). Thus, these devices, 
when discarded without being used, are likely to be heavily bioactive. 
Two main approaches can manage APIs in the environment (Daughton, 2014b). 
The first is monitoring a more extensive number of APIs, which should lead to greater 
detection of previously ignored, potentially hazardous pharmaceuticals. A second, 
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highlighting the upstream approach, is that knowledge of the relative impact of specific 
APIs could lead to prescribing those drugs that intrinsically provide minimal toxic risk 
and impact on the environment. Daughton’s ongoing extensive research highlights 
numerous knowledge gaps that have persisted for more than a decade (Daughton, 2003a, 
2003b, 2014a, 2014b; Daughton & Ruhoy, 2008; Ruhoy & Daughton, 2008). 
The most prevalent and powerful criticism of the existing research is that most 
studies focus on the short-term effects of individual agents, whereas little is known about 
the cumulative and synergistic effects of the plethora of bioactive chemicals discharged 
into the environment on a daily (and increasing) basis (Corcoran et al., 2010; Daughton, 
2014b; de Cazes et al., 2014; Fatta-Kassinos et al., 2011; A. Kumar et al., 2010; Ortner & 
McCullagh, 2010; Rahman et al., 2010; Rodriguez-Mozaz & Weinberg, 2010; WHO, 
2011). Among the pharmacokinetic properties of APIs is their interaction with other 
drugs (Daughton, 2014b). The effects of drug interactions in the human body are not 
necessarily well understood. The current trend in research examining single APIs in 
geographic isolation as well as isolation from other substances precludes greater 
understanding of the potential synergistic effects of drug interactions in the natural 
environment. A. Kumar et al. (2010) could find no studies investigating the effects of 
mixtures of pharmaceuticals. They described this lack of knowledge of pharmaceutical 
interactions as an “important uncertainty” (p. 3946). In fact, the uncertainty attached to 
long-term persistent exposure to bioactive chemicals in water, soil, and sediments, even 
at low concentrations, is a pervasive theme in the literature. 
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Types of Drugs and Effects 
Virtually all classes of drugs have been detected in the environment. Estrogens, 
antidepressants, and antibiotics have all aligned with abnormalities in aquatic life 
(Corcoran et al., 2010; Ortner & McCullagh, 2010). The term endocrine disrupting 
chemical entered the lexicon in 1991 at a conference organized by Colbern, a zoologist 
and former pharmacist who first called attention to the phenomenon of endocrine 
disruption in the 1970s after reviewing hundreds of studies investigating the impact of the 
contamination of wildlife in the Great Lakes (Ortner & McCullagh, 2010). A study 
conducted to assess the status of the water quality of Lake Huron, the second-largest of 
the Great Lakes, revealed the presence of atrazine, fluoxetine, and carbamazepine at trace 
concentrations (> 58 ng/L) in at least four samples, and ibuprofen and atorvastatin in one 
sample (Rahman et al., 2010). Although not widely prescribed, carbamazepine emerged 
in numerous samples, due to its low biodegradability (Corcoran et al., 2010). According 
to Rahman et al. (2010), the presence of atrazine in Lake Huron has particular health 
implications because it has the potential to contaminate drinking water in downstream 
regions. The researchers acknowledged that “the occurrence of these compounds … does 
not necessarily confirm health risk” but “neither does non-detection guarantee safety” 
(p. 227). This statement highlights the uncertainty that runs through the literature. 
No uncertainty exists, however, on the impact of endocrine-disrupting chemicals 
on the aquatic environment. The adverse effects of estrogens on fish populations are 
probably the most documented consequences of pharmaceutical pollution (Corcoran et 
al., 2010; Ortner & McCullagh, 2010). These effects include alterations in mitochondrial 
activity, energy metabolism, and cell-cycle regulation, as well as the feminization of male 
66 
 
fish and the development of genital abnormalities, in some cases leading to the collapse 
of fish colonies due to reproductive failure. 
NSAIDs are the most widely used class of drugs (Ortner & McCullagh, 2010). 
NSAIDs reduce inflammation by inhibiting the synthesis and release of prostaglandins. 
Examples of NSAIDs include acetylsalicylic acid (aspirin), ibuprofen, and diclofenac. 
These drugs have the potential to damage the kidneys, an effect documented by kidney 
failure in animals exposed to NSAIDs in water. One striking study reported the deaths of 
vultures in India and Pakistan due to kidney failure from feeding on the carcasses of 
livestock treated with diclofenac (Rahman et al., 2010; Rodriguez-Mozaz & Weinberg, 
2010). The vulture population declined dramatically in the course of 3 years. 
The term anti-infectives encompasses several bioactive compounds with the 
capacity to inhibit the growth or survival of microorganisms without harming the host 
(Segura et al., 2009). This category includes some antifungal agents and synthetic drugs, 
but in particular, antibiotics, which have become a major focus of attention in the 
literature on pharmaceutical pollution due to the presence of ARGs found in water 
supplies, soils, and sediments and their potential negative impact on human health (Fatta-
Kassinos et al., 2011; Marti et al., 2013; Milic et al., 2013; Uslu et al., 2013; Zhang et al., 
2009). Tetracycline was one of the first drugs detected in the environment, and the 
growth of tetracycline-resistant bacteria has been reported ever since (Zhang et al., 2009). 
In fact, hundreds of ARGs linked with resistance to a wide variety of antibiotics have 
been discovered in wastewaters, wastewater treatment facilities, surface water, ground 
water, and drinking water. These microorganisms have the potential to be transferred to 
humans from the environment through direct and indirect contact. Even at very low 
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levels, antibiotics may act as “signaling agents in microbial environments” to various 
plants that have receptors for antibiotics and disinfectants (Fatta-Kassinos et al., 2011, 
p. 228). 
Adding to the prospective threat posed by ARGs in the environment, ARGs are 
also resistant to wastewater treatment and advanced treatment techniques (de Cazes et al., 
2014; Milic et al., 2013; Zhang et al., 2009). Advances in removing pharmaceuticals from 
the environment have not kept up with the ability to detect them. Segura et al. (2009) 
stated that: “Anti-infectives, the miracle drugs of the 20th century have become 
environmental contaminants of emerging concern in the 21st century” (p. 682). Upstream 
and downstream approaches are needed to address the problem of the increasing pollution 
of the environment by pharmaceutical compounds. Green pharmacy is still in a fledgling 
state, but consumers, pharmacists, nurses, and other health professionals, as well as 
concerned businesses, have the power to reverse the increasing dispersal of 
pharmaceuticals into the environment by proper disposal of unused and expired 
medications. 
Evolution of Medication Disposal Policy and Practice 
A number of countries, including Australia, France, Sweden, Portugal, Spain, the 
United Kingdom, and New Zealand, have had formal programs to collect unused drugs 
for some time (Ruhoy & Daughton, 2008). European Union directives require member 
states to have suitable collection systems in place for the return of unused and expired 
drugs (Health Canada, 2009). Australia’s Return Unwanted Medicines Project is financed 
by the federal government. Sweden has an unusual retail-pharmacy system organized into 
a single government-owned chain called Apoteket B. Apoteket B operates an 
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environmental program driven by targeted public-awareness campaigns to educate the 
public about the adverse effects of flushing medications down the drain or throwing them 
into the trash. The focus on public awareness seems to be working: more than 70% of 
consumers with leftover drugs return them to the pharmacy. The Spain Integrated Waste 
Management System also carries out intensive campaigns to raise public awareness, 
successfully producing large volumes of returned medications. In contrast, in Poland, 
environmental awareness is low, and consumers have few places to return unused drugs, 
resulting in improper medication disposal (Zimmermann et al., 2011). 
Disposing of unused drugs in the United States has long been complicated by 
contradictory regulations from various agencies, and legal regulations on controlled 
substances that even with DEA involvement still clash with state laws. The first federal 
guidelines for the disposal of prescription drugs were issued in 2007 (Ortner & 
McCullagh, 2010; Ruhoy & Kaye, 2010). Consumers were provided a list of options for 
disposing of medications: 
● Take advantage of community take-back programs that allow the public to 
bring unused pharmaceuticals to a designated location for proper disposal. 
● Remove unused prescription drugs from their original containers and throw 
the loose medications in the trash. 
● Mix prescription medications with an unappetizing substance such as coffee 
grounds or cat litter and put them in impermeable, nondescript containers to 
ensure they are not diverted. 
● If the patient information specifically instructs, flush prescription medications 
down the toilet. 
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The guidelines were issued with the dual goals of preventing prescription drugs 
from being diverted and protecting the environment (Thompson, 2007). Although these 
guidelines represented an important step forward, they became a source of derision for 
the inclusion of cat litter as a disposal option (Knopf, 2013). In 2010, the White House 
announced that the guidelines for individual medication disposal had been replaced by 
official take-back days. However, the FDA (2011) still recommends mixing unused drugs 
with unpalatable substances and putting the mixture into sealed containers. The recent 
federal guidelines do not recommend throwing loose medications in the trash, and are 
quite explicit about taking advantage of take-back programs and properly disposing of 
drugs. The guidelines also state to not flush medications down the toilet unless the 
instructions specifically say to do so. The FDA recommends flushing 26 drugs because of 
the high risk associated with keeping these drugs in the house, such as fentanyl patches 
for pain. The FDA estimated that in 2009, about 5,000 children had accidental exposure 
to drugs in the house, and about 100 died (Mitka, 2009). 
In the 1990s, people saw a proliferation of numerous studies documenting the 
presence of pharmaceuticals in the environment and effects on aquatic life. In the early to 
mid-2000s, a few studies emerged in the United States and other countries examining 
consumers’ medication disposal knowledge and attitudes. At the time, the outpatient 
pharmacy at Madigan Army Medical Center at Fort Lewis in Washington State had a 
policy that allowed patients to return unused or expired medication, which would be 
disposed of as medical waste (Seehusen & Edwards, 2006). Controlled substances were 
excluded from the program. Information about the policy was clearly stated on the 
instruction sheets that patients received when they received medication, specifying that 
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this was the preferred mode of medication disposal. In addition, patients also had the 
option to return unused or expired drugs to a provider. 
In another study, the researchers’ goal was to gain insight into hospital patient 
practices for disposing of medication and their beliefs about medication disposal 
techniques. A total of 301 patients completed the survey, most taking no more than five 
medications or having more than five medications at home (Seehusen & Edwards, 2006). 
Less than 20% of participants had received any guidance from a health professional about 
proper disposal of medication. Given the time of the study and lack of professional 
advice, it is unsurprising that more than half the participants kept unused or expired drugs 
at home, and a similar proportion flushed drugs down the toilet. Slightly more than one-
third rinsed drugs down the drain. Only 14% returned unused drugs to a health care 
provider, and 23% returned drugs to a pharmacy. 
A marked contrast arose between participants’ beliefs about drug disposal and 
their behavior (Seehusen & Edwards, 2006). The portions of individuals who deemed it 
acceptable to return drugs to a pharmacist or health care provider far surpassed the 
proportion of those who actually did so, whereas the reverse was true for disposing of 
drugs in the toilet or sink. In other words, people were disposing of drugs in ways they 
did not really consider acceptable. Their behavior might have been dictated by habit or by 
lack of awareness of alternative options. 
Notably, having been educated about safe disposal practices strongly linked with 
returning drugs to a pharmacy or to a health care provider. Patterns between frequent 
pharmacy visits, being prescribed more drugs, and returning unused drugs, suggested 
patients were given advice on drug disposal when they returned for new medications 
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(Seehusen & Edwards, 2006). Seehusen and Edwards (2006) strongly advocated patient 
education. They proposed that health professionals and pharmacy staff could discuss drug 
disposal with patients, and that patients could be provided written information when 
receiving medications or medication labels or pill bottles could display information about 
disposal. This last suggestion is admirable but misguided. Patients routinely do not read 
the label or simply ignore instructions (Bound & Voulvoulis, 2005). 
Seehusen and Edwards (2006) asserted that persuading patients to believe it is 
desirable to return drugs to a health professional or pharmacy is a prerequisite for getting 
them to actually carry out the behavior. However, their own findings revealed a gap 
between beliefs and behaviors. Even pharmacists (Abahussain et al., 2012) and nurses 
(McCullagh et al., 2012) do not always act in accordance with their knowledge of proper 
drug disposal. Models of behavior change rest on recognition that education is a requisite, 
but not sufficient to change behavior (Bandura, 1997; Nisbet & Gick, 2008; Strecher & 
Rosenstock, 1997). 
In the United Kingdom, Bound and Voulvoulis (2005) examined household 
practices in disposing of unused and expired medication in a general population survey of 
400 respondents in southeastern England. They broke down disposal practices by drug 
type. Virtually all respondents had some medications at home. Most households had a 
combination of prescription and OTC drugs (60.2%), and close to one-third had only 
OTC drugs. Most respondents reported using all the painkillers they purchased or were 
prescribed (80%). However, the figure for antibiotics was striking: only 16% of 
respondents consumed all the antibiotics they had acquired. Many people stop taking 
antibiotics as soon as their symptoms disappear, even though they are told to finish the 
72 
 
supply. Antibiotics are also notoriously overprescribed (Daughton & Ruhoy, 2013; 
Ruhoy & Daughton, 2008). Overprescribing and poor adherence to antibiotics contributes 
to the presence of antibiotics in the environment and drives concerns about antibiotic 
resistance (Lubick, 2011; Marti et al., 2013; Sahoo et al., 2010). 
Most UK respondents disposed of drugs with household trash (Bound & 
Voulvoulis, 2005). Only a small fraction (11.5%) disposed of drugs in the sink or toilet, 
and no respondents who took hormone medications disposed of their medication in that 
manner; all returned unused medications. That effect might have been due to awareness 
of the effects of hormones on the aquatic environment. 
The most striking finding was the comparison by Bound and Voulvoulis (2005) of 
their findings with data from the United States. In the British sample, 21.8% returned 
their medication to the pharmacy compared to a scant 1.4% in the United States. In 
contrast, 11.5% of the UK respondents flushed medication down the toilet or sink versus 
35.4% in the United States. The researchers speculated this result might have reflected 
different regulations and advice in the two countries. In fact, U.S. residents were 
instructed to dispense of medications in the sink or toilet, and at the time of the survey, 
few available locations existed for returning unused medicines. 
The presence of leftover prescription drugs beyond antibiotics suggested that 
many respondents were not adhering to their medication as prescribed. Bound and 
Voulvoulis (2005) concluded that a substantial amount of pharmaceuticals were finding 
their way into the environment. The United Kingdom has since adopted a formal 
medication-return program (Health Canada, 2009). At the same time, deeply ingrained 
practices can be difficult for people to change. 
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It is important to recognize that in the United States in particular, changes to 
federal guidelines and regulations and the implementation of the DEA program are driven 
primarily by dangers posed by rampant prescription-drug abuse (ONDCP, 2011). 
Replacing flushing medications with returning them reflects recognition of the harmful 
effects of pharmaceuticals on the natural environment and their potentially harmful 
effects on human life, but the emphasis in awareness campaigns is on the hazards of 
keeping unused medications in the home. That may actually be advantageous to changing 
behavior in that it emphasizes the more immediate threat (poisoning) over the more 
distant threat (pollution). At the same time, environmental protection is a powerful 
motivator for many participants at take-back events (Gray & Hagemeier, 2012). For 
health care facilities that have large quantities of unused pharmaceuticals, protecting the 
environment is a major issue. 
Attitudes and Behavior of Health Professionals and Patient Health Care Facilities 
In response to compelling evidence of detectable levels of various pharmaceutical 
compounds in waterways across the United States, the EPA (2008, 2010) embarked on 
research investigating the pharmaceutical disposal practices of health care facilities. The 
study was driven by the assumption that health care facilities continue to discard large 
quantities of unused pharmaceuticals to sewers, to the detriment of the environment and 
public health. For the most part, federal, state, and local regulations governing the 
disposal of medical waste were the main influence on disposal practices. However, size, 
ease, and access of disposal, and financial cost also impacted unused pharmaceutical 
disposal. Due to differences in regulations governing hospitals and long-term care 
facilities, long-term care facilities had more constraints on returning unused medications. 
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The investigators concluded that the widespread adoption of best management practices 
could have a substantial impact on the amount of unused pharmaceuticals entering the 
aquatic environment (EPA, 2008, 2010). 
To encourage proper disposal, the EPA (2010) developed a list of best-practice 
guidelines for health care facilities. The first step in the process entails conducting an 
inventory of pharmaceuticals used at the institution, and identifying the unused 
pharmaceuticals, the reasons for waste, and the practices currently used for management 
and disposal (EPA, 2010). Taking inventories and maintaining a comprehensive database 
is essential to the practice of green pharmacy (Daughton, 2003a, 2003b). 
The initiation of a waste-management program includes a set of diverse 
techniques for waste segregation to meet all relevant regulations and potentially minimize 
costs (EPA, 2010). An essential component of a good waste-management program is staff 
training for pharmacists, nurses, and other personnel involved in managing unused 
pharmaceuticals. The EPA recommends that staff members are trained to recognize when 
unused medications should be returned to the pharmacy or when they should be 
discarded, and in what manner. Training should be ongoing with refresher sessions to 
keep staff members current, and their feedback should be solicited for continuous quality 
improvement. Other strategies include prominent signs and posters to remind staff 
members of the disposal policy, and waste-management audits conducted at the time of 
pharmaceutical stocktaking. Sapkota, Gupta, and Mainali (2014) presented the case study 
of a hospital in Nepal that radically transformed poor waste-management practices with 




Sapkota et al. (2014) presented the first study from Nepal to examine the impact 
of a training intervention on the health care waste-management practices of hospital staff. 
Prior to the intervention, the government hospital in Katmandu had no formal policy or 
protocols for handling health care waste. Under the leadership of the hospital’s executive 
director, a health care waste-management committee was organized, with the director 
assuming responsibility for all the committee’s activities. Representatives from all 
hospital units and departments served on the committee, which drew up a policy and 
standard operating procedures aligned with national waste-management and 
environmental regulations. Participants in the training program were nurses, doctors, and 
waste handlers from the hospital’s obstetrics, gynecology, pediatrics, medicine, and 
orthopedic wards. Based on safe health care waste-management practices recommended 
by WHO, the program included orientation to health care waste management, standard 
operating protocols, and legal provisions for safe waste management, segregation, 
collection, and handling techniques for different types of hospital waste, along with safe 
occupational health and safety issues and safe injection practices. 
A nurse from each ward was entrusted to counsel and record activities related to 
waste management (Sapkota et al., 2014). As each new patient was admitted, the nurse 
would give caregivers a brochure developed by the committee, containing comprehensive 
information on the hospital’s waste-management protocol. The committee enacted 




Pre- and postinformation on the waste-management practices, before the study 
and 8 months later, was compared using the Individualized Rapid Assessment Tool 
created by the United Nations Development Program Global Environment Project 
(Sapkota et al., 2014). The preintervention assessment revealed highly inadequate waste-
management practices. Prior to the study, the hospital tended to work on the principle of 
reduce, reuse, and recycle, which could be dangerous in a hospital setting. Procedures 
changed dramatically after the intervention. Procedures were carried out meticulously. 
Improvements were captured in postintervention Individualized Rapid Assessment Tool 
scores, which soared from a dismal 26% to 86% (Sapkota et al., 2014). 
Several positive features contributed to the success of the project: a dedicated 
waste-management team, effective leadership, diligent planning, sound organization, 
sufficient funding, and the enthusiastic involvement of trained staff (Sapkota et al., 2014). 
These attributes are valuable, if not indispensable, for any change-management initiative. 
In addition to standardizing and improving waste management in health care settings, the 
same type of leadership, teamwork, planning, and organization could transfer to 
community programs for encouraging safe and environmentally friendly disposal of 
pharmaceutical waste. 
Nurses 
Given the holistic and caring orientation of nursing, the nursing literature is 
replete with calls to adopt safe practices that protect the environment (McKown & 
Pawloski, 2013; Ortner & McCullagh, 2010; Shaner-McRae, McRae, & Jas, 2007). 
Nurses counsel and educate patients, which provides them with excellent opportunities to 
inform and educate patients about safe medication disposal. At the same time, it is 
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unclear if nurses follow best practices in disposing of pharmaceuticals. In particular, 
nurses who work in home care are not governed by the stringent regulations for disposing 
of hospital waste. 
McCullagh et al. (2012) explored the medication disposal practices and attitudes 
toward medication disposal of home hospice nurses. Home hospice nurses provide 
holistic palliative care to terminally ill patients and their families. Educating patients and 
caregivers regarding how to safely store, manage, and dispose of medications is an 
essential part of their professional role. Upon a patient’s death, however, the nurse is 
often entrusted with the responsibility of discarding unused medications. 
McCullagh et al. (2012) developed their survey based on items drawn from a 
previous study. The researchers pretested the items with a group of five home hospice 
nurses, and revised based on their feedback. McCullagh et al. designed two parallel 
measures to capture  drug disposal practices among nurses and related attitudes and 
beliefs among nurses. A total of 138 home hospice nurses completed the online survey. 
As a group, participants were experienced health care professionals and close to two-
thirds (64%) had been working in hospice care for more than 5 years. Almost half the 
nurses (44%) reported disposing of 11 or more medication doses upon a patient’s death. 
Although roughly two-thirds (64%) of the nurses reported always or often mixing the 
drugs with undesirable substances, as recommended, more than half reported discarding 
them in the toilet or drain with the same frequency. 
The nurses overwhelmingly endorsed the practice of mixing medications with an 
unpleasant substance as acceptable (94%) and safe (91%). Most deemed it unacceptable 
to return the drugs to the hospice (79%) as unsafe or extremely unsafe (61%). The nurses’ 
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rejection of returning drugs to the hospice aligned with legal restrictions on nurses 
transporting controlled substances (McCullagh et al., 2012). 
Nurses obtained their information on medication disposal mainly from the hospice 
manual, regulations, other documents, or in-service training (McCullagh et al., 2012). A 
substantial proportion of nurses, close to one-third, acknowledged they were unfamiliar 
or only minimally familiar with the Centers for Medicare & Medicaid Services Hospice 
Conditions of Participation rules for disposing of medications. Most of the group 
expressed concern about legal and environmental issues, but considered the prospect of 
drug diversion as the foremost issue. 
McCullagh et al. (2012) noted that gap between nurses’ regular practices in 
disposing of medication and federal guidelines for disposing of drugs in home hospice 
care. A marked gap emerged between the almost unanimous endorsement of the safety 
and acceptability of mixing drugs with an unpleasant substance and the number of 
participants who regularly disposed of drugs in that manner. Nurses placed high priority 
on ensuring drugs were not diverted, which could help explain why they were inclined to 
dispose of medication in the toilet or drain. In fact, McCullagh et al. attributed their 
strong concern for drug security to a sociopolitical environment where the “war on 
drugs” is heavily publicized, and health care professionals are acutely aware of their role 
in ensuring drug security: lax drug disposal practices could jeopardize their professional 
license. At the same time, the guidelines for supplanting sewage disposal with the mixing 
technique come from federal agencies. 
In-service training was one source of information on proper medication disposal, 
although it did not appear to be prevalent, as most nurses acquired information though 
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reading materials. Only 16% of nurses had learned about safe medication disposal in 
nursing-education programs. However, McCullagh et al. (2012) acknowledged that this 
could be due to the emphasis on direct patient care in undergraduate nursing education, 
with medication management perceived as the pharmacist’s role. Another reason may be 
that respondents had completed their education before environmental issues were 
recognized as a public health concern. 
The proposed explanation of McCullagh et al. (2012) that nurses’ continued 
disposal of medications to sewage might be due to the high priority they place on drug 
security is consistent with the finding of Cote et al. (2012) that nurses are motivated by 
strong moral norms. In their research, Cote et al. used the TPB to explore the intentions 
of nurses at a Quebec hospital to integrate research evidence into their clinical decision 
making. The researchers noted that since the 1990s, a powerful drive has taken place to 
implement evidence-based practice in health care. Nurses not only represent the largest 
group of health professionals but are considered uniquely important due to their closeness 
to individual patients, sensitivity to community needs, and involvement in virtually all 
aspects of health care, including health promotion, disease prevention, and clinical care. 
Nurses are entrusted with educating patients and caregivers on safe medication storage 
and disposal (McCullagh et al., 2012). Theoretically, nurses’ integration of best-practice 
guidelines for proper medication disposal into their daily decision making constitutes 
evidence-based nursing practice. 
In addition to expanding the TPB to include moral norms, Cote et al. (2012) also 
explored the influence of past behavior. Together, moral norms, normative beliefs, 
perceived behavioral control, and past behavior accounted for 70% of the variation in 
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nurse intentions to integrate research evidence into their practice. Past behavior may be 
especially salient to understanding medication disposal, because disposing of drugs to 
sewage was the accepted practice for so many years (McCullagh et al., 2012; Ortner & 
McCullagh, 2010). Findings by McCullagh et al. (2012) and Cote et al. suggested nurses 
should be educated on why and how current guidelines for medication disposal represent 
clinical best practices. 
Pharmacists 
Abahussain et al. (2012) examined the attitudes and practices of pharmacists in 
Kuwait toward returning unused pharmaceuticals for disposals. The Kuwaiti Ministry of 
Health established guidelines for the disposal of medical waste by hospitals and other 
health care facilities, but with no parallel measures guiding the disposal of medications 
returned by the general public, nor does Kuwait have take-back programs for unused 
medications. Abahussain et al. believed pharmacists are ideally positioned to influence 
the medication disposal practices of consumers. A previous study disclosed that 54% of 
Kuwaiti pharmacists deemed it appropriate for consumers to return unused medications. 
Abahussain et al. addressed the question of whether pharmacists actually received unused 
medications from the public and how they managed their disposal, along with their 
knowledge of environmental knowledge and opinions of medication disposal. 
The sample consisted of 144 pharmacists from six large government hospitals and 
12 specialized clinics (Abahussain et al., 2012). Close to three-quarters of the participants 
(72%) had received unused medications and disposed of them (71%) at their workplace. 
Most participants (73%) simply threw the materials in the trash. Only 16% followed the 
Ministry of Health guidelines for disposing of medical waste. 
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At the same time, the overwhelming majority of pharmacists agreed that 
environmental damage results from disposing of medications in the trash (83%) or in the 
sink or toilet (83%). Virtually all (97%) agreed that protecting the environment is one of 
their personal responsibilities (Abahussain et al., 2012). Most pharmacists viewed their 
workplace as a good venue for disposing of unused medications (86% from clinics, 88% 
of the hospital pharmacists). Other venues suggested were private pharmacies (67%) and 
supermarkets (70%). 
Abahussain et al. (2012) noted that the disposal practices of pharmacists—
throwing unused drugs in the trash or in the sink or toilet—were the same practices used 
by the general public in Kuwait. Therefore, carrying out an effective drug take-back 
program would entail developing guidelines to dispose of returned medications. An 
obvious dichotomy emerged between pharmacist recognition that their disposal practices 
were detrimental to the environment and their sense of responsibility for environmental 
protection. The absence of a formal policy and system for managing unused 
pharmaceuticals that are not classified as medical waste seemed to be the main barrier to 
proper disposal. 
According to Abahussain et al. (2012), pharmacy students “have a golden 
opportunity to participate in promoting awareness and establishing a national drug take-
back program” (p. 199). Pharmacy students represent the future of the profession and 
have the potential to draw effective guidelines and promote their implementation. The 
authors envisioned a central role for pharmacists in conducting patient and community 
education and raising awareness and understanding of the damaging consequences of 
accumulating unused pharmaceuticals and improperly disposing of them. 
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Abahussain et al. (2012) cited a study from the United States documenting a 
successful collaboration between pharmacy students and local officials and businesses in 
providing safe and appropriate medication disposal for the community. Pharmacy 
students often play a central role in drug take-back events in the United States. Ma et al. 
(2014) described the Drug Take-Back events that arose from partnership between the 
Hawaii Narcotics Enforcement Division and the University of Hawaii at Hilo Daniel K. 
Inouye College of Pharmacy. In Broward County’s Operation Medicine Cabinet events, 
pharmacy students and pharmacists count, identify, separate, and document all 
uncontrolled medications, which greatly aids the data-collection process (Fass, 2011). In 
addition, pharmacists and pharmacy students disseminate medication-safety information 
and answer questions raised by consumers, consistent with the role Abahussain et al. 
envisioned. 
Participation by pharmacy students in the United States also reflects the vision of 
pharmacy students as the future direction of the profession. Fourth-year students 
participate in drug take-back events as part of their advanced pharmacy-practice drug-
information rotation (Fass, 2011). Before participating in drug take-back events, students 
are educated on all relevant issues, including prescription-drug abuse, national and 
statewide trends, pharmacology, drug disposal laws and regulations, drug information 
resources, and the role of pharmacists in preventing prescription drug abuse. Students 
must be equipped with requisite knowledge and skills to counsel consumers. The training 
they receive in preparation for drug take-back events is equally applicable to their future 
careers and professional roles when interacting with consumers and educating them about 
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medication use and disposal. Pharmacy students and pharmacists also educate law-
enforcement officials about drugs being returned (Fass, 2011). 
Patients 
The use of oral anticancer medications has increased tremendously since the early 
2000s (Lester, 2012). According to an analysis of insurance claims in Massachusetts, 
16.1% of patients being treated with chemotherapy received oral chemotherapy, and that 
figure is expected to reach 25% as new drugs are continually being developed in response 
to consumer demand (Neuss et al., 2013). Oral medications offer many advantages to 
patients, including the convenience and comfort of being able to administer the drugs at 
home, fewer side effects, less disruption to daily activities, enhanced quality of life, 
sustained exposure to medication, decreased reliance on health care resources, and 
satisfactory outcomes (Lester, 2012; Trovato & Tuttle, 2014). An additional psychosocial 
benefit of taking medication at home is a shift in perspective that views cancer as a 
chronic condition conducive to self-management. 
However, despite the benefits, the new cancer agents have raised concerns 
regarding safe storage and disposal. If not stored properly, the drugs can become 
degraded or contaminated, compromising safety and efficacy. Indoors, the drugs can pose 
a risk to other people and pets, and if disposed of improperly, they can be hazardous to 
the environment. 
Lester (2012) declared, “Information about safe handling and disposal practices 
should be incorporated into professional, patient, and family education” (p. e192). In 
addition, institutions should have standard operating protocols to educate patients and 
family members about safety. In many facilities, however, patient education is not 
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standardized (Trovato & Tuttle, 2014). Standard guidelines exist for the preparation, 
handling, and administration of parenteral chemotherapy in the health care setting, but 
lack parallel guidelines for handling and disposing of oral chemotherapy medications at 
home. 
Various recommendations address the handling of oral anticancer medications 
derived from expert opinion, published recommendations, and policies adopted at the 
government or hospital level (Trovato & Tuttle, 2014). Recommendations for patients 
and caregivers include following written instructions for storing a medication, wearing 
gloves to administer a drug, washing hands after medication administration, limiting 
others’ access to the medication, and returning unused medication to the pharmacy, 
doctor’s office, or hospital. Also included in recommendations are practices to avoid, 
such as exposing the drug to direct sunlight or moisture, leaving medication where 
children or pets can reach it, crushing or breaking pills, and disposing of medication in 
the garbage or toilet. 
The Oncology Nursing Society and the American Society of Clinical Oncology 
jointly developed national standards for the safe administration of oral chemotherapy, 
revised, updated, and expanded in 2012 (Neuss et al., 2013; Trovato & Tuttle, 2014). The 
most recent guidelines, which expound on issues raised by the growing reliance on oral 
chemotherapy, include a detailed section on patient consent and education (Neuss et al., 
2013). Information on the storage, handling, preparation, administration, and disposal of 
oral chemotherapy is an essential component of patient education. 
Adherence is an important issue with a prescribed drug regimen, as inadherence 
adversely affects the ability of the medication to control or eliminate the cancer (Lester, 
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2012). Adherence to anticancer drugs has also become a greater challenge due to the 
increased amount of drugs, drugs that are taken in combination, the longer duration of 
therapy, and the increasing age of patients with cancer. Broadly, all these factors involve 
the increasing presence of pharmaceuticals in the environment (Daughton, 2003a, 2003b; 
Ruhoy & Daughton, 2008; Ruhoy & Kaye, 2010). 
In a rare study on the handling, storage, and disposal practices of patients taking 
anticancer drugs at home, Trovato and Tuttle (2014) surveyed 42 patients (95% male) 
under treatment at a VA hospital. The use of oral chemotherapy at the hospital outpatient 
chemotherapy clinic escalated in the course of a year. Patients were receiving education 
from medical, nursing, and pharmacy staff, but without standardized practices, yielding 
information that was unreliable. 
Of participants who did have unused medication, six returned any leftover drugs 
to the pharmacy (Trovato & Tuttle, 2014). However, another six threw extra medication 
in the garbage. Two participants were uncertain of what they should do with the extra 
medication. Close to half the patients (45%) had not received information on safe 
handling and storage practices. Those who were informed received their information 
from nurses and pharmacists and, to a lesser extent, from physicians. 
Most patients (79%) felt their oral chemotherapy drugs were safe from the 
perspective that the side effects were tolerable (Trovato & Tuttle, 2014). However, 
several raised concerns related to storage, handling, and disposal. Health professionals 
who counsel patients about anticancer drugs often concentrate primarily on 
administration and potential side effects (Trovato & Tuttle, 2014). Time may be a factor, 
so the issues viewed as the most important from the perspective of health professionals 
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are given top priority. The responses clearly revealed a need for better patient education 
on the topic of storage, handling, and disposal of anticancer agents. Notably, the 
pharmacist authors changed their practices following the survey. The pharmacist provides 
patient education immediately after the patient and physician have completed the consent 
process, and the new patient-education guidelines include standard criteria for proper 
drug storage, handling, and disposal that could be adopted by all health care 
professionals. As an additional safeguard, the pharmacist provides a follow-up phone call 
to the patient to reinforce safe-handling procedures, as well as to monitor the patient for 
adverse effects. 
Drug Take-Back Programs 
In 2010, the DEA held the first national Take-Back Days, which produced more 
than 4.1 million pounds of medications in little more than a week (Fain & Alexander, 
2014). However, Fain and Alexander pointed out that although that figure may seem 
impressive, it represents only a small fraction of the medications stored in U.S. homes. 
Fain and Alexander (2014) put forth that retail pharmacies are the ideal venue for 
returning unused medications. More than 70% of people across the United States live 
within 5 miles of a pharmacy chain and make frequent trips to the pharmacies not only to 
fill prescriptions, but to purchase items on a regular basis. In addition to the convenience 
to consumers, pharmacies are well-equipped to develop and implement take-back 
programs, given that they already have systems in place to manage and dispose of unused 
drugs from their inventory. 
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Pre-DEA Involvement in Take-Back Programs 
Pharmacy programs to promote the safe disposal of unused medication predate 
DEA sponsorship. A program involving seven clinic-associated Group Health 
Cooperative pharmacies in Washington State began operations in fall 2006 (Thompson, 
2007). Each pharmacy has a medication disposal bin in their public area. The Washington 
State Board of Pharmacy and Department of Ecology were both involved in the pilot 
program (Thompson, 2007). Pharmaceuticals From Households: A Return Mechanism 
tested two return-and-disposal program models. One model, which works with clinics 
and pharmacies, was designed for consumers, school districts, childcare centers, hospice 
patients’ families, and hotels. The second model was developed for nursing home 
residents. Both models dispose of unused pharmaceuticals through incineration. 
Other programs emerged in other parts of the country. Good Samaritan Hospital 
in San Jose, CA, held a Safe Drug Drop at its pharmacy during National Patient Safety 
Week (Thompson, 2007). The city’s major newspaper provided publicity for the event. 
Plastic storage bags were provided for people to empty the drugs they brought, and a 
pharmacy technician poured the contents into pharmaceutical waste bins. After eight 
hours, the drug drop produced 144 gallons of medication, including one supply that had 
been purchased when Ronald Reagan was president. The pharmacy locked the bins and 
sent them to a firm that incinerates pharmaceuticals. After the 1-day event, the pharmacy 
began keeping a locked disposal box outside so people could simply discard their unused 
pharmaceuticals without help. This practice is now recommended to make it easy for 
people to return unused drugs (Fain & Alexander, 2014). 
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Musson et al. (2007) initiated a self-serve pilot project in Florida, introduced to 
enable people to properly dispose of prescription and nonprescription medications. In an 
area that includes small communities and the city of Gainesville, the researchers chose 
sites to reach the largest number of people. Participants deposited their medications 
directly into a collection container containing tap water or an aqueous acidic solution that 
rendered the medication unrecognizable and unusable. An extensive advertising 
campaign to inform local residents of the program accompanied the inception of the 
program. The campaign made use of newspapers, local cable television, and the Internet. 
Challenges encountered in developing the program highlighted how much drug 
disposal programs have progressed in the last decade (Musson et al., 2007). Despite 
multiple attempts to gain their participation, major pharmacy chains declined to 
participate, due to possible public perceptions that pharmacies would reuse the returned 
medications, legal implications of accepting drugs dispensed by another pharmacy, 
concerns that patient confidentiality would be compromised, concerns over the security 
of controlled substances, and lease provisions that prohibited the acceptance and storage 
of returned merchandise. In spite of the obstacles, Florida residents did have access to a 
simple and convenient way to dispose of medications. Recent take-back programs 
addressed some of the concerns expressed by pharmacies, and with the involvement of 
the DEA, returning controlled substances is not a barrier. Some pharmacies have raised 
issues about cost due to new DEA regulations (Fain & Alexander, 2014). Now, as when 
Musson et al. (2007) began the self-serve pilot project, consumers are attracted to an 
option to dispose of drugs that is simple and available. 
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Post-DEA Involvement Take-Back Programs 
Gray and Hagemeier (2012) investigated characteristics of individuals who 
participated in medication take-backs, and the medicines they disposed of in the rural 
Appalachian area of northeast Tennessee and southwest Virginia. The study covered 11 
events held between 2009 and 2011. During that time, 752 individuals donated 16,956 
containers of medications prescribed for 1,210 patients. Donors were overwhelmingly 
White, averaged 40 years old, and women comprised more than half of the group (57%). 
In descending order, the main reasons for participating were a desire to clean out their 
medicine cabinets (68%), environmental concerns related to disposing of drugs and other 
waste materials (45%), and concerns about accidental poisoning (14%). 
Safe Medicine Disposal for the State of Maine (ME) has been hailed as a model 
program for medication disposal (Ruhoy & Kaye, 2010). The unique program allows 
people to anonymously mail controlled and uncontrolled drugs free of charge through the 
postal service. High rates of deaths from prescription drug overdose throughout the state 
drove the Maine initiatives (Stewart et al., 2015). In 2009, prescription overdose 
surpassed all other causes of death among Maine residents, and in 2012, the Centers for 
Disease Control and Prevention reported that of all states, Maine has the highest rate of 
prescriptions for high-dose opioid pain relievers. 
The mail-in program accompanied DEA take-back events until 2013 (Stewart et 
al., 2015) and currently runs under the direction of the University of Maine Center on 
Aging. Consumers obtain prepaid tamper-resistant envelopes from roughly 150 
community distributors, including pharmacies, medical offices, community 
organizations, police departments, hospice, and other sites located throughout the state 
90 
 
(Ruhoy & Kaye, 2010). Each envelope has clear, explicit instructions for safely 
packaging and mailing pharmaceuticals in various forms. Although program advocates 
often cite the ease of returning drugs through the postal services as its defining 
characteristic, Ruhoy and Kaye (2010) viewed its outstanding feature as that the program 
systematically collected data on the returned medications and the people participating in 
the program. Ruhoy and Daughton (2008) consistently called for a comprehensive 
database on returned medications (Daughton, 2003a, 2003b; Ruhoy, 2009; Ruhoy & 
Daughton, 2008). 
According to the collected data, each returned envelope contained roughly seven 
ounces of drugs and an average of four medications (Ruhoy & Kaye, 2010). Controlled 
substances constituted nearly 14% of the returned drugs. Painkillers, antianxiety drugs, 
antidepressants, and cardiovascular drugs comprised about 25%. Accompanying surveys 
provided valuable information. Nearly half of participants reported they would have 
flushed the drugs down the toilet without the simple option of the mail-back program, 
and one-third would have discarded them in the trash. The survey data also revealed 
numerous reasons for accumulating drugs in the home, including discontinuation due to 
allergies or side effects, death of the patient, explicit instructions by the doctor to 
discontinue the medication, feeling better, and not wanting to take the drug as it was 
prescribed. 
Ruhoy and Kaye (2010) attributed much of the program’s success to collaboration 
across multiple agencies. Furthermore, the process is simple and user friendly, has 
numerous quality and safety checks built into the design, minimizes the number and cost 
of intermediary staff, and demands minimal effort on the part of the participants. Safe 
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Medicine Disposal for ME was initially funded by the Aging Initiative to serve Maine’s 
aging population. The program also sponsors a cadre of older adults who provide 
presentations on medication disposal to community groups. These volunteers are the 
cornerstone of the program’s outreach and education initiative. They offer community 
members opportunities to discuss various issues relevant to their communities. 
Safe Medication Disposal for ME is a model program for several reasons (Ruhoy 
& Kaye, 2010). First and foremost, the program prevents the damaging environmental 
impacts and health hazards of disposing of drugs by flushing or throwing them in 
household trash. Second, the process is easy, convenient, and anonymous. Third, the 
program takes advantage of the security protocols of the postal service. Fourth, Maine 
has a large rural population, and the program is easily accessible to individuals residing 
in rural areas with no take-back events or drug disposal sites. Moreover, the program also 
appeals to individuals who might not be able to take advantage of events, such as those 
who are ill or infirm. Finally, the program is able to accept controlled substances because 
the drugs are mailed directly to the Maine Drug Enforcement Agency. 
The program builds on a unique collaborative partnership between environmental, 
drug enforcement, and health care officials at the federal, state, and local levels (Ruhoy & 
Kaye, 2010). From a social perspective, the program addresses the concerns of multiple 
stakeholders because it has the capacity to reduce the number of drug-related crimes and 
opportunities for drug abuse. It is also cost efficient because it provides consumers with a 
safe alternative to keeping drugs at home. As information about Safe Medication 
Disposal for ME has been disseminated, it has become a model for shaping state and 
national public policy, medical prescribing practices, and health-education outreach 
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tactics. Reflecting the green pharmacy or upstream approach to reducing medical waste 
in the environment (and opportunities for drug abuse), in 2009, Maine began limiting 
first-time prescriptions to 15 days for certain drugs prescribed for Medicaid recipients. 
Subsequently, the state has added more drugs to that list. 
The Maine Prescription Monitoring Program database acts as a tracking and 
monitoring system for the prescription and distribution of controlled substances. 
However, at the time of their study, only about half the state’s prescribers were registered 
with the program (Stewart et al., 2015). Despite widespread publicity on prescription-
drug misuse nationwide, researchers noted remarkably little knowledge attests to 
prescription waste in communities across the country. Stewart et al. (2015) analyzed data 
on unused medications collected in 11 Maine cities from 2011 to 2013, covering six DEA 
take-back events. The researchers had two major goals: to provide information to health 
care providers and public health officials about the amount and types of prescription-drug 
waste, and to raise awareness of medication waste in local communities and its potential 
consequences in poisoning, abuse, misuse, and diversion of prescription drugs. 
Doctor of pharmacy candidate volunteers carried out the project, supervised by 
licensed pharmacists, with direct oversight from local law-enforcement officials (Stewart 
et al., 2015). The take-back events generated 13,599 medications of all types returned by 
1,049 participants. Controlled substances represented 9.1% of the drugs collected, 
virtually identical to the proportion reported in the Appalachia study (Gray & Hagemeier, 
2012). Uncontrolled prescription drugs accounted for 56.4% of the medications collected 
(Stewart et al., 2015). Cardiovascular drugs consistently formed the largest proportion of 
drugs returned. Beyond medication disposal programs, “medication education is an 
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essential component of the overall solution” to the escalating public health problem of 
prescription drug overuse (Stewart et al., 2015, p. e69). The ONDCP (2011) report 
contained a large section on education. The report pointed out that antidrug campaigns 
have such great emphasis on illicit drugs that people are unaware of the dangers of 
prescription drugs. Education covers health care providers as well as consumers (with 
special attention to parents and youth), and is an important strategy to reduce 
overprescribing. Safe medication disposal is an essential component of education for 
health professionals and the general public. One strategy in the ONDCP (2011) report 
involves working with private-sector groups to create an evidence-based media campaign 
on prescription-drug abuse tailored to parents, to inform them of the risks and importance 
of storing drugs securely and disposing of them properly. 
Ma et al. (2014) presented the results of 11 drug take-back events in which the 
University of Hawaii, College of Pharmacy collaborated with the Narcotics Enforcement 
Division. The events took place in 2011 and 2012. The Good Life Senior Expo in 
Honolulu, an annual 3-day exposition, hosted two of the largest events. Several Kaiser 
Permanente clinics hosted the remaining nine events. Both events were advertised in the 
media (television, radio, and newspapers), through brochures and flyers in pharmacies 
and doctors’ offices, and by word of mouth. All returned medications were recorded with 
their generic name, drug class, dose, quantity, and dosage format. Narcotics Enforcement 
Division agents and students and faculty of the pharmacy college counted, identified, and 
documented the drugs. As with all drug take-back events, law-enforcement officials were 
present at all times, and were responsible for the destruction of the drugs. 
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Ma et al. (2014) surveyed participants at the 2011 Good Life Senior Expo 
regarding their prior experiences with unused or expired medications. Most participants 
learned about the event through newspaper or TV advertisements. Before the take-back 
events, the most common methods for managing unused drugs were throwing them in the 
trash (34%), keeping them at home (32%), or flushing them down the toilet (24%). Only 
10% had returned medications to a pharmacy or medical office. Two-thirds of 
participants kept unused medications at home for a year or more. Virtually all participants 
(> 99%) wanted the take-back events to continue. 
The 11 events produced a total of 8,011 pounds of medication, with most drugs 
taking the form of pills or tablets (Ma et al., 2014). Participants returned few liquids, 
intravenous drugs, dermal patches, lotions, creams, or suppositories. The largest quantity 
fell into the category of “Other” or miscellaneous. Antihypertensives were the next 
largest drug class, consistent with the overriding presence of cardiovascular drugs in the 
Maine take-backs (Stewart et al., 2015). Other drugs returned in large quantities were 
gastrointestinal drugs and analgesics. The most prevalent OTC drugs were in this last 
category: aspirin, naproxen, and ibuprofen. In addition, participants returned a substantial 
amount of pseudoephedrine. Pseudoephedrine is used in the manufacture of 
methamphetamine and is one of the most common OTC drugs returned. 
Controlled substances comprised 10% of the drugs returned (Ma et al., 2014). 
Similar proportions seem to be relatively consistent with other take-back programs (Gray 
& Hagemeier, 2012; Stewart et al., 2015). Although consumers returned most of the 
drugs, clinics and other facilities also returned drugs such as long-term-care facilities and 
95 
 
clinical trials. The researchers did not collect demographic information about 
participants. 
Ma et al. (2014) are staunch advocates for continuing and expanding medication 
take-back programs. Clearly, the results of their survey confirmed the popularity of take-
back for the Hawaiian public. Following the example of Alameda County, California, the 
researchers called for efforts to identify potential champions and stakeholders including 
consumers, government organizations, and “all parties involved in the medication chain 
of manufacturing, ordering, prescribing, dispensing, administering, and monitoring” 
pharmaceuticals (Ma et al., 2014, p. 30). Soliciting involvement from all entities would 
greatly expand the number and type of facilities to which consumers could return 
medications. To facilitate ease and convenience and make disposal immediately 
accessible, Ma et al. recommended strategies such as installing take-back lock boxes in 
pharmacies and law-enforcement offices, regularly scheduled medication take-back 
events in accessible venues, and the distribution of prepaid return envelopes with all 
medications dispensed. 
Kotchen et al. (2009) queried respondents on their willingness to pay for a 
medication disposal program in their survey of medication disposal preferences and 
practices. One problem with surveys of medication disposal is that most are based on 
small convenience samples. Kotchen et al. gathered data from respondents to the annual 
Central Coast Survey covering 1,005 California households. In addition to questions 
regarding general awareness of pharmaceutical pollution, disposal practices, and 
willingness to participate in a disposal program, the authors added the question of paying 
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to establish a drug disposal program. The cost would be a surcharge added to 
prescriptions. 
The effect derived from their analysis was that starting with a mean bid of $1.07, 
every increase of $.10 decreases the likelihood of an affirmative response by 0.01. 
Overall, however, Kotchen et al. (2009) found that a substantial proportion of 
respondents were willing to pay. Less than half the respondents (43%) were aware that 
pharmaceutical substances had been found in their wastewater. For disposal practices, the 
findings were largely consistent with most studies, with disposal in the trash as most 
prevalent (45%), followed by disposal in the sink or toilet (25%). Only 5% returned their 
unused drugs to a pharmacy or a hazardous-waste site; 12% of the sample kept 
medications at home. Knowledge proved to be an important predictor of behavior. 
Respondents who were aware of environmental pollution were less likely to dispose of 
medications to trash or sewage, and three times more likely to return them to a pharmacy 
or bring them to a hazardous waste site. Older respondents were more than twice as likely 
to return drugs to a pharmacy than were younger adults, possibly because they used more 
prescriptions and thus had more pharmacy visits. 
Recycling and Environmental Protection 
Pearson et al. (2012) examined attitudes and behavior regarding recycling among 
low-income Latina women attending a clinic in southeast Texas. The influence of 
sociocultural factors, including acculturation, was a key focus of study. According to 
Pearson et al., the women held two contrasting viewpoints on the environmental attitudes 
of individuals born in developing countries. From one perspective, participants thought 
they were less likely to engage in behavior to protect the environment as a result of more 
97 
 
immediate concerns about economic security. However, that viewpoint would seem to be 
more of a matter of socioeconomic status than cultural influence, and might be equally 
applicable to low-income individuals regardless of heritage. According to the contrasting 
perspective, individuals from developing countries might be more sensitive to 
environmental issues due to environmental damage in their home countries. The literature 
on pharmaceuticals and the environment suggested the problem draws extreme concern 
in developing countries due to the latter reason, and a lack of government regulations on 
medication disposal (Abahussain et al., 2012; A. Kumar et al., 2010; Sahoo et al., 2010; 
Sapkota et al., 2014). 
Participants were 1,512 Latinas, with 37% born in the United States and the 
remaining participants born in Mexico, Puerto Rico, and various Central American and 
South American countries (Pearson et al., 2012). An acculturation scale accompanied a 
survey designed to assess knowledge, beliefs, behavior, and the type of recycling services 
offered in their locale. Highlighting the importance of having convenient, accessible 
facilities, women residing in areas where recycling facilities included both curbside 
services and drop-off facilities were more likely to recycle than those living in areas with 
no recycling facilities or only one of the two services. 
Knowledge and convenience positively linked with recycling, whereas lack of 
knowledge and inconvenience were major barriers to recycling (Pearson et al., 2012). 
Acculturation inversely linked with recycling, and income was not a factor, possibly due 
to the relatively small variation in income among participants. As a group, the women 
who were less predisposed to recycle were not aware that recycling saves landfill space, 
and considered it too time-consuming. Less than half the women recycled or lived with 
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someone who recycled. These findings are congruent with the HBM (Nisbet & Gick, 
2008; Strecher & Rosenstock, 1997). It seems probable that similar patterns would 
emerge in returning medications to a disposal site. The difference is that recycling 
facilities are far more prevalent in most communities. The Pearson et al. assertion that 
education would overcome lack of awareness of the importance of recycling runs 
throughout the literature on medication disposal. 
Focus groups can serve as excellent vehicles to solicit input from prospective 
participants on what community programs may need to be successful in managing 
hazardous substances. Smolenske and Kaufman (2007) aimed to guide the design of a 
community-education program to raise awareness of hazardous substances in the home 
and promote safe storage and disposal practices. The project began with a pilot survey 
based on data analyzed from calls to a poison-control center in Genesee County, 
Michigan. The researchers selected a total of 10 substances that presented the greatest 
hazard to children. Smolenske and Kaufman gave prescription medications the highest 
hazard rating of substances, which also included ibuprofen, acetaminophen, bleach, 
cosmetics, birth-control pills, silica gel packets, vitamins with iron, hydrogen peroxide, 
and mercury thermometers. Notably, more than half the hazardous substances are 
pharmaceuticals. 
Smolenske and Kaufman (2007) chose 13 residents for the focus group and used 
their input to refine the survey (Smolenske & Kaufman, 2007). The survey covered four 
broad areas: (a) room location and storage elevation, (b) awareness of the Poison Control 
Center, (c) sources of information about hazardous household materials, and 
(d) residents’ participation in activities such as recycling and pickup programs for 
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hazardous household materials. The survey proved to be an effective assessment tool to 
understand consumers’ perceptions of poisoning risk. The level of awareness was low, 
confirming the need for an education campaign. Others can use a similar strategy to 
create an educational campaign to raise people’s awareness of the risk of storing 
medication at home and of proper disposal practices. Focusing the campaign at the 
community level also provides an opportunity to solicit opinions and preferences related 
to drug take-back programs and other options to dispose of unused pharmaceuticals. 
Summary and Conclusions 
During the 1990s, a proliferation of scientific studies documented the presence of 
trace amounts of pharmaceuticals in the aquatic environment. Pharmaceutical pollution of 
the environment is a global problem (WHO, 2011). In the United States, previous advice 
to consumers and health care professionals alike had been to dispose of unused 
medication by flushing it down the toilet or rinsing it down the sink drain (McCullagh et 
al., 2012; Ortner & McCullagh, 2010). Pharmaceutical compounds remain in treated 
sewage and have even been found in drinking water. Thus, improper disposal of 
medication is a threat to the natural environment and to public health. 
With collaboration from the DEA and laws that include the disposal of controlled 
substances, drug take-back programs are the best mode for disposing of unused and 
unwanted medications. Current data is preliminary, but programs have brought in 
millions of pounds of pharmaceuticals and have been greeted favorably by participants 
(Fain & Alexander, 2014; Gray & Hagemeier, 2012; Ma et al., 2014). Participants who 
attended take-back events expressed a desire for ongoing programs. Availability and 
convenience emerged as key factors in participation. Providing consumers with a locked 
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disposal bin that they can access at all times may be critical to promoting widespread 
participation. 
Education is another important concern in raising awareness of drug take-back 
programs, but also of proper (and improper) medication disposal practices and the 
dangers of keeping unused or expired medications in the home. Similarly, numerous 
studies by health psychologists demonstrate that knowledge per se is inadequate to 
change behavior (Nisbet & Gick, 2008). Even nurses and pharmacists displayed a gap 
between what they consider best practices in medication disposal, and their actual 
behavior (Abahussain et al., 2012; McCullagh et al., 2012). Based on the limited research 
on medication take-back programs and studies involving recycling behavior, removing 
barriers and easing access to drug return sites may be the most effective way to 
encourage proper disposal practices. Maine’s mail-back program requires minimal effort 
by consumers and is successful (Ruhoy & Kaye, 2010). Stakeholders have hailed the 
program as a model program, and other states and communities are learning from the 
features that contribute to its success. 
This study examined the associations of knowledge of the environmental and 
human-health impacts of medication disposal, knowledge of proper medication disposal 
practices, and the availability and convenience of disposal sites in a sample of residents 
in the northeast United States. In Chapter 3, I describe the methodology that I used to 
conduct and analyze the data from this study. 
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Chapter 3: Research Method 
Introduction 
The purpose of this quantitative cross-sectional study was to investigate 
consumers’ practices in disposing of unwanted, unused, and expired pharmaceutical 
prescriptions drugs. In addition, I provide insights as to whether disposal practices are 
influenced by consumers’ knowledge of the impact of pharmaceutical disposal on the 
environment and human health, and awareness of the recommended disposal options. An 
analysis of the most applicable theoretical frameworks in the context of pharmaceutical 
disposal has provided important insights, identifying key dependent and independent 
variables used in this study. 
According to Nisbet and Gick (2008), despite parallels between health and 
environmental behavior, the fields of health promotion and health behavior change are 
rarely applied to environmental issues. Environmental behavior is multifactorial; 
consequently, I considered two theoretical frameworks for behavior change: the HBM 
and the TPB. 
The TPB was most relevant to the issue of proper pharmaceutical disposal from 
the perspective of the motivation that results in the intention to perform an action or 
behavior. The aim was to discern whether consumers’ knowledge or perceptions of 
disposal practices and their impact on human health precipitated motivation. In addition, I 
aimed to determine whether information received, if any, on disposal recommended 
practices motivated consumers. Finally, I evaluated whether both factors influenced 
consumer action and to what degree. 
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In the literature, the HBM aligned with studies that involved recycling and 
environmental protection. Strecher and Rosenstock (1997) discussed how perceived 
barriers were the decisive factor in the adoption of health-related behaviors. 
Consequently, one objective of this study was to examine the degree to which the 
availability and convenience to reach and use locally available disposal options impacted 
consumers’ actual disposal practices. 
This chapter contains a discussion of the research design and the methodology of 
the study. In the next section, I discuss the rationale for the research design, followed by 
discussions of the population, the sample, data collection, and instrumentation. I describe 
the data-analysis plan, followed by discussions of validity and ethical issues of the study. 
Finally, I conclude this chapter with a brief summary. 
Research Design and Rationale 
Actual disposal practices was the outcome (dependent) variable in this study. As 
suggested by the reviewed literature, this study used the following key independent 
variables: (a) knowledge of environmental and human-health impact, (b) knowledge of 
recommended disposal practices, and (c) availability of disposal options. Data on the 
outcome variable and the independent variables were collected using a questionnaire. 
The research design was quantitative and cross-sectional. A quantitative method 
is appropriate when the researcher’s goal is to examine associations between quantifiable 
and objectively measurable concepts (Howell, 2010). My main objective in this study 
was to investigate the hypothesized association between consumers’ actual disposal 
practices (outcome of interest/dependent variable) and the factors (independent variables) 
that may have influenced them. Because the variables under investigation are quantifiable 
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and objectively measurable, a quantitative method was appropriate. Specifically, I 
selected a cross-sectional design because my aim was to examine the associations 
between variables measured at a single point in time. Typical disadvantages of using a 
cross-sectional design include the challenges associated with establishing causal 
inferences, and the notion that the findings represent the phenomenon in a single time and 
place (Pine et al., 1997). To inspire social change, results from this study provide the 
basis for recommendations that include the design of health-promotion programs that 
encourage optimal drug disposal practices, encourage the simplification of disposal 
options, improve patient drug compliance, and generate momentum for the development 
of drugs that are less toxic to the environment. In aggregate, if adopted, the 
aforementioned approaches could mitigate the risks to human health posed by 
pharmaceutical contaminants in the environment. 
Methodology 
Population 
The population of this study was a sample of residents of the northeast United 
States. The U.S. Census Bureau (n.d.) defined the northeast region as comprising nine 
states: Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont, 
New Jersey, New York, and Pennsylvania. As of 2013, the estimated size of this 
population was approximately 56 million residents. 
Sampling and Sampling Procedures 
The sampling approach for this study was convenience sampling. A convenience 
sampling method is appropriate when a true random sample is not feasible to obtain. 
Because I was unable to survey all possible residents in the northeast United States, a 
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convenience sample approach was appropriate. The participant sample for this study 
consisted of residents of the northeast region of the United States who were aged 18 years 
or older and had used a prescription drug in the prior two years. I recruited participants 
who met these criteria using SurveyMonkey’s online participant pool. I calculated the 
appropriate sample size using the SurveyMonkey sample-size tool, using the following 
parameters: (a) population size = 55,943,073, corresponding to the entire northeast region 
(U.S. Census Bureau, n.d.), (b) confidence level = 95%, and (c) margin of error = 5%. 
The resulting sample size was 385 (SurveyMonkey, 2016) 
Procedures for Recruitment, Participation, and Data Collection 
After obtaining IRB approval to conduct the study, I employed SurveyMonkey’s 
online survey platform to recruit participants for this study. Cottrell and McKenzie 
(2010) argued that researchers could not assume that most U.S. residents would be 
sufficiently computer literate and have Internet access to complete a survey online. In the 
last few years, however, Internet access and broadband have become so widely available 
that even large and popular government programs, such as the Affordable Care Act 
(HHS, n.d.), are administered through the Internet. In addition, according to the U.S. 
Census Bureau, the northeast United States has one of the highest rates of Internet access 
in the country (File, 2013). Thus, I deemed the online medium to be practical and 
efficient for the administration of the survey questionnaire. The survey was anonymous, 
compliant with the data-privacy rule (HHS, 1996), and administered electronically 
through the Internet using a secure (encrypted) line. Potential participants were people 
who had used SurveyMonkey’s Audience services in the past, and had participated in 
other surveys. SurveyMonkey sent an invitation to these potential responders to 
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participate in the survey; for each completed survey, SurveyMonkey made a donation to a 
charitable institution; participants did not receive any monetary incentive from 
participating except that completion of the survey would result in a donation to charity. 
Aligned with Walden University’s IRB policy regarding participation in surveys 
in which the participants have the option to take or decline to take a survey, I had no need 
for a separate consent form; however, I informed potential participants of their rights and 
provided them with contact information for the Walden University IRB and me, in case 
they had any questions. Individuals who agreed to participate and met the inclusion 
criteria were directed to the survey that contained the study instrument. I planned the 
survey to be open to potential participants for 3 weeks; however, the target sample size 
was reached and exceeded in a shorter period of time. At the end of the survey 
recruitment period, SurveyMonkey made available for download from their secure server 
two files with all the data: one Excel and one SPSS-formatted file. I stored the data files 
on a password-protected personal computer to which I was the only one with access. In 
addition, all data were backed up onto a password-protected external storage medium, 
stored safely in a location different from that of the personal computer. 
Instrumentation and Operationalization of Constructs 
The contents of the survey instrument for this study were adapted from items used 
by Seehusen and Edwards (2006). I received approval for the use and adaptation of the 
questionnaire from the main author, and the approval letter can be found in Appendix A. 
The final draft version of the questionnaire was pilot tested after IRB review and 
approval, following the process recommended by Radhakrishna et al. (2003) and 
Bolarinwa (2015). The process for pilot testing consisted of providing the questionnaire 
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to a convenient subsample, separate and in addition to the final target sample (N = 385). 
The subsample was originally planned to be 10% of the final target sample, and thus to 
include 39 participants; however, the final number of the subsample consisted of a larger 
number of participants, thanks to an efficient recruitment by SurveyMonkey’s service. As 
part of the pilot testing, subsample participants evaluated each question of the 
questionnaire for clarity, legibility, and comprehensiveness. Seehusen, author of a 
published study on medication disposal, reviewed the content and provided favorable 
feedback. I archived Seehusen’s feedback and e-mail exchanges (see Appendix A). 
The survey (see Appendix B) consisted of content questions used to measure the 
constructs of interest, as well as demographic questions. The first question of the survey 
was intended to measure the dependent variable—actual disposal practices—and asked 
survey participants, “What is your most used method for disposing of unused or expired 
medications?” Participants answered this question by selecting one of eight possible 
response options that included “I flush them down the toilet, “ and “I follow the disposal 
instructions that accompany the medicine,” among others. 
The next questions on the survey were, “In your area, is there a designated 
collection location where you can dispose of your unused or expired medication?” and 
“How convenient is it for you to reach the designated disposal location?” I used these 
questions to represent the independent variable: available disposal options. Next, 
participants answered the question, “Do you believe that improper disposal of 
medications in the environment could have negative consequences on human health?” 
Participants responded to this question on an ordinal scale, and I used their responses to 
represent the independent variable: knowledge of environmental and human health 
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impact. I also asked participants four questions using categorical and ordinal response 
scales to assess knowledge of disposal practices. I used these questions to represent the 
independent variable: knowledge of recommended disposal practices. Finally, I asked 
participants to provide basic demographic information. Specifically, I asked them to 
report their gender, year of birth, race, highest level of education completed, and state of 
residence. 
I scored questions related to knowledge and awareness using a coded ordinal 
scale, as suggested by Monnin and Perneger (2002). In contrast, data from the dependent 
variable, actual disposal practices, were categorical. A dichotomous, Yes/No outcome 
was used to assess and code the dependent variable. 
Data-Analysis Plan 
I conducted all data analyses using SPSS (IBM, 2016). SPSS is a software 
package used to perform statistical analysis. In 2009, IBM acquired SPSS Inc., and since 
then, its official name has become IBM SPSS Statistics. Although originally intended to 
be used in the realm of social sciences, this software is used in a variety of fields, such as 
data mining, market research, government, and education. The latest version of SPSS 
Statistics v 24.0 was released on March 15, 2016. 
Upon completion of the data collection, I reviewed and cleaned the data to ensure 
all the records had sufficient and accurate data for analysis. I accomplished this process 
by running frequency distributions for each variable, ensuring the data were within the 
acceptable range. Given that the data were collected electronically, using a web-based 
form that only accepts predefined input values, there were no out-of-range data values; 
however, there were records with missing data. In Chapter 4, I describe the specific 
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information regarding missing data and the records that had to be removed from the 
analyses due to incomplete data inputs. 
In addition to descriptive statistics, binary logistic regression was the key 
statistical procedure employed to address and explore the following research questions 
and hypotheses: 
RQ1: Is there an association between knowledge of the environmental and the 
human-health impact of pharmaceutical disposal and actual disposal 
practices? 
H01: No significant association exists between knowledge of the environmental 
and the human-health impact of pharmaceutical disposal and actual disposal 
practices. 
RQ2: Is there an association between knowledge of recommended disposal 
practices and actual disposal practices? 
H02: No association exists between knowledge of recommended disposal 
practices and actual disposal practices. 
RQ3: Is there an association between available disposal options and actual 
disposal practices? 
H03: No association exists between available disposal options and actual disposal 
practices. 
RQ4: To what degree can actual disposal practices (the dependent variable) be 
explained by the combined and differential contribution of the three 
independent variables, specifically, knowledge of the environmental and 
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human health impact, knowledge of recommended disposal practices, and 
locally available disposal options? 
H04: Actual disposal practices cannot be explained to a significant degree by the 
combined and differential contribution of knowledge of the environmental and 
the human-health impact, knowledge of recommended disposal practices, and 
locally available disposal options. 
RQ5: Do differences exist among RQ1, RQ2, and RQ3 across demographic 
groups? 
H05: No significant demographic differences exist in the relationships of 
knowledge of the environmental and the human-health impact, knowledge of 
recommended disposal practices, and locally available disposal options to 
actual disposal practices. 
Binary logistic regression is an appropriate statistical-analysis procedure when the 
researcher’s aim is to determine whether significant associations exist between multiple 
independent variables and a single dichotomous dependent variable. In this analysis, the 
dependent variable was actual disposal practices. I coded actual disposal practices as a 
dichotomous variable where 0 = unrecommended disposal practice, and 1 = 
recommended disposal practice, based on participants’ responses to the question, “What 
is your most used method for disposing of unused or expired medications?” The 
independent variables were the survey questions pertaining to knowledge of 
environmental and human-health impacts, knowledge of recommended disposal 
practices, and availability of disposal options. I assessed the significance of the overall 
model using the chi-square fit statistic at a significance level of .05. I calculated 
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McFadden’s R2 to assess model fit, where values of .2 or greater indicated good model fit 
(Louviere, Hensher, & Swait, 2000). The plan was that if the overall model was 
significant, I would explore individual model coefficients to determine which 
independent variables were significantly associated with the dependent variable. 
Given that logistic regression is heavily influenced by multicollinearity, I used 
SPSS to run collinearity diagnostics to measure the degree to which the independent 
variables related to each other. Ideally, independent variables strongly relate to the 
dependent variable and do not strongly relate to each other. To this end, I assessed 
multicollinearity using the variance inflation factors (VIF). According to Menard (2009), 
VIF values greater than 10 indicate a multicollinearity problem. The plan was that if I 
detected multicollinearity, I would remove the predictors with the highest VIF values. 
After conducting a binary logistic regression that included the key independent 
variables (i.e., knowledge of environmental and human health impact, knowledge of 
recommended disposal practices, and availability of disposal options), I conducted a 
second binary logistic regression with the demographic variables included as predictors. I 
conducted this second regression model to address Research Question 5. I evaluated this 
regression in the same manner as the first regression, then compared the second 
regression model to the initial model to determine the influence of the demographic 
variables. 
Threats to Validity 
External validity is the extent to which the results of the study may be generalized 
to other populations or contexts. Because the population under investigation included 
only residents of the northeast United States, the results of this study may not be 
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generalizable to other regions of the United States or to other countries. As indicated in 
the 2010 U.S. Census (U.S. Census Bureau, 2011), the socioeconomics characteristics of 
the northeast region of the United States include the following: 
• Median household income ($53,283), compared to the Midwest = $48,445, 
the South = $45,492, and the West = $53,142. 
• Percent in poverty level (11.8), compared to the Midwest = 13.3, South = 
15.7, and the West = 14.8 
• Number of people without health insurance coverage (11.8), compared to the 
Midwest = 12.7, the South = 19.2, and the West = 17.7 
These data illustrate that the northeast has socioeconomic characteristics more 
favorable than those of other regions. Consequently, the generalization of the results of 
this study to the general U.S. population had to be considered with caution. In fact, 
socioeconomic characteristics such as income, employment status, and health insurance 
coverage have aligned with health care use and interactions with health care professionals 
(Blackwell et al., 2009), and, by inference, may have impacted the likelihood of 
consumers receiving drug disposal information. 
Additionally, results from this study may not apply to the disposal of 
nonprescription drugs or other substances. Given the emphasis on prescription drugs in 
the national strategy to reduce the amount of pharmaceuticals in the environment, this 
study was restricted only to individuals who have used at least one prescription drug. 
However, OTC drugs, especially NSAIDs, are widely used, and, like prescription drugs, 
have the potential to pollute the environment and present a threat to human health. Thus, 
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this study is limited by excluding a sizable proportion of consumers of common 
pharmaceuticals who may be less likely than those with prescription drugs to have 
accurate knowledge of recommended disposal practices. 
The use of the Internet may also have excluded those people who are unfamiliar 
or uncomfortable with this technology. In spite of optimistic figures of a large diffusion 
of Internet use, groups of people, due to age or financial condition, may not have had the 
opportunity to be part of the population sample. The survey was in English only; 
therefore the chance exists that people who are not fluent in English did not complete it, 
and consequently it may not be known what disposal practices that population group 
uses. 
Internal validity is the extent to which the results of the study are attributable to 
the independent variables, and that the study survey measured the variables that it 
intended to measure. To increase internal validity, I pilot tested (N=65) the survey 
instrument prior to conducting the main study. Additionally, to help ensure participants 
provided honest and accurate responses, I assured participants that their responses would 
be anonymous and kept confidential. Finally, statistical-conclusion validity is the extent 
to which the results of the data analysis are statistically valid. To ensure statistical-
conclusion validity, I performed an a priori sample-size calculation to determine the 
minimum number of participants needed to obtain statistically valid results. 
Ethical Procedures 
I conducted this study in accordance with the ethical procedures required by the 
Walden University IRB. I obtained IRB approval prior to collecting any data (approval 
number 03-07-17-0129575). To protect participants’ rights, I informed each participant 
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that input in the study was completely voluntary, and that participants had the right to 
stop taking the survey at any point in time without consequence. I also informed 
participants that their responses would remain anonymous and kept confidential. In 
addition, I assured participants I am the only one with access to the data, and the data will 
be stored on my password-protected computer and backed up on a secure medium. 
Aligned with Walden University IRB procedures, the survey included information on 
participants’ rights and contact information for the IRB and me. 
Summary 
The key objective of this cross-sectional retrospective study was to attempt to 
close a knowledge gap about the disposal practices of pharmaceutical products in the 
general population. The data accrued from a convenient sample of the population residing 
in the northeast region of the United States. The key research questions explored the 
hypothesized relationship between actual disposal practices and people’s knowledge of 
appropriate disposal practices, the potential impact these practices could have on human 
health, and the availability of convenient disposal options. Although a retrospective 
cross-sectional study is, by definition, unable to establish a causal relationship, the results 
of the statistical analyses provided important insights and clues to the development of 
social-change strategies. The ultimate goal of this study was to learn how to improve 
drug disposal practices, and thus reduce the likelihood that improperly disposed 
pharmaceutical products in the environment will negatively impact human health. 
In Chapter 4, I am providing an in-depth description of the statistical analyses that 
were performed, and the interpretation of the study findings with respect to the stated 
research questions and hypotheses. 
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Chapter 4: Results 
Purpose of Study 
The purpose of this study was to assess the prescription drug disposal practices of 
adults living in the northeast United States, and how an individual’s knowledge of 
environmental and human health impact, knowledge of appropriate disposal practices, 
and locally available disposal options influence one’s disposal practices. My aim in this 
study was to identify the key factors that may influence compliance with the 
recommended disposal practices (e.g., returning unused pharmaceuticals to a pharmacy), 
so that future work can take steps to promote safe disposal practices, in turn protecting 
the environment and human health. The Walden University IRB reviewed and approved 
this study design and its survey tool on March 7, 2017. 
This chapter begins by reviewing the five research questions of interest and the 
hypotheses for each. Subsequently, I present and discuss the results of the pilot study (n = 
62), and those of the main study (n = 485). 
Research Questions and Hypotheses 
Research Question 1. Is there an association between knowledge of the 
environmental and the human-health impact of pharmaceutical disposal and actual 
disposal practices? 
H01: No significant association exists between knowledge of the environmental 




H11: A significant association exists between knowledge of the environmental and 
the human-health impact of pharmaceutical disposal and actual disposal 
practices. 
Research Question 2. Is there an association between knowledge of recommended 
disposal practices and actual disposal practices? 
H02: No association exists between knowledge of recommended disposal 
practices and actual disposal practices. 
H12: An association exists between knowledge of recommended disposal 
practices and actual disposal practices. 
Research Question 3. Is there an association between available disposal options 
and actual disposal practices? 
H03: No association exists between available disposal options and actual disposal 
practices. 
H13: An association exists between available disposal options and actual disposal 
practices. 
Research Question 4. To what degree can actual disposal practices (the 
dependent variable) be explained by the combined and differential contribution of the 
three independent variables, specifically, knowledge of the environmental and human 
health impact, knowledge of recommended disposal practices, and locally available 
disposal options? 
H04: Actual disposal practices cannot be explained to a significant degree by the 
combined and differential contribution of knowledge of the environmental and 
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the human-health impact, knowledge of recommended disposal practices, and 
locally available disposal options. 
H14: Actual disposal practices can be explained to a significant degree by the 
combined and differential contribution of knowledge of the environmental and 
the human-health impact, knowledge of recommended disposal practices, and 
locally available disposal options. 
Research Question 5. Do differences exist among RQ1, RQ2, and RQ3 across 
demographic groups? 
H05: No significant demographic differences exist in the relationships of 
knowledge of the environmental and the human-health impact, knowledge of 
recommended disposal practices, and locally available disposal options to 
actual disposal practices. 
H15: Significant demographic differences exist in the relationships of knowledge 
of the environmental and the human-health impact, knowledge of 
recommended disposal practices, and locally available disposal options to 
actual disposal practices, when controlling by demographic variables (e.g., 
age, race, education level). 
Pilot Study 
I first conducted a pilot study with two objectives: to assess the legibility of the 
questions to be used in the actual survey, and to estimate the number of respondents who 
did not meet the inclusion criteria, enabling me to adjust the study’s target sample size 
(see Appendix C). Given these objectives, only descriptive statistics and related figures 
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are being reported for the pilot study. In contrast, I employed descriptive- and inferential-
statistical procedures to address the research questions of the actual study. 
Participants 
Participants for the pilot study consisted of 71 adults aged 18 to 75 years, 37 of 
whom were female, living in the northeast United States (Connecticut, Maine, 
Massachusetts, New Hampshire, Rhode Island, Vermont, New Jersey, New York, 
Pennsylvania). Pilot participants completed the survey using the SurveyMonkey web-
based data-collection platform between April 17, 2017, and April 19, 2017. I excluded 
data from six participants (8.5% of the data) because they had not taken a prescription 
drug in the past 2 years and I excluded data from an additional three participants (4.2% of 
the data) because they did not complete the survey (see Figure 1). As a result of the 
information on these exclusions, the target sample for the study was adjusted and 
increased from 385 to 485 to account for participants potentially not meeting inclusion 
criteria or not completing the survey. 
 
Figure 1. Participants in the Pilot Study. 









Of the remaining 62 adults, the largest number were aged 30 to 44 years (see 
Figure 2). A large majority (41) of participants identified themselves as Caucasian (see 
Figure 3). More than half had completed college (n = 13) or graduate school (n = 18; see 
Figure 4). 
 
Figure 2. Pilot Study Participants by Age Group. 
Note. Percentage of total participants presented above each bar. 
 
Figure 3. Pilot Study Participants by Race/Ethnicity. 




























































Figure 4. Pilot Study Participants by Education Level. 
Note. Percentage of total participants presented above each bar. 
Survey: Assessment of Legibility 
After every survey question, participants indicated if the question was easy to 
understand. If the participant answered “no,” they had the opportunity to explain how the 
question could be improved. The vast majority of the time (96.6% of all responses for all 
questions combined), respondents indicated the question was legible. Thus, I considered 
the survey suitable to use to collect a full sample, with only minor changes in wording. 
Figure 5 depicts, for each question, the percentage of respondents who considered the 
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Figure 5. Legibility Assessment by Question. 
 
Data Collection 
A total of 681 individuals completed the survey using the SurveyMonkey web-
based data-collection platform between April 21 and 24, 2017. Of the total number of 
respondents, 515 met the inclusion criteria: they were at least 18 years of age, had taken a 
prescription drug in the past 2 years, and resided in the northeast United States. Data 
from an additional 30 respondents were excluded for not completing the survey in its 
entirety. 
0% 10% 20% 30% 40% 50% 60% 70% 80% 90%100%
Inclusion questions (Q1-Q3)
Actual Disposal Practices (Q6)
Availability of Disposal Options 1 (Q9)
Availability of Disposal Options 2 (Q12)
Knowledge of Environment &  Health Impact
(Q15)
Knowledge of Disposal Practices 1 (Q18)
Knowledge of Disposal Practices 2 (Q21)
Knowledge of Disposal Practices 3 (Q24)
Knowledge of Disposal Practices 4 (Q27)
Demographic questions (Q30-Q34)




Thus, the final sample consisted of 485 participants. This target sample size is 
above the previously calculated one of 385 and can be considered representative of the 
target population. The target 95% confidence level and the 5% margin of error remained 
unchanged. Survey participants were aged 19 to 87, 265 of whom were female. Of these 
485 adults, 174 were aged 60 or older (see Figure 6). Identified as Caucasian were 410 of 
the 485 participants (see Figure 7). A third had completed college (n = 105) and a quarter 
had a graduate degree (n = 122). By state of residence, 39 participants lived in 
Connecticut, 19 in Maine, 78 in Massachusetts, 20 in New Hampshire, 79 in New Jersey, 
138 in New York, 94 in Pennsylvania, 8 in Rhode Island, and 9 in Vermont (1 declined to 
respond). Graphical representation of the study’s key demographic variables follows: 
 
Figure 6. Study Participants by Age Group. 































Figure 7. Study Participants by Race/Ethnicity. 
Note. Percentage of total participants presented above each bar. 
 
Figure 8. Study Participants by Education Level. 
Note. Percentage of total participants presented above each bar. 
84.5% 




























































After providing a description of the sample and its demographic characteristics in 
the previous sections, Table 1 shows the study variables and their attributes, as they were 
used in the data-analysis process. 
Table 1 
Dependent and Independent Variable Key Characteristics 
Variable name 
Dependent/ 






Dependent Dichotomous categorical ADP Coded as either “recommended 









Ordinal KEH Represents knowledge and 
beliefs regarding impact of 
medications disposal practices 






KDP1 = Dichotomous 
Categorical 
KDP2 = Dichotomous 
Categorical 
KDP3 = Ordinal 
KDP4 = Dichotomous 
Categorical 
KDP1–4 The survey had four questions 
addressing knowledge of 
disposal practices, hence 





ADO1 = Dichotomous 
Categorical 
ADO2 = Ordinal 
ADO1–2 The survey had two questions 
addressing the availability of 
disposal options, hence variable 
names: ADO1–2. 
Note. ADP = actual disposal practices. 
Descriptive Statistics 
Descriptive statistics for the dependent variable as well as each independent 
variable are presented here, with missing data discussed. 
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Actual disposal practices (ADP). Responses to the question, “What is your most 
used method for disposing of unused or expired medications?” represented the dependent 
variable of interest, ADP. I coded the eight possible response options either as a 
recommended disposal practice (I return them to the pharmacy or to another designated 
take-back location, I mix them with coffee grounds or kitty litter or dirt and then in the 
trash, using a non-permeable container to avoid spill, I follow the disposal instructions 
that accompany the medicine, Not applicable—I always take my medications as 
prescribed; n = 226) or un-recommended disposal practice (I flush them down the toilet, I 
rinse them down the sink drain, I simply put them in the trash, I store them in my house 
for possible future use of family or friends, Other; n = 259). Therefore, I treated ADP in 
all analyses as a dichotomous categorical variable. 
Knowledge of environment and human health impact (KEH). I coded 
participants’ responses to the question, “Do you believe that improper disposal of 
medications in the environment could have negative consequences on human health?” on 
an ordinal scale to represent the independent variable Knowledge of Environment and 
Human Health Impact. Participants had four possible response choices: Not sure—no 
idea (n = 25), No—not at all (n = 174), Yes—somewhat (n = 158), and Yes—definitely (n 
= 228). 
Knowledge of disposal practices (KDP1–4). Participants answered four 
questions that represented the independent variable Knowledge of Disposal Practices. 
The first question (KDP1) was, “To your knowledge, are there any local, or state, or 
federal guidelines for the proper disposal of unused or expired medications?” I treated 
responses as a dichotomous categorical variable: No/I don’t know (n = 350) or Yes (n = 
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135). I treated responses to the second question (KDP2), “Do you know what the current 
recommended disposal practices are?” as a dichotomous categorical variable, with 
possible answer choices being No (n = 185) and Yes (n = 300). The third question 
(KDP3) asked, “How often has a health care provider informed you about the proper way 
to dispose of your unused or expired medications, in the past two years?” I treated 
responses to this question as an ordinal variable with four levels: Never (n = 421), 
Sometimes (n = 41), Often (n = 13), and Always (n = 10). Finally, Question 4 (KDP4) 
asked, “Are you aware of any promotion material (such as pamphlets, posters, web info) 
that deal with the proper disposal of unused or expired medications?” Respondents had 
two possible response options, No (n = 375) and Yes (n = 110), making this a 
dichotomous categorical variable. 
Availability of disposal options (ADO1–2). Responses to two questions 
represented the independent variable Availability of Disposal Options. The first question 
was, “In your area, is there a designated collection location where you can dispose of 
your unused or expired medication?” I treated responses to this question (ADO1) as a 
dichotomous categorical variable with possible responses of No/I don’t know (n = 350) 
and Yes (n = 185). I also treated responses to the second question (ADO2), “How 
convenient is it for you to reach the designated disposal location?” as an ordinal variable 
with three levels: Almost impossible to reach (n = 6), It takes some effort (n = 76), and 
Convenient (n = 128). Due to the high amount of missing data for variable ADO2 (n = 




I chose a binary logistic regression as the statistical method to answer Research 
Questions 1–4, with ADP as the dependent variable and KEH, KDP1-4, and ADO1 as 
independent variables. A binary logistic regression assumes independence of errors, 
which was true for the present data, as each case represents a single unrelated participant. 
Additionally, a binary logistic regression assumes that none of the independent variables 
in the present data set highly correlated with one another. To assess whether 
multicollinearity was an issue in the present data set, I obtained the VIF and tolerance 
statistics, as suggested by Zuur, Ieno, and Elphick (2010). As shown in Table 2, all VIF 
values were well under 10 and tolerance values were more than 0.1, thereby indicating 
that multicollinearity was not an issue (Bowerman & O’Connell, 1990; Myers, 1990), 
and the analysis could proceed. 
Table 2 
Questions 1–4: Variance Inflation Factors and Tolerance Values 
Variable VIF Tolerance 
KEH 1.053 0.950 
KDP1 1.201 0.832 
KDP2 1.186 0.843 
KDP3 1.162 0.860 
KDP4 1.223 0.818 
ADO1 1.216 0.822 
 
Research Question 5 asked whether ADP differ by demographic group. Thus, I 
conducted an additional binary logistic regression with the demographic variables of 
gender, race, education, and age included. To assess multicollinearity for this model, I 
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carried out VIF and tolerance statistics. The obtained values indicated that the variable, 
age, was causing an issue with perfect collinearity and the VIF statistics could not be 
computed. Consequently, I removed this variable from further analyses. The VIF and 
tolerance statistics for a model without age appear in Table 3 and indicate that 
multicollinearity is not an issue for this model (i.e., VIF values are below 10 and 
tolerance values are above 0.1). 
Table 3 
Question 5: Variance Inflation Factors and Tolerance Values 
Variable VIF Tolerance 
KEH 1.223 0.818 
KDP1 1.217 0.821 
KDP2 1.211 0.825 
KDP3 1.282 0.780 
KDP4 1.253 0.798 
ADO1 1.261 0.793 
Gender 1.375 0.727 
Race 1.948 0.513 
Education 1.849 0.541 
 
Research Questions 1–4 
To determine whether KEH, KDP, or ADO align with ADP (Research Questions 
1–4), I performed a binary logistic regression with ADP as the dependent variable and 
KEH, KDP1–4, and ADO1 as the independent predictor variables. Logistic regression is 
the ideal tool for modeling a binary-response variable; in this case ADP, which can be 
either categorized as “recommended disposal practices” or “unrecommended disposal 
practices” on the independent variables KEH, KDP1–4, and ADO1. I used the Hosmer–
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Lemeshow test, best suited for a sample size greater than 400, to assess the goodness of 
fit of the model (Bewick, Cheek, & Ball, 2005). Table 4 shows the result of the model 
analysis. 
Table 4 
Actual Disposal Practices and Knowledge of Environment and Human-Health Impact, 
Knowledge of Disposal Practices 1–4, and Availability of Disposal Options 
Variable B SE p 95% confidence intervals 
Constant -2.937 0.453 < .001 0.021 0.126 
KEH 0.724 0.129 < .001 1.612 2.670 
KDP1 0.280 0.258 .278 0.799 2.200 
KDP2 0.685 0.231 .003 1.262 3.122 
KDP3 -0.114 0.203 .575 0.607 1.353 
KDP4 0.137 0.281 .626 0.661 1.200 
ADO1 0.970 0.241 < .001 1.652 4.253 
Note. Model as a whole: R2 = .171 (Hosmer–Lemeshow). Model X2(6) = 114.522, p < .001, Table shows 
the unique impact of each predictor toward explaining ADP, KEH = knowledge of environment and 
human-health impact, KDP = knowledge of disposal practices, ADO = availability of disposal options. 
Research Question 1 asked whether ADP align with an individual’s KEH. The 
regression analysis indicated a significant and positive relationship between the variables 
ADP and KEH (p < .001), in line with hypothesis H12. People who believe that 
improperly disposed pharmaceuticals will harm the environment or human health are 
more likely to practice recommended disposal practices. This trend can be further 




Figure 9. Proportion of Actual Disposal Practices by Knowledge of Environment and 
Human Health Impact. 
Note. Error bars represent -/+ 1 standard error of the mean. 
Research Question 2 asked whether an individual’s KDP aligns with their ADP. 
The results of the regression show partial support for Hypothesis H12; three of the four 
variables meant to represent KDP do not significantly align with ADP. Specifically, those 
are KDP1 (“To your knowledge, are there any local, or state, or federal guidelines for the 
proper disposal of unused or expired medications?”), KDP3 (“How often has a health 
care provider informed you about the proper way to dispose of your unused or expired 
medications, in the past two years?”), and KDP4 (“Are you aware of any promotion 
material (such as pamphlets, posters, web info) that deal with the proper disposal of 






































recommended disposal practices are?”) did significantly and positively align with ADP 
(p = .003, see Table 4). Figures 7–10 display the relationships between ADP and KDP1, 
KDP3, KDP4, and KDP2. However, only KDP2 significantly aligned with ADP. 
 
Figure 10. Proportion of Actual Disposal Practices by KDP1. 
Note. Answering, “To your knowledge, are there any local, or state, or federal guidelines 
for the proper disposal of unused or expired medications?” Error bars represent -/+ 1 







































Figure 11. Proportion of Actual Disposal Practices by KDP2. 
Note. Answering “Do you know what the current recommended disposal practices are?” 







































Figure 12. Proportion of Actual Disposal Practices by KDP3. 
Note. Answering “How often has a health care provider informed you about the proper 
way to dispose of your unused or expired medications, in the past two years?” Error bars 







































Figure 13. Proportion of Actual Disposal Practices by KDP4. 
Note. Answering  “Are you aware of any promotion material (such as pamphlets, posters, 
web info) that deal with the proper disposal of unused or expired medications?” Error 
bars represent -/+ 1 standard error of the mean. 
Research Question 3 concerns the hypothesized association between ADP and 
ADO (as measured by the question “In your area, is there a designated collection location 
where you can dispose of your unused or expired medication?”). The regression model 
shows a significant positive relationship between ADP and ADO (p < .001, see Table 4). 
Participants who were aware of the existence of a designated pharmaceutical-collection 
location were more likely to practice recommended disposal practices, in line with 







































Figure 14. Proportion of Actual Disposal Practices by Available Disposal Options. 
Note. Error bars represent -/+ 1 standard error of the mean. 
Research Question 4 asked to what degree variance in ADP can be explained by 
the three independent variables KEH, KDP, and ADO. The results of the regression 
model showed that, in support of Hypothesis H14, ADP is predicted significantly better 
by a model that includes KEH, KDP, and ADO as compared to a model that includes the 
intercept only (i.e., a model without the predictor variables), X2(6) = 114.522, p < .001, 
R2 = .171. 
Research Question 5 
Research Question 5 asked whether ADP varied by demographic variables. To 
that purpose, I conducted a binary logistic regression with ADP as the dependent variable 






































variables. As shown in Table 5, the model is not significantly better than a model without 
the demographic variables included, X2(16) = 21.994, p = .143, R2 = .033. Thus, I 
concluded that no demographic differences exist in the present data set, in line with 
Hypothesis H05.  
Table 5 
Model Coefficients for Logistic Regression  
Variable B (SE) SE p 95% Confidence Intervals 
Constant -2.331 2.834 .411 0.001 40.122 
KEH 0.844 0.143 <.001 1.769 3.105 
KDP1 0.290 0.266 .276 0.794 2.258 
KDP2 0.673 0.239 .005 1.227 3.140 
KDP3 -0.222 0.216 .306 0.530 1.247 
KDP4 0.283 0.292 .332 0.750 2.365 
ADO1 0.943 0.251 <.001 1.575 4.229 
Gender: Female 0.610 2.812 .828 0.020 741.364 
Gender: Male 1.199 2.812 .670 0.037 1357.401 
Race: American Indian -0.663 2.438 .786 0.004 63.113 
Race: Asian/Pacific Islander -0.704 1.938 .717 0.009 22.952 
Race: Black or African American -0.761 1.756 .665 0.011 14.818 
Race: Hispanic -2.489 1.823 .172 0.002 2.889 
Race: Other -0.446 1.821 .806 0.014 23.011 
Race: Prefer not to answer -0.696 1.749 .691 0.012 15.537 
Education: Completed graduate 
school  -1.134 
1.317 .389 0.013 3.336 
Education: Some graduate school -0.610 1.380 .659 0.020 6.537 
Education: Completed College -1.133 1.315 .389 0.013 3.316 
Education: Some college -0.456 1.320 .730 0.025 6.653 
Education: Completed high 
school -0.833 
1.340 .534 0.017 4.733 
Education: Some high school -1.920 2.057 .351 0.002 7.761 
Education: Prefer not to answer 0.045 1.626 .978 0.028 23.822 
Note. KEH = knowledge of environment and human-health impact, KDP = knowledge of disposal 
practices, ADO = availability of disposal options. R2 = .033 (Hosmer-Lemeshow). Model X2(16) = 21.994, 
p = .143. 
136 
 
Kruskal–Wallis Rank-Sum Test (Nonparametric Equivalent of One-Way ANOVA) 
An additional set of analyses determined whether ADP differed across levels of 
individual demographic variables, irrespective of other factors. I ran a series of one-way 
ANOVAs, one for each demographic variable (education, race, age, and gender) with 
ADP as the dependent variable. I considered only the 453 participants who had provided 
responses for the four demographic questions for inclusion in the analyses. However, 
ANOVA procedures can be effectively carried out if the two key assumptions are met: 
homogeneity of variances and normal distribution of the residuals of the dependent 
variable at each level of the independent one. I assessed the assumption for homogeneity 
of variances using Levene’s tests (Levene, 1960). These tests provided a p value greater 
than .05 (statistically nonsignificant), indicating that the assumption was met for all 
planned analyses (see Table 6). I assessed the ANOVA assumption for normal 
distribution of the residuals of the dependent variable at each level of the independent 
variable using Shapiro–Wilk tests. The obtained p values were smaller than .05 
(statistically significant), indicating that this assumption was violated in all cases (see 
Table 7). Consequently, I could not use the ANOVA procedure and conducted the 
Kruskal–Wallis rank-sum tests—the nonparametric equivalent of the one-way 
ANOVA—instead. 
The Kruskal–Wallis test with education as the independent variable and ADP as 
the dependent variable did not reach significance, 𝜒𝜒2(5) = 4.811, p = .439, suggesting that 
pharmaceutical disposal practices do not differ by education level (see Figure 15). The 
corresponding Kruskal–Wallis test for race was also nonsignificant, 𝜒𝜒2(5) = 6.286, 
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p = .279, indicating that the race of an individual does not affect pharmaceutical disposal 
practices (see Figure 16). 
Table 6 
Levene’s Tests for Demographic Changes in Actual Disposal Practices 
 df F p 
Education 6 0.491 .783 
Race 6 0.710 .616 
Age 3 0.410 .746 
Gender 1 0.557 .456 
 
Table 7 
Shapiro-Wilk Tests for Demographic Changes in Actual Disposal Practices 
 W p 
Education 0.721 < .001 
Race 0.672 < .001 
Age 0.723 < .001 





Figure 15. Actual Disposal Practices by Education Level. 
Note. Error bars represent -/+ 1 standard error of the mean. 
 
Figure 16. Actual Disposal Practices by Race. 














































































The Kruskal–Wallis test with age as the independent variable and ADP as the 
dependent variable did not reach significance, 𝜒𝜒2(3) = 5.789, p = .122 (see Figure 17). In 
other words, ADP did not vary across age groups. Finally, the Kruskal–Wallis test for 
gender indicated that ADP did not differ between men and women, 𝜒𝜒2(1) = 0.557, p 
= .455 (see Figure 18). 
 
Figure 17. Actual Disposal Practices by Age Group. 







































Figure 18. Actual Disposal Practices by Gender. 
Note. Error bars represent -/+ 1 standard error of the mean. 
In conclusion, the Kruskal–Wallis rank-sum test confirmed the results obtained 
using the logistic regression procedure. In the sampled population, the demographic 
variables (i.e., education level, age, ethnicity, gender) do not have a significant impact on 
people’s behavior with respect to their disposal practices of unwanted pharmaceuticals. 
Summary 
The results of a large-scale survey spanning the northeast United States showed 
significant associations between an individual’s knowledge of environmental and human-
health impacts, knowledge of recommended disposal practices, and locally available 
disposal options, with a person’s likelihood to practice recommended pharmaceutical 






































disposal practices, the environmental and health impacts of improper disposal, and who 
live in an area with official disposal options are more likely to practice recommended 
disposal of prescription drugs. These three factors significantly predict an individual’s 
likelihood to practice recommended prescription-drug disposal. Moreover, these 
relationships are stable across various demographic groups, suggesting no specific group 
should be targeted with, for example, promotional material explaining how to properly 
dispose of unwanted pharmaceuticals. Rather, interventions may seek to focus on 
increasing knowledge of environmental and health impact for people of all demographics, 
as well as increasing the availability of official disposal locations. 
In the next chapter, I discuss the findings of the study through the perspective of 
the conceptual framework, the implications for social change, and recommendations for 
potential actions. In addition, I discuss the limitations of the study and provide 
recommendations for future research. 
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Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
For decades, recommendations for disposing of unused or expired medications 
were guided by concerns about inadvertent or intentional poisoning. Flushing them down 
the toilet or rinsing them down the drain were considered safe and simple ways to dispose 
of unwanted drugs (McCullagh et al., 2012; Ortner & McCullagh, 2010). A 2008 report 
entitled PharmaWater I (Donn, Mendoza, & Pritchard, 2008) described how at least 41 
million Americans were served by water supplies with evidence of pharmaceuticals 
including anticonvulsants, antibiotics, mood stabilizers, and hormones. Researchers have 
documented the consequences of pollution by pharmaceuticals on the environment’s 
ecosystems and its potential effects on human health and studied the disposal practices of 
specific populations (e.g., nurses and pharmacists). However, a gap existed in the 
scholarly literature regarding the disposal practices for pharmaceuticals in the general 
population. 
I conducted this study to address the disposal practices of unused or expired 
prescription medications in a sample of the general population residing in the northeast 
United States. In this study, I examined people’s disposal practices, local availability of 
disposal options, awareness of proper disposal practices, and the potential correlations 
between people’s ADP and their knowledge of the impact that disposal practices may 
have on the environment and human health. 
My aim in this study was to identify the key factors that may influence 
compliance with the recommended disposal practices (e.g., returning unused 
pharmaceuticals to a pharmacy), so future work can take steps to promote safe disposal 
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practices. My final goal for this study was to acquire the necessary data to support a 
social-change strategy that could translate into an actual behavioral shift. To select an 
appropriate study design, I had to identify a conceptual framework so research questions 
could align with time-tested behavioral models. To this end, an extensive literature 
review pointed to the HBM and the TPB to support the behavior-inquiry aspect of this 
study. The HBM was applicable for its approach in defining barriers to the adoption of 
health-related behavior (Strecher & Rosenstock, 1997). The TPB was relevant from the 
perspective of motivation factors that precipitate the intention to perform an action or 
behavior (i.e., proper disposal practices). In summary, the HBM and the TPB conceptual 
frameworks guided the development of the study design and the survey tool for data 
collection. 
I used a cross-sectional approach to investigate measurable hypothesized 
associations at a specific point in time, despite the difficulties in definitively determining 
cause–effect relationships (Pine et al., 1997). The research questions, and the key 
findings of the study follow: 
Finding 1 
RQ1: Is there an association between knowledge of the environmental and the 
human-health impact of pharmaceutical disposal and actual disposal 
practices? 
Greater knowledge of the environmental and health threats resulting from 




RQ2: Is there an association between knowledge of recommended disposal 
practices and actual disposal practices? 
Greater knowledge of recommended disposal practices aligned with higher rates 
of proper disposal practices. 
Finding 3 
RQ3: Is there an association between availability of disposal options and rates of 
actual disposal practices? 
Having safe disposal options available aligned with higher rates of proper 
disposal practices. 
Finding 4 
RQ4: To what degree can actual disposal practices (the dependent variable) be 
explained by the combined and differential contribution of the three 
independent variables: knowledge of the environmental and human health 
impact, knowledge of recommended disposal practices, and locally available 
disposal options? 
A statistically significant model using the independent variables (predictors) 
combined, and differential contribution of knowledge of the environmental and health 
impact, knowledge of recommended disposal practices, and locally available disposal 
options could predict the dependent variable: participants’ disposal practices. These 
findings suggest that participants’ disposal practices aligned with the combined 




RQ5: Do differences exist among RQ1, RQ2, and RQ3 across demographic 
groups? 
No significant differences emerged with respect to knowledge of the 
environmental and human-health impact of pharmaceuticals, knowledge of recommended 
disposal practices, and locally available disposal options across demographic variables. 
Discussion 
The purpose and the results of this study need to be viewed through the optics of a 
larger context. Environmental contaminants generated by the inappropriate disposal of 
prescription drugs by consumers may be merely a portion of the total pharmaceutical 
contaminants that reach the environment through various routes. The results of this study 
suggested that social and organizational programs need to take appropriate steps, 
discussed in this chapter, to facilitate broad social change and improve disposal practices. 
In practice, pharmaceutical companies and governmental agencies, at federal and local 
levels, will need to demonstrate their commitment to social responsibility by ensuring the 
entire development and marketing lifecycle of pharmaceutical products are controlled and 
pose minimal environmental and human-health risks. In line with these considerations, 
Daughton (2014a) considered the lifecycle development by defining upstream and 
downstream approaches to minimizing environmental contamination by pharmaceutical 
products. 
The upstream approach consists of minimizing the amount and toxicity that a 
given pharmaceutical product would release when discarded in the environment. From 
the upstream approach, pharmaceutical companies should prioritize adopting the so-
146 
 
called green pharmacy or ecofriendly pharmacy” in their development portfolio to adopt 
and design drugs with maximum absorption potential, ensuring that smaller traces would 
be excreted in the environment. For drugs currently on the market, an upstream approach 
would leverage on the social responsibility of pharmaceutical companies in various 
activities to improve patient adherence to the prescribed drug regimen. For example, field 
staff, during their routine interactions with health care personnel (e.g., physicians and 
nurses), could promote not only the drugs, but also the drugs’ optimal disposal practices. 
The downstream approach focuses on promoting the safe and proper disposal of 
unused, unwanted, and expired medications (Ruhoy & Daughton, 2008). From a social-
change perspective, this approach would leverage on the social responsibility of local 
health departments to ensure they have the budget and the resources to support drug take-
back programs, media campaigns on proper disposal practices, and conveniently located 
disposal options (e.g., malls, supermarkets, pharmacies, and post offices). To ensure 
consistency, various stakeholders—local health departments, schools, pharmacies, 
hospitals, clinics, and health care providers—would coordinate effort to communicate 
strategy on drug disposal standards that clearly align with current research. Such 
strategies should be designed to be easily adaptable to change, and customizable to local 
as well as specific populations’ needs. 
The HBM and the TPB conceptual-framework models were quite helpful in the 
design of this study. The HBM model, which has been used in previous studies of 
environmental and health-related behaviors, was employed in the past to explore how 
consumers perceive the potential benefits of safe pharmaceutical disposal at take-back 
centers. Perceived barriers crucially limit the likelihood of safe disposal practices as well 
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as other health-related preventive behaviors (Strecher & Rosenstock, 1997), a finding 
confirmed by this study. In the TPB model, ethical norms (Cote et al., 2012) are key 
predictive factors. The TPB model relates to the motivations that trigger certain 
environmental behaviors; in the present study, I used the TPB to explore and identify 
factors that may precipitate, inhibit, or be of no consequence to specific drug disposal 
practices. One key finding from this study was that the ease of access to disposal options 
increases the likelihood of proper disposal. This finding is consistent with the outcome of 
Ruhoy’s (2009) study, determining that the ready availability of medication disposal 
options was a significant predictor of safe medication disposal behaviors. Similarly, Ma 
et al. (2014) found that the majority of participants in a take-back program in Hawaii 
would have discarded drugs improperly without this program and the instructions 
received on best practices, again underscoring the significance of convenient safe 
disposal options and clear disposal instructions as predictors of safe disposal practices. 
Examining prior research conducted on drug disposal helps provide context for 
the interpretation of the present study findings. For example, Gray and Hagemeier (2012) 
surveyed 752 participants in the Appalachian regions of Tennessee and Virginia between 
2009 and 2011. The researchers considered demographic factors such as race, age, and 
gender, along with reasons for participation in the take-back program. Gender stood out 
as a demographic factor predicting higher return rates, as more women than men 
participated in the take-back program (Gray & Hagemeier, 2012). This result stands in 
contrast to the present study, in which particular demographic factors did not align with 
higher rates of safe disposal practices. 
148 
 
The present study supported the finding of Kotchen et al. (2009), who determined, 
in a survey of consumers in California, that those with higher levels of environmental 
awareness were more likely to practice safe disposal. Comparing the rates of safe 
disposal in Sweden and Poland underscored this study’s findings regarding the 
significance of environmental awareness, knowledge of safe disposal methods, and 
available safe disposal options in predicting environmentally sound disposal behaviors 
(Zimmermann et al., 2011). In addition to the United States, several European countries, 
Australia, and New Zealand have initiatives in place to safely dispose of unused drugs 
(Ruhoy & Daughton, 2008). Swedish consumers have high levels of environmental 
awareness and knowledge of safe disposal methods due to effective public education 
campaigns by a government-owned pharmacy chain with a convenient take-back 
program; as a result, more than 70% of Swedish consumers with unused drugs returned 
them to local pharmacies. In Poland, in contrast, consumers had lower levels of 
environmental awareness and few safe disposal options, resulting in high rates of unsafe 
drug disposal (Zimmermann et al., 2011). 
A high degree of knowledge about environmental impacts has not always resulted 
in optimal disposal practices. Even trained, knowledgeable health care professionals such 
as pharmacists (Abahussain et al., 2012) and nurses (McCullagh et al., 2012) did not 
always practice safe drug disposal, underscoring that knowledge is not invariably the 
only driving force in behavior change (Bandura, 1997; Nisbet & Gick, 2008; Strecher & 
Rosenstock, 1997). Seehusen and Edwards (2006), who surveyed 301 consumers at a 
medical center in Washington State, discovered gaps between knowledge and safe 
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disposal practice, and highlighted the lack of access to safe disposal options in reducing 
the likelihood of safe disposal practices. 
Implications of the Findings: Potential Impact for Social Change 
The envisioned outcome of this research is to inspire positive social change by 
improving the rates of safe pharmaceutical disposal, and, in doing so, increase the ease 
and availability of safe disposal options, enhance patient adherence to medication 
recommendations, and advocate for “green pharmacy”, all of which will help protect the 
environment and reduce the risks to human health. One key finding of the present study 
was that the availability of safe medication disposal options was a significant predictor of 
safe medication disposal behaviors. This finding confirmed the research of Ruhoy and 
Kaye (2010), who investigated a program in Maine called Safe Medicine Disposal and 
found that convenient safe disposal options predicted a higher likelihood of safe disposal 
practices. In Maine, a state in the present study’s geographic focus that was hard hit by 
the opioid crisis and high death rates from prescription medication (Stewart et al., 2015), 
patients were able, through this drug take-back program, to anonymously mail back 
medications at no cost. The program was remarkable for providing an easily available 
option for medication disposal, and also provided helpful data on returned drugs and 
program participants (Ruhoy & Daughton, 2008). Significantly, without the program, the 
majority of participants indicated they would have either disposed of the unused 
medications by flushing them down the toilet or throwing them away in the trash. Ruhoy 
and Kaye concluded that Safe Medicine Disposal for ME was a user-friendly, low-cost, 
effective program that could serve as a model for initiatives elsewhere. The research, 
150 
 
then, is clear about the importance of taking steps to ensure safe, convenient disposal 
methods in promoting the envisioned social change. 
The key findings of the present study have advanced knowledge of a significant 
public health and environmental problem by demonstrating, in the general population of 
the northeast United States, the significant association between the dependent variable 
(recommended methods of pharmaceutical disposal) and the three dependent variables: 
knowledge of the impact of unused prescription drugs on the environment and human 
health, knowledge of best practices in drug disposal, and easily available, user-friendly 
disposal options. No significant associations emerged between demographic factors and 
pharmaceutical disposal practices; rather, consistency arose across the demographic 
cohorts surveyed. Key findings confirmed the importance of knowledge of environmental 
and health impacts, safe disposal practices, and availability of user-friendly take-back 
programs and disposal options in increasing adherence to recommended pharmaceutical 
disposal practices. 
This study extends knowledge of disposal practices to the general population of 
the northeast United States and complements findings previously obtained in studies 
conducted in specific populations (e.g., nurses and pharmacists) in other regions of the 
United States. Recommendations for practice include promoting awareness of the impact 
of improperly disposed pharmaceuticals on the environment and human health across 
demographic cohorts, and promoting user-friendly return programs and disposal 
locations. The potential impact for positive social change at the levels of individuals, 
families, organizations, and policymaking is significant. With safer disposal methods 
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involving multiple stakeholders, the harm caused by improper pharmaceutical disposal to 
the environment and to public health will diminish. 
The data for this study was collected by administering an Internet questionnaire to 
a sample of adult residents of the northeast United States who had taken a prescription 
medication within the previous 2 years. I designed the study to learn about the disposal 
practices in the general population, and how these practices could be linked to people’s 
knowledge of the environmental and health effects resulting from improper disposal. It 
was also important to explore the degree to which the availability of locally available 
disposal options could be linked to disposal practices. By studying current disposal 
practices in the sample and learning about what promotes or inhibits the likelihood of 
safe disposal practices, this study has contributed to a better understanding of the problem 
and to ways to increase a collective social-change process. 
The ultimate goal of this study was to provide the data, and the rationale to 
promote a series of actions, including additional research, that encompass a broad 
strategy, at multiple organizational and functional levels, in both the private and public 
domains. The strategy for optimal disposal will have to include broad public education 
campaigns aimed at all demographic groups, as well as to health care providers. Equally 
important, the strategy will have to engage pharmaceutical companies, policymakers, and 
the DEA, for providing the budgets and the scientific support for a coordinated, effective, 
and efficient approach at reducing and ultimately eliminating the human health risk 
associated with pharmaceutical entering the environment. Educating the public on the 
risks of improper disposal is not enough. There has to be an infrastructure (i.e., scientific, 
organizational, budget, staff) in place to adequately sustain and monitor the health of our 
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environment, which directly and indirectly supports human health, and the life of the eco-
systems that sustain global health on the planet. 
Limitations of the Study 
I adapted a questionnaire administered online by SurveyMonkey, using items by 
Seehusen and Edwards (2006), following these authors’ formal approval (see Appendix 
A). Given widespread Internet use and availability, an online questionnaire was ideal for 
this study, though some authors have noted that some cohorts of Americans may lack 
access to the Internet (Cottrell & McKenzie, 2010). 
This study had some limitations and the results may be generalizable with 
caution. The northeast United States has unique demographic factors, such as more 
favorable socioeconomic characteristics (U.S. Census Bureau, 2011), that may limit to 
the degree to which it may be possible to generalize the results of this study to other 
geographic regions of the United States or to other countries. Researchers have cited the 
role of socioeconomic factors such as income and health insurance coverage in 
individuals’ interactions with the health care system (Blackwell et al., 2009), which, in 
turn, may impact the information they receive about recommended pharmaceutical 
disposal. This study was also limited to prescription drug disposal practices; therefore, 
the study generated no new information about disposal practices pertaining to widely-
used OTC drugs, which also impact the environment and human health. Because this 
study involved an Internet survey in English, two subpopulations—those who do not use 
the Internet and individuals with limited English—were excluded from the population 
sample and no new knowledge was gained about their disposal practices. 
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In spite of these limitations, this study surveyed a significant sample of the 
general population of the northeast; the target sample size was exceeded by 100 
participants, as 485 successfully completed the survey compared to the calculated target 
sample of 385. Furthermore, I successful examined the survey’s content validity by using 
a pilot survey, and addressed validity of the statistical conclusions by assessing, a priori, 
the assumptions of the statistical tests leading to the acceptance or rejection of the null 
hypotheses and answering the research questions. 
This study’s theoretical framework involved the use of the HBM and TPB 
models. The study was innovative in bridging the knowledge gap between health and 
environmental behavior. Despite being related fields, models used to study health 
behavior change have not often been used in environmental studies (Nisbet & Gick, 
2008). 
Recommendations for Future Research 
When considering the original scope of this study, its research questions, findings, 
and potential limitations, a number of future lines of research have emerged. In the 
northeast, new studies could be carried out to determine which kinds of public-education 
campaigns are particularly effective, when, as noted, becoming more knowledgeable does 
not invariably lead to behavioral change. Researchers could study which messages, and in 
which contexts (e.g., schools, pharmacies, hospitals, and health departments) are most 
effective in promoting environmentally sound disposal behaviors that focus on increasing 
knowledge of the environmental and health impact, recommended disposal practices, or 
awareness of safe disposal locations. 
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Researchers could conduct comparative studies in other regions of the United 
States in order to address regional or population specific needs. The comparative context 
could be extended further, with additional studies conducted across countries; ideally 
coordinated on a global basis, such studies could use the same study design and protocol 
to ensure results could be easily compared. Other populations to consider might be 
consumers in developing nations where pollution and public health threats are serious 
problems and environmental awareness is low. Previous studies have focused largely on 
North America, Western Europe, and Australia and New Zealand. Researchers could use 
other research designs, such as interviews, focus groups, rather than Internet surveys, to 
investigate drug disposal practices in developing nations where fewer people have access 
to the Internet. 
The EPA has been tracking pharmaceutical contaminants in public water systems 
(in addition to other chemicals used in commerce, agriculture, etc.) in their “Contaminant 
Candidate List 4-CCL4,” as part of the EPA’s Federal Register Notices (EPA, 2016). 
However, these contaminants are not subject to any national regulation or policy aiming 
at reducing them. Future researchers should target this list of contaminants not only to 
assess their public health impact, but also to discern the potential synergistic effect that 
several contaminants may have when reacting with one another in the same medium (e.g., 
potable water). As noted by the EPA, this synergistic impact is currently unknown, as is 
its potential impact on human health. 
Summary and Conclusion 
Ultimately, the main goal of this study was to promote positive social change by 
using research-based evidence to address the knowledge gap on drug disposal in the 
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general population, and facilitate the development of strategies that aim at the protection 
of the environment, and minimize human health impact. A range of constituencies, from 
consumers to health care professionals, health and environmental policymakers, and 
leaders of pharmaceutical companies could be interested in this study’s findings. The 
greater the knowledge of the environmental and health impact, of recommended disposal 
practices, and the availability of convenient disposal options, the greater the likelihood 
that safe disposal methods will be implemented effectively and efficiently. 
Although the contamination from prescription drugs is only a small portion of the 
contaminants that reach and harm the environment, their dissemination remains an issue 
that has the potential to impact human health. In retrospect, given the analyses conducted 
in this study, the mitigation to this problem area is not difficult and could be achieved if 
the appropriate social change were implemented at various levels and across key 
stakeholders. Pharmaceutical companies should demonstrate their corporate 
responsibility and focus on the green pharmacy drug development process. Local and 
federal agencies need to provide the policies, budget, resources, and guidance to facilitate 
optimal disposal practices thru education and logistical solutions. Finally, consumers 
need to comply with the prescribed medication regimen to optimize efficacy and lessen 
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